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TO MY MOIHER AND FATHER
SUMMARY
The r a t  and human p reg n a n t m yom etrium  and human p la c e n t a ,  when 
chopped and in c u b a te d  in  T r is - b u f f e r e d  s a l i n e  (25%, 50% & 50% w /v  
r e s p e c t iv e ly )  r e le a s e d  m a t e r ia l s  w ith  a n t i-a g g r e g a to r y  a c t iv i t y .  The 
m y o m étr ia l a c t i v i t i e s  w ere  s t a b l e  a t  pH 1 2 .0 , and u n s t a b le  a t  pH 4 .0 .  
Optimum c o n d i t io n s  fo r  th e  r e le a s e  o f th e  a n ti-a g g r  egatory  a c t i v i t i e s  
w ere 1 5 , 30  and 15 m in u te s  in c u b a t io n  r e s p e c t iv e ly  a t  20°C a t  pH 8 .0 . 
The r e l e a s e  o f  a n t i - a g g r  e g a to r y  a c t i v i t y  by human m yom etrium  was 
stim u la te d  by arach id on ic  a c id  and phosphol ip a se  A2 (FLA2 ) in h ib ite d  
by indom ethacin. Human m yom étrial incubate d id  not p o sse ss  ad en osin e-  
d ip h o s p h a ta se  a c t i v i t y .  T h is  a n t i - a g g r e g a t o r y  a c t i v i t y  r e le a s e d  by  
pregnant r a t  and human myometria was a ttr ib u te d  t o  p r o s ta c y c lin  (PGI2 ) .  
Human p la c e n ta l a n ti-a g g reg a to ry  a c t iv i t y  was u n stab le  a t  both pH 12.0  
and pH 4 .0 , was n ot in h ib ite d  by a d m in istra tio n  o f indom ethacin and had 
th e  a b i l i t y  to  degrade adenosine diphosphate.
PGI2 s y n th e s is  by human pregnant myometrium was low  up t o  week 37 
of pregnancy and then in creased  p r o g r e ss iv e ly  t o  a maximum a t  week 40  
(term ). Two p a t ie n ts  who did  not p rogress t o  labour by week 42 had a low  
c a p a c i t y  t o  r e l e a s e  PGI2 . In c u b a tio n  o f  human m y o m étr ia l t i s s u e  w ith  
o x y t o c in  and e r g o m e tr in e  d id  n o t  a l t e r  PGI2 s y n t h e s i s .  PGI2 in h ib i t e d  
th e  spontaneous c o n t r a c t i l i t y  o f  human p reg n a n t m yom etrium  b ath ed  in  
Krebs' s o lu t io n  in  3 /4  sam ples and reduced b asa l tone in  2 /4 .
S t u d ie s  on p reg n a n t r a t  m y o m étr ia l PGI2 s y n t h e s i s  show ed th a t
removal o f th e  deciduum by scraping w ith  a m icroscope s l id e  r e su lted  in
canpared to
g r e a t ly  in crea sed  sy n th e s iso f  PGI2 jjteasing. Chopping in creased  th e  ra te  
o f s y n th e s is  o f  th e  scraped sam ples, and maximal sy n th e s is  o f th e  teased  
sam ples.
P r e -in cu b ation  o f  scr^>ed m yom étrial t i s s u e  w ith  u ter in e  s tim u la n t  
drugs (oxy tocin , a n g io ten sin  & 5 -h y d r o x y tr y p ta m in e  [5-H T]) s t im u la t e d  
PGI2 s y n th e s is  in  a dose r e la te d  fa sh io n . M iethysergide , w h i ls t  reducing  
s y n th e s is , in h ib ite d  th e stim u la n t e f f e c t  o f  5-HT. The u te r in e  re laxan t  
sa lb u ta m o l in h ib i t e d  s y n t h e s i s  by day 21 b u t n o t day 19 p reg n a n t  
myometerium, and was antagonised  by propranolo l. The ad eny la te  c y c la se  
s tim u la n t, fo r s k o lin , reduced PGI2 sy n th e s is .
Bat u te r in e  homogenate, when incubated in  HEPES b u ffer  (pH 8.0; + 
T r ito n  X-lOO ) r e le a s e d  ^ H -o le ic  a c id  from  I ' - o l e o y l ,  2 ' - [^ H j - o le o y l-  
p h o s p h a t id y lc h o l in e  (^H-dPC). Two m eth ods w ere  a s s e s s e d  fo r  th e  
s e p a r a t i o n  o f  r e l e a s e d  o l e i c  a c i d  fro m  t h e  ^H-dPC. T h in  l a y e r  
chromatography was found to  be th e  method o f ch o ice .
The r e l e a s e  o f  ^ H -o le ic  a c id  by l a t e  p reg n a n t r a t  u t e r in e  
homogenate a c id  was Ca"^"*" dependent, p ro te in  dependent, had a pH optimum 
a t  01 8 .0  and was in h ib ite d  by mepacrine and te tr a c a in e . This a c t iv i t y  
w as a t t r ib u t e d  t o  PLA2 . P e r fu s io n  o f  th e  u t e r in e  v a s c u la r  bed w ith  
Krebs* s o lu t io n  t o  remove blood e lem en ts in creased  a c t iv i t y  as measured 
by t h i s  method.
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1 .0 ) In trod u ction
1 .1 ) HISTORY
The i n i t i a l  d isco v ery  o f a p r in c ip le  p o ssess in g  vasodepressor and 
sm ooth  m u sc le  s t im u la n t  a c t i v i t y  in  sem en i s  a t t r ib u t e d  t o  G o ld b la t t  
(1933) and von Euler (1937) which was subsequently  named p rostag lan d in  
(PG). von Euler ch a ra cter ised  t h is  as a l ip id  so lu b le  f a t t y  a c id  which  
conta in ed  an hydroxy group.Bergstrom and Sjoval (1957; 196Oa,b) succeeded  
in  i s o la t in g  and determ ining th e s tru c tu re  o f  two pure PGs from sem in al 
f l u i d  and c a l l e d  them  PGF and PGE d e n o t in g  p r e f e r e n t i a l  s o l u b i l i t y  in  
p h o sp h a te  b u ffe r  and e th e r  r e s p e c t i v e l y .  F u rth er  p r o s ta g la n d in s  w ere  
d e s ig n a te d  by l e t t e r s  from  th e  b e g in n in g  o f  th e  a lp h a b e t  and have now 
rea ch ed  th e  'I ' s e r i e s .
The s t r u c t u r e  and c o n f ig u r a t io n  o f  PGF2 d was co n fir m e d  by X -ray  
c r y s t a l lo g r a p h y  (Abraham sson, B ergstrom , & S a m u e lsso n , 1 9 6 2 ) , a s  a 
member o f  the c la s s  o f compounds ch em ica lly  r e la te d  to  p ro sta n o ic  a c id . 
R esearch then a scer ta in ed  th e  b io sy n th e tic  pathway fo r  th e  PGs and was 
f i r s t  achieved in  1964 (van Dorp, B eerth u is, Nugteren & Vonkeman 1964a). 
Bergstrom sim u ltan eou sly  showed th a t arach id on ic  a c id  (AA) was converted  
t o  PGE2 by sh eep  v e s i c u l a r  g la n d s  w h ich  was s u b s e q u e n t ly  found t o  be 
sec o n d a ry  t o  th e  p r o d u c tio n  o f  e n d o p ero x id e  in t e r m e d ia t e s  (Hamberg & 
Sam uelsson 1973; Nugteren & H azelhof 1973). These are sy th e s ise d  from AA 
and c o n v e r te d  t o  PGF2 a r PGD2 , and PGE2 a s  w e l l  a s  a n o n -p r o s ta n o id  
group o f  compounds c a lle d  thromboxanes (Hamberg, Svensson & Samuelsson  
1 9 7 6 ). Under a y ea r  l a t e r  6 -oxo-PG F2 a was i s l o l a t e d  from  r a t  s to m a ch , 
g u in ea -p ig  lung and r a t carageenan-induced granuloma (Pace-Asciak 1976; 
Chang, Murota, Matsuo & T su ru fu ji, 1976; Dawson, Boot, C o c k e r ill , M alien  
& O sborne, 1 9 7 6 ). A t te n t io n  was th en  drawn t o  a r e p o r t  t h a t  PG 
e n d o p e r o x id e s  w ere c o n v e r te d , by a r t e r i a l  w a l l s ,  t o  a p o te n t  a n t i ­
aggregatory substance, PGX (Gryglewski, Bunting, Moncada, Flower & Vane,
Figure 1) S tru ctu re  and pathway for  arach idon ic  a c id  m etabolism  v ia  th e  
cyclooxygenase pathway.
P r o s ta g la n d in  (EGl s y n t h e s i s .
1) Cyclooxygenase
2) Peroxidase
3) PG-endoperoxide F -redu ctase
4) PGE-iscmerase
5) PGD-iscmerase
6 /7 ) Thromboxane sy n th eta se
8 ) P r o s ta c y c lin  sy n th eta se
9) 9 K eto-reductase
PcQstaglandin I pgL metabolism
10) PG 15-dehydrogenase
11) PG 13 -red u ctase
1 2 ) -o x id a t io n , 2 s te p s .
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1 9 7 6 ). PGX w as l a t e r  renamed a s  p r o s t a c y c l in  (PGI2 ) and 6 -o x o -P G F i*  
a s c e r t a in e d  t o  be th e  h y d r o ly s is  p ro d u ct o f  PG%2 in  a c id  or aqueous  
media.
1 .2) CHEMISTRY
1.2 i)  Chem istry a t  prostagl9nd.iD5.».
PGs are C-9 oxygenated chem ical d e r iv a t iv e s  o f p ro sta n o ic  a c id  y a 
tw enty carbon m onocarboxylic a c id  con ta in in g  a cyclop en tane ring  jo in in g  
th e  tw o ca rb on s a t  C- 8  and C-12 numbered from  th e  c a r b o x y l group . The 
PGs are la b e lle d  a lp h a b e tic a lly  and are m ainly d is t in g u ish e d  by th e  typ e  
and o r ie n ta t io n  o f  th e  su b s titu e n t groups in  th e  r in g . PGA , PGB and PGC 
c o n ta in  a C-9 k e to n e  and d i f f e r  by th e  p o s it io n  o f  a d o u b le  bond w it h in  
th e  cyclopentane r in g , w h ils t  PGD, PGE and PGF are  d is t in g u ish e d  by th e  
p r e se n c e  o f  h y d ro x y l a n d /o r  k e to n e  grou p s a t  C-9 and C -11 . PGG and PGH 
a r e  c y c l i c  9 ,1 1  e n d o p e r o x id e s , and PGG (and i t s  m e t a b o l i t e s )  i s  
e x c e p t io n a l  in  c o n ta in in g  a h yd rop eroxy  group a t  C-15 in s t e a d  o f  th e  
hydroxyl group found w ith  a l l  o th er PGs (see f ig u r e  1 fo r  s tr u c tu r e s ) .
T hese group s a r e  fu r th e r  su b d iv id e d  in t o  th e  1 , 2 , or  3 s e r i e s  
according to  th e  number o f double bonds found in  th e  s id e  ch a in s. These 
a r e  d e r iv e d  from  8 ,1 1  e ic o s a d ie n o ic  a c id s .  C y c lo -o x y g e n a se  w i l l  th u s  
con vert 8 ,11,14 e ic o s a tr ie n o ic  a c id  (d ih om o7lin o le ic  a c id , DHYLA) t o  th e  
'1' s e r i e s ,  5 ,8 ,1 1 ,1 4  e ic o s a t e t r a e n o ic  a c id  (a r a c h id o n ic  a c id ,  AA) t o  
th e  '2' s e r ie s  and 5 ,8 ,11 ,14 ,17  e ico sap en taen o ic  a c id  to  PGs o f th e  *3* 
s e r i e s .  The c o n f ig u r a t io n  o f  th e  d o u b le  bonds a r e  t r a n s ,  c i s  , t r a n s  
r e s p e c t iv e ly .  The is o m e r ic  form  o f  th e  F - s e r i e s  i s  fu r t h e r  d en o ted  by 
su b sc r ip ts  which in d ic a te  th e o r ie n ta tio n  o f th e  C-9 hydroxyl group as  
above (®) or below (?) th e  p lane o f th e  cyclop en tane rin g .
The p r o s t a c y c l in s  (PGI) and throm boxanes a r e  n o n -p r o s ta n o id  
t r a n s fo r m a t io n  p r o d u c ts  o f  th e  e n d o p ero x id e  in t e r m e d ia t e .  PGI i s  
b ic y c l ic  con ta in in g  th e  cyclopentane ring  and a fur an ring  betw een C- 6  
and C-9 o f  th e  p r o s ta n o ic  a c id  m o le c u le . The throm boxanes c o n ta in  a 
pyran ring  as opposed to  th e  cyclopentane ring  and are d iv id ed  in to  two  
s e r i e s .  The o x e to n e  fo r m a tio n  o f  throm boxane A (TxA) i s  r a p id ly  
h y d r o ly se d  t o  form  throm oxane B (TxB). PGI, TxA and TxB a r e  s p l i t  in t o  
th e  mono, b is  or t r i s  s e r ie s  a s  w ith  th e  c la s s i c a l  PGs and derived  from  
th e  same p recu rsors.
1 .2  i i )  Q iem istiy . o L  phospholipids.
The p h o s p h o lip id s  ( a ls o  named p h o sp h a tid e s )  r e le v a n t  t o  PG 
b io ch em istry  are d e r iv a t iv e s  o f  g ly c e r o l which can be regarded as th e  
chem ical backbone to  which th e  oth er components are lin k ed  (see  f ig u r e
2). The I'C ) p o s it io n  i s  gen era ly  occupied by th e  sa tu ra ted  f a t t y  
a c id s  s t e a r ic  or p a lm it ic  a c id s  w h ils t  th e  2 ' ( ) ,,pt'>sition (which i s
a s s y m e tr ic )  i s  o c c u p ie d  by th e  P G -p recu rsor u n sa tu r a te d  f a t t y  a c id s  : 
DH LA, AA or 5 ,8 ,1 1 ,1 4 ,1 7 - e ic o s a t e t r a e n o ic  a c id .  S e r in e ,  i n o s i t o l ,  
c h o l in e  and e th a n o la m in e  a r e  th e  m ost common b a se s  p h o sp h o r y la te d  a t  
p o s i t i o n  3 ( y  ) . Thus a p h o sp h o lip id  c o n ta in in g  a 1' s t e a r i c  a c id ,  
2' AA and 3* i n o s i t o l  w ould be c a l l e d  1 ' - s t e a r o y l ,2 '-a r a c h id o n o y l-  
p h o s p h a t id y l in o s i t o l .  T h is  i s  more o f t e n  sh o r te n e d  t o  p h o s p h a t id y l-  
in o s i t o l  and th e  sa tu ra ted  and unsaturated f a t t y  a c id s  not s p e c i f i c a l ly  
n o ted .
1.3) Arachidonic a c id  r e le a se  and m etabolism
AA i s  c o n c e n tr a te d  a s  th e  e s t e r  m a in ly  in  th e  form  o f  g ly c e r o -  
p h o s p h o lip id s  and i s  th e  p r e fe r r e d  u n sa tu r a te d  f a t t y  a c id  (Danon,
Figure 2) The stru ctu re  o f th e commonly occurring g lycero-p h osjiio lip id s  
in to  which prostaglandin precursors are incorporated ( i l lu s tr a t in g  the  









































































Heimberg & O ates, 1975) even though DHYLA i s  an in te r m e d ia te  fo r  AA 
s y n t h e s is  in  th e  r a t  (M arcel, C h r is t ia n se n  & Holman, 1968). AA can be 
o b ta in ed  in  th e  d i e t  or s y n th e s is e d  from d ie ta r y  l i n o l e n i c  a c id  by 
d e s a tu r a t io n  and ch a in  e lo n g a t io n  in  th e  l i v e r  form in g DHYLA. T h is i s  
further desaturated to  form a double bond c h a r a c te r is t ic  o f th e 2-  
s e r i e s  o f  PGs. AA i s  m e ta b o lise d  through two independant pathw ays: 
prostaglandin synthetase and lipoxygenase to  form the prostagland ins and 
hydroxyacids r e s p e c t iv e ly .
1.3 i) Role af phospholipases. in M  release
Phosphol ip a s e s  a re  a la r g e  group o f  enzym es th a t  h y d ro ly se  
j^ osp h olip id s. They d if fe r  in  th e ir  s p e c i f ic i t y ,  pH optim a, su b ce llu la r  
lo c a lis a t io n  and requirem ents for calcium  ions. Those required for PG 
b io s y n t h e s is  a re  p h o sp h o lip a se s  o f th e  A^, A2 , C and D s e r i e s  (see  
f ig u r e  3 ) .  Phosphol ip a s e  D i s  o n ly  found in  p la n ts  and w i l l  n o t be 
d iscussed  fu rther. PLA^  hydrolyses th e saturated  fa t ty  acid  from the 1 ' 
p o s it io n  of the glycerophospholip id  lea v in g  a I 'ly so p h o sp h a tid e  w h i l s t  
PLA2 i s  s p e c i f i c  fo r  th e  2 ' p o s i t io n  r e le a s in g  th e  u n sa tu ra ted  f a t t y  
acid  and leav in g  th e 2 '-lysophosgdiatide. PLC r e le a se s  the phosphorylated  
b ase  from p o s it io n  3' le a v in g  1 ,2  d ia c y lg ly c e r o l .  The ly so p h o sp h a tid e s  
are c y to to x ic  and are reacylated  to  phosphatides or fu rther degraded by 
lysophosphatidases.
PGs are  n o t s to r e d  w ith in  c e l l s  (P iper & V ane,1971) and a re  
s y n th e s is e d  d^ noYû p r io r  t o  r e le a s e .  The f r e e  a c id s  a re  req u ired  by 
cyclo-oxygenase (Lands & Samuelsson,1968; Vonkeman & van Dorp,1968) and 
f r e e  a c id  l e v e l s  a re  low  (Kunze & V o g t,1971). Kunze and Vogt a ls o  
suggested th a t the re lea se  o f fr e e  AA may be co n tro lled  by a FLA which
F igu re  3) A diagram  t o  i l l u s t r a t e  th e  a c t io n s  o f  d i f f e r e n t  phospho- 
l ip a s e s  on th e  p h o sp h o lip id  l - s t e a r o y l , 2 -a r a c h id o n o y l-p h o sp h a t id y l-  
in o s i t o l .
PLAj -  Phospholipase-A^
PLA2 “ Phosj^olipase-A2 
PLC -  Phospholipase-C  
FID -  Phospholipase-D
The 1 ,2 -d ia cy 1 -g ly cero l produced under th e a ctio n  o f phospholipase-C i s  
fu r th e r  a lt e r e d  by 1 , 2 - d ia c y lg ly c e r o l  k in a se  and 1 , 2 - d ia c y lg ly c e r o l  
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may be th e  r a t e  l i m i t i n g  s t e p  in  PG b i o s y n t h e s i s .  AA and PLA2 
a d m in is tr a t io n  le a d s  t o  a la r g e  in c r e a s e  in  PG r e le a s e  when in fu se d  
through frog in te s t in e  (B artels, Kunze, Vogt & W il l i s ,1970). Bradykinin­
induced PG r e le a s e  from g u in e a -p ig  lu n g  i s  in h ib it e d  by m ep acrin e , a 
PLA2 in h ib i t o r ,  w h i l s t  AA s t im u la te d  r e le a s e  i s  n o t (V a rg a ftig  & Dao 
H a i,1 9 7 2 ). R a d io la b e lle d  AA i s  in co rp o ra ted  in to  th e  n e u tr a l  and 
2 ' l e c i t h i n - l i k e  p h o sp h o lip id  p o o ls  o f  th e  g u in e a -p ig  s p le e n  and 
ra d io la b elled  AA i s  released  on shaking from th e phospholipid fr a c tio n ,  
n o t th e  n e u tr a l l i p i d s  (F low er & B la c k w e l l ,1976). These r e s u l t s  show 
th a t PGs are not released  them selves by cleavage from the phospholipids  
but th a t the precursor AA i s .
More recen tly  i t  has been found th a t p la t e le t  aggregation r e s u lt s  
in  a lo s s  o f AA from the p h o sp h a tid y lin o sito l (p%)  ^ p^ osfiia tidy lcholin e  
(PC) and p h o sp h a tid y le th a n o la m in e  (PE) p o o ls  in  th e  p lasm a membranes 
(B la c k w e ll, Duncombe, F lo w er , Parsons & V ane,1977). T h is was tak en  as  
e v id e n c e  th a t  p l a t e l e t  AA i s  r e le a s e d  by PLA2 . However R itte n h o u se -  
Simmonds (1979) and B e l l ,  K ennerly , S tan ford  & M ajereus (1979) have 
provided evidence for a PI s p e c if ic  PLC which r e le a ses  th e corresponding 
1 ,2-d ia lc y lg ly c e r o l which i s  then subsequently m etabolised. 1 ,2-d ia c y l-  
g ly c e r y l  l ip a s e  (d ig ly c e r id e  l ip a s e )  c le a v e s  both the unsaturated and 
sa tu r a te d  f a t t y  a c id s  from th e  d ig ly c e r id e  making i t  d i f f i c u l t  to  
d is t in g u is h  t h i s  a c t io n  from PLA2 . T h is d oes n o t p rec lu d e  a r o le  fo r  
p l a t e l e t  PLA2 s in c e  AA i s  s t i l l  r e le a s e d  from  PC and PE w hich a re  n o t  
su b stra tes for  th e PI s p e c if ic  PLC.
1.3 i i )  Prostaglandin and. thromboxane sy n th es is
F ig u re  1 i l l u s t r a t e s  th e  mechanism o f  PG b io s y n t h e s is .  AA i s  
i n i t i a l l y  d io x y g en a ted  to  PGG2 r in v o lv in g  C-11 and C-15 hydro­
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peroxidation , C-13 dehydrogenation, w ith  c y c lisa t io n  a t  C- 8  and C-12 by 
PG endoperoxide syn th etase (Miyamoto, Ogino, Yamamoto & H ayaishi,1976). 
A p e r o x id a se  c a t a ly s e s  th e  C-15 hyd rop eroxide t o  th e  hydroxy group o f  
PGH2 (van Dorp, Buytenhek, C h r is t -H a z e lh o f , N ugteren & van der  
Oudera,1978).
PG endop eroxide F -r e d u c ta se  i s  p r e se n t  in  th e  c y t o s o l  (van Dorp 
e t .a l . ,  1978) converting PGH2 to  PGF2 „. PGE-isomerase u t i l i s e s  PGG2 (but 
p refers PGH2 ) y ie ld in g  15-hydroperoxy-PGE2 (and PGE^ ) (Ogino, Miyamoto, 
Yamamoto & H ayaishi,1977).
C o n tr o lle d  ex p er im en ts  have shown th a t  PGE i s  n o n -e n z y m a tic a lly  
dehydrated  to  PGA when th e  pH i s  a llo w e d  t o  drop below  3.5 or h ig h  
tem p era tu res  occur p r io r  t o  e x tr a c t io n  (Jonsson & P ow ers,19 8 1 ). The 
enzym atic production o f  PGD2 has a lso  been questioned , as has i t s  r o le  
in  b io lo g ic a l system s, s in ce  i t  i s  e a s i ly  formed non-enzym atically  ( lik e  
PGE2) from PGH2 (Hamberg & Samuelsson,1974a; Nugteren & Hazelhof ,1973). 
However r a t  s p le e n  (C h r is t-H a ze lh o f & N u g teren ,1979) and r a t  b r a in  
(Shimizu, Yamamoto & Hayaishi,1979) have y ie ld ed  PGD-isomerases.
Thromboxane synthetase was f i r s t  d iscovered in  p la t e le t  microsomes 
by Keedleman, Moncada, Bunting, Vane, Hamberg & Samuelsson (1976) a fte r  
throm boxane was found t o  be p r e se n t  in  p l a t e l e t  e x t r a c t s  (Hamberg & 
Samuelsson,1974b; Hamberg, Svensson & Samuelsson,1975). Equal amounts o f  
1 2 -h y d r o x y -h e p ta d e c a tr ie n o ic  a c id  w ith  m alon d ia ld eh yd e (D ic z fa lu s y ,  
Falardeau & Hammarstrom,1977) are released  w ith  TXA2 .
P r o s ta c y c lin  sy n th e ta s e  was o r i g in a l ly  d e scr ib e d  in  a r t e r i a l  
microsomes (Moncada, Gryglewski, Bunting & Vane,1976). The potent a n t i­
aggregatory factor released  was named PGX (Gryglewski e t .a l . ,  1976) and 
found to  be an a r te r ia l  relaxant (Moncada e t .  a l . ,1976). PGX was renamed
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PGl2 (Johnson, Morton, Kinner, Gorman, McGuire, Sun, W hittaker, Bunting, 
Salmon, Moncada & Vane,1976).
F in a lly  9-oxo reductase a c t iv i t y ,  converting PGE to  PGF i s  found 
in  blood, heart and l iv e r  (Hensby,1975). I t  has a lso  been noted th a t the  
o p p o s ite  r e a c t io n  can o c cu r (i* e . d eh y d ra tio n  c o n v e r t in g  PGF t o  PGE) 
(Pace-Asciak & M iller  ,1974) in  th e ra t kidney.
1.3 iv) Lipoxygenase pathway
A further transform ation o f AA to  hydroxy fa t ty  acid s can occur v ia  
the lipoxygenase pathway to  form a newly discovered group of compounds 
named le u k o tr ie n e s  (Sam uelsson & Hammarstrom,1980). These were f i r s t  
found to  be r e le a s e d  from  le u c o c y t e s  (B orgeat & S am u elsson ,1979) and 
t h e ir  s tr u c tu r e  e lu c id a te d  as  hydroxy or hydroperoxy-eicosapolyenoic  
a c id  d e r iv a t iv e s  depending apon th e  p recu rso r  f a t t y  a c id  a s  w ith  th e  
PGs. The l ip o x y g e n a s e  p r o d u c t s  a l s o  in c lu d e  t r i ,  d i  or m ono- 
hydroxyeicosapolyenoic ac id s . The le u k o tr ie n e s  a re  p o te n t c o n s t r ic t o r s  
o f  a irw a y s  (L ew is, A u sten , D razen, C lark , M arfat & C orey ,1980) and 
in c r e a s e  v a sc u la r  p r e m e a b il ity . L eu k o tr ien e  B  ^ i s  c h e m o ta c tic  and 
c h e m o k in e t ic  and t h e  h y d ro x y  a c id  1 2 - h y d r o p e r o x y - 5 ,8 ,1 0 ,1 4 -  
e ic o s a t e t r a e n o ic  a c id  (12-HPETE) i n h ib i t s  PGI2 s y n th e ta s e  ( S e ig e l ,  
McConnel, Abrahams, Porter & Cuatrecasas,1979) .
1.3 v) Prostaglandin and thromboxane metabolism
The rapid lo s s  o f b io lo g ic a l a c t iv i t y  o f th e  PGs and thromboxanes 
are both a r e su lt  o f enzymic ox id ation  by prostaglandin-15-dehydrogenase  
(PGDH) (S am uelsson , G ranstrom , Green, Hamberg & Hammarstrom,1975) and 
th e  h y d r o ly s is  o f  PGI2 and TXA2 to  6 - 0 x0 - PGF^o and TXB2 r e s p e c t iv e ly  
(se e  f ig u r e  1 ) . The 1 5 -oxo  m e ta b o lit e s  may th en  be reduced by
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r e d u c ta se  to  form  15-oxo-13 ,14 -d ih yd roP G s (Sam uelsson e t .  a l . ,1 9 7 5 ). 
F u rther ch a in  sh o r te n in g  b y - o x i d a t i o n  le a d s  t o  d in o r -  or t e t r a n o r -  
compounds (Hamberg,1968) and w -o x id a tio n  leading to  d io ic  a c id s . PGF 
and PGE w ere th e  f i r s t  PGs d e sc r ib e d  t o  undergo m etab o lism  by t h i s  
pathw ay (Sam uelsson e t .  a l . ,1 9 7 5 ). PGD2 a l s o  undergoes m etab o lism  by 
th ese  pathways but may a ls o  form dinor-PGF^a m etab o lites  (E l l is ,  Sm igel, 
O a tes , O elz & Sw eetm an,1979). Thromboxane r e le a s e  from s e n s i t i s e d  
gu in ea-p ig  lung i l lu s t r a t e s  th a t TXA2 i s  a su b strate  for  PGDH as 15-oxo- 
dihydroTxB2 i s  th e  m ajor m e ta b o lite  s y n th e s is e d  (B oot, C o c k e r i l l ,  
D aw son , M a lie n  & O sb o r n e ,1 9 7 8 ) and n o t  d in o rT x B 2 i n  v iv o  
(S v en sso n ,1 9 7 9 ). TXB2 i s  n o t a s u b s tr a te  fo r  PGDH in  v i t r o  and i s  n o t  
m e ta b o lise d  t o  15-oxo-dihydroT xB 2 in  th e  monkey (K in d ah l,1977). TXA2 
h y d ro lysis  may then be preceded by metabolism by PGDH and A^^-reductase 
s in c e  TXA2 i s  rap id ly  trapped by albumin which increases the plasma h a lf  
l i f e  (F o lco , Granstrom & K in d ah l, 1 977). TXB2 i s  o n ly  produced on 
a c i d i f i c a t i o n  o f  p lasm a p r o te in s  on e x tr a c t io n  o f  TXA2 (M aclouf, 
Kindahl, Granstrom & Samuelsson,1980).
PG%2 a lso  undergoes h yd ro lysis  to  e-oxo^PGFj^, , however only 0  and 
CO -  ox id ation  products of the e-oxo-PGF^^ are found on adm in istration  
o f  6 -oxo-PG Fj~ t o  r a t s  (P a ce-A scia k , C arrera & D om azet,1977). 6 - 0 x0 -  
PGF^ c^  i s  a poor s u b s tr a te  fo r  PGDH but o th er  m e ta b o lit e s  o f  PG%2 have  
been  found (McGuire & Sun,1978). These w ere m e ta b o lise d  in  th e  norm al 
way by C-15 d eh yd rogen ation  and A ^ ^ -red u ctio n . There i s  a l s o  th e  
p o s s ib i l i t y  o f spontaneous h yd rolysis o f PG%2 to  6-oxo-PGF2 « and then C- 
9 d eh y d ro g en a tio n  t o  y ie ld  th e  a n t i-a g g r e g a to r y  prod u ct 6 - 0 X0 -PGE2 
(Wong, M alik, Sun, Lee & McGiff,1978).
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1.3 V i )  Pharm acological m anipulation o f  th a  ayac)iidQnj.c a c id  pathway
P h o sp h o lip a ses  A2 and C a re  both  Ca'*"*’ dependant th u s ca lc iu m  
ion o p h o res  sh ou ld  a c t iv a t e  th e  AA c a sca d e . T h is i s  tr u e  fo r  PLA2 
(P ick ett fJesse & Cohen,1977) but Ca'*"*' m o b ilisa tio n  by A23187 does not 
a c t iv a te  PLC in  in ta c t  c e l l s  (Lapetina & Cuatrecasas,1979). Mepacrine i s  
a d ir e c t  in h ib it o r  o f  PLA2 (V a r g a ftig  & D a o tt i,1 9 7 2 )  a s  i s  t e t r a c a in e  
(Kunze, Bohn & Vogt, 1974) and p-bromophenacylbromide (M itch ell, Poyser, 
& W ilso n ,1977). S t e r o i d a l  a n i - in f la m m a t o r y  d ru g s  i n h i b i t  PLA2 
(Flower ,197 8) probably v ia  th e novo sy n th es is  o f an endogenous PLA2 
in h ib ito r  (Flower & B lack w ell,1979). In h ib itio n  o f PLA2 w i l l  l im i t  the  
production o f a l l  AA m etab o lites.
S e le c t iv e  in h ib it io n  o f AA metabolism v ia  th e PG synthetase pathway 
using a sp ir in  was f i r s t  reported by Vane (1971). Cyclo-oxygenase was a t  
one tim e  th ou gh t t o  be inseparable from p e r o x id a se , however i t  i s  now 
known th a t  a s p ir in  s p e c i f i c a l l y  in h ib i t s  c y c lo o g e n a se  (van Dorp e t .  
a l . ,1978). Indomethacin, a r ev ers ib le  cyclo-oxygenase in h ib ito r  (Crook 
& C oll in s ,1977) e ith e r  reduces enzyme a f f in i t y  fo r  the su b strate  (Lands, 
La T e l l i e r ,  Rome & Vanderhoek,1973) or a c t s  by c o m p e t it iv e  in h ib i t io n  
(Flower, Cheung & Cushman,1973). A spirin  a c e ty la te s  cyclo-oxygenase and 
thus i t s  a ction  i s  ir r e v e r s ib le  (Roth, Stanford & Majerus,1975).
P ero x id a se  on th e  o th er  hand i s  s t im u la te d  by s e v e r a l  hydro­
peroxides (Okhi, Ogino, Yamamoto & H ayaishi,1979), tryptophan (Miyamoto 
e t .  a l . ,1976) and adrenaline (Sih, Takeguchi & F o ss ,1970).
Of th e  iso m e r a se s  o n ly  PG E-isom erase has been s u c c e s s f u l ly  
in h ib i t e d  s p e c i f i c a l l y ,  by 5 ,8 ,1 1 - e ic o s a t r ie n o ic  a c id  (van E v ert, 
N ugteren & Van Dorp,197 8 ) .  On th e  o th er  hand s e v e r a l  in h ib i t o r s  o f  th e  
s y n th e ta s e  enzym es fo r  PGI2 and TXA2 have been e lu c id a te d . 1 5 -h y d ro -  
p ero x y a ra ch id o n ic  a c id  (Moncada, G ryg lew sk i, Bunting & Vane,1976) and
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other l ip id  hydroperoxides (Salmon, Smith, Flower, Moncada & Vane,1976) 
i n h ib i t  PGI2 s y n th e ta s e . T ranylcyprom ine (G ryglew sk i e t . a l . ,  19 7 6 ), 
n ic o t in e  (Wennmalm,1978) and 3-hydroperoxy-3-m ethyl-2-phenyl-3-indole  
(Terashita, Nishikawa, Terao, Nakagawa & Hino,1979) are a lso  in h ib ito rs . 
However th e  a c t io n  o f  tra n y lcy p ro m in e  i s  now c o n s is e r e d  to  be non- 
s e le c t iv e  (Rajtor & de Gaetano, 1979).
Thromboxane s y n th e ta s e  i s  in h ib it e d  by im id a z o le  a n a lo g u es  
(Moncada, Bunting, Mullane, Thorogood, Vane, Raz & Needleman,1977). 1 -n -  
bu tylim idazole  has no phosphodiesterase in h ib ito ry  a c t iv i ty  and i s  thus 
more u s e fu l  a s  an in h ib it o r  o f  throm boxane sy n th e ta s e  than im id a z o le  
(B lackw ell, Flower, Russel 1-Sm ith, Salmon, Thorogood & Vane,1978) s in ce  
TxA2 i s  aggregatory ( Hamberg, Svensson & Samuelsson, 1975) and e levated  
cAMP l e v e l s  a re  a n t i-a g g r e g a to r y  in  p l a t e l e t s  (M ills  & S m ith , 1971). 
Lack o f  s e l e c t i v i t y  and o f  o r a l  a c t i v i t y  have p reclu d ed  th e  use o f  
in h ib i t o r s  such as  benzydam ine, (D ic z fa lu sy  & Ham m arstrom ,1977), 
n ic tin d o le  (Gryglewski, Korbut, O cetkiew icz & Stachura,1978) and N-0164 
(Eakins, Rajadhyaksha & Schroer,1976).
Lipoxygenase has proved eq u ally  d i f f i c u l t  to  in h ib it  s e le c t iv e ly .  
Dual c y c lo o x e g e n a se -1 ip o x y g e n a se  in h ib i t o r s  have been u s e fu l  s in c e  
in d om eth acin  i s  r e l a t i v e l y  in a c t iv e  a g a in st lipoxygenase and thus the  
pharm acological or p h y sio lo g ia ca l e f f e c t s  o f the two enzymes or th e ir  
p ro d u cts  can be d i f f e r e n t ia t e d  by com parison. BW-755C, a pyrazolid in e  
d e r iv a t iv e ,  i n h i b i t s  PGE2 s y n t h e s is  by carageenan  sp on ges in  r a t s  as  
w e ll as p la t e le t  lipoxygenase (Higgs, Flower & Vane,1979; Higgs, Eakins, 
Mugridge, Moncada & Vane,1980). E ic o s a -5 ,8 ,1 1 ,1 4 - t e t r a y n o ic  a c id  (TYA) 
i s  t h e  o th e r  m o st com m only u sed  d u a l i n h i b i t o r  (Hamberg & 
Sam uelsson,1974) w ith  s im ila r  IC^q values for both enzymes.
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The m e ta b o lic  d eg ra d a tio n  o f  th e  PGs can a l s o  be m an ipu lated  by 
the add ition  o f NAD"** and other NAD analogues!as PGDH i s  an NAD"*” dependant 
enzyme. PG analogues such as th e isomer of PGE ,^ ISRrPGE  ^ and PGs o f the  
B s e r i e s  in h i b i t  PGDH (N alcano, Angaard, & Sam u elsson , 1969). A sp ir in  
and in d om eth acin  have a l s o  been rep o rted  t o  i n h ib i t  b o v in e  lung PGDH 
(Hansen, 1974) b u t th e  c o n c e n tr a t io n s  needed a re  c o n s id e r a b ly  h ig h er  
than those required to  in h ib it  cyclo-oxygen ase.
1.4 ) Aiachidcniç acid, metabolism and uterine function
Smooth m u scle  c o n tr a c t in g  su b s ta n c e s  p resen t in  human menstrual 
f l u i d  w ere f i r s t  r ep o rted  in  1957 by P ic k le s  and c h a r a c te r is e d  as  PGs 
(E g lin g to n , R aphael, S m ith , H a ll & P i c k le s ,1963). PGs have s in c e  been  
id e n t i f i e d  in  th e  u te r in e  t i s s u e s  o f  v a r io u s  s p e c ie s  (fo r  r e v ie w s  s e e  
W illiam s & Vane,1975; Horton & Poyser,1976)
S tu d ie s  o f  PG p ro d u ctio n  o f  human and r a t  u t e r i  show g r e a t  
v a r ia tio n s  in  AA metabolism in  the 2 u ter in e  fr a c tio n s  c o n stitu tin g  the  
uterus. Human endom etrial PGE and PGF le v e l s  are high as compared to  6-  
oxo-PGFja w hich i s  u n d e te c ta b le  by GCMS (K e lly , Sm ith , Cooper & 
A b e l,1980). T h is  i s  con firm ed  u s in g  human e n d o m etr ia l hom ogenates 
incubated w ith  ^^C-AA (Abel & K elly ,1979). The human myometrium was a lso  
shown to  sy n th es ise  large  amounts o f 6-oxo-PGF2 @ compared to  PGE and PGF 
and th is  was increased considerably on incubation w ith  endometrium. The 
human pregnant myometrium and deciduum has however a lso  been reported to  
s y n t h e s is e  eq u a l am ounts o f PGE2 and PGF2 qj (S yk es, W illia m s  & 
R o g ers ,1 9 7 5 ). But c o fa c to r s  were used  and i t  has s in c e  been found th a t  
the human decidua and amnion re lea se  considerab ly  greater q u a n tit ie s  of 
PGE and PGF than th e  myometrium i n  v i t r o  w ith o u t c o fa c to r s  (S atoh , 
Yasumizu, Kawai, Ozaki, Wu, K inoshita & Sakamoto,1981). The myometrium
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r e le a s e s  te n  t im e s  more G-oxo-PGF^o; than d ec id u a  and am nion. S im ila r  
r e s u l t s  have been found w ith  th e  r a t  pregnant u te r in e  f r a c t io n s .  The 
d e c id u a l m icrosom es s y n t h e s is e  PGE2 , TXB2 (W illia m s &
Downing,1977) and th e  myometrium m a in ly  6 - 0 x0- PGF c^  ^ (Downing & 
W illia m s ,1977). I t  has a l s o  been  con firm ed  th a t  chopped l a t e  p regn an t  
rat myometrium re le a se s  more PGl2“l ik e  an ti-aggregatory  m ateria l than 
the decidua (W illiam s, Dembinska-Kiec, Zmuda & G ryglewski,1978) but th a t  
th is  d ifferen ce  i s  due to  th e presence of blood elem ents in  the decidual 
t is s u e  re lea sin g  a lipoxygenase product which in h ib it s  myométrial PGI2 
s y n th e s is  (E lTahir & W ill ia m s , 1981). Human m yom étria l t i s s u e  a ls o  
r e l e a s e s  PG l2 ~ l i k e  a n t i - a g g r e g a t o r y  a c t i v i t y  (O m in i, F o lc o  
,P asarg ic lion , Fano & B erti,1978) and th is  in creases a t  term (Bamford, 
Jogee & W ill ia m s ,1980) in  a manner s im i la r  to  th a t  found in  th e  r a t  
(W illiam s & ElTahir, 1980a).
PG c a t a b o l i s m  w i t h i n  th e  p r e g n a n t  u t e r u s  h a s b een  m a in ly  
in v estig a ted  using human t is s u e s .  The p lacenta  i s  c e r ta in ly  a prime s i t e  
fo r  PGDH a c t i v i t y  (Jarabak,1972) ) .  The f o e t a l  membranes a ls o  c o n ta in  
s i g n i f i c a n t  q u a n t i t ie s  o f  PGDH as w e l l  a s  A ^ ^ -red u cta se  (K eirse  & 
T u rn b u ll,1975 ; K e ir se , W illia m so n  & T u rn b u ll,1975). PGDH a c t i v i t y  
w ith in  the myometrium and decidua i s  very low and i t  seems th a t t is s u e s  
of trop h ob lastic  o r ig in  (p lacenta, chorion and amnion) contain  the most 
s ig n if ic a n t  amounts o f PGDH.
1.5 ) Role qL prostaglandins in p a rtu ritio n
E vidence fo r  th e  r o le  o f  PGs in  r a t  and human p a r tu r it io n  has  
n ec essa r ily  come from r a d ic a lly  d if fe r e n t  sources.
Karim and D e v lin  (1967) f i r s t  showed th a t  PGF co u ld  be found in
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a m n io tic  f l u i d  o f  women during la b o u r . The PGF was th en  shown to  be 
greater a t  term than mid-pregnancy (K eirse, F lin t  & Turnbull,1974) and 
plasm a l e v e l s  o f  15-oxo-PGF2qt have been shown to  r i s e  d u rin g  lab ou r  
(Karim ,1968). K eirse , M itch ell and Turnbull (1977) found th a t pregnant 
women who had low  l e v e l s  o f PGF2 in  t h e ir  a m n io tic  f l u i d  d id  n o t  
p r o g r ess  a d e q u a te ly  t o  th e  f i r s t  s ta g e  o f  lab ou r  in  c o n tr a s t  t o  th o se  
w ith  high PGF le v e l s  (however care must be taken in  in terp retin g  th ese  
r e s u lt s  s in c e  frequent amniotomy or am niocentesis may induce PG re lea se  
[M itch e ll, K eirse , Anderson & Turnbull,1977] ).
Primary evidence of PG involvem ent in  th e ra t p artu ritio n  process  
i s  th a t PGF2 r e lea se  from ra t pregnant uterus i n  v itr o  in creases from 
day 17 to  22 and decreases post-partum  (W illiam s,1973; W illiams,Sneddon 
& Harney,1974). This preceded th e d iscovery  th a t PGF le v e ls  in crease  
co in c id en ta ly  w ith  o e stra d io l in  the ovarian venous plasma o f r a ts , then  
drops on day 23, th e  day a fter  d e liv ery  (Labhsetwar & Watson,1974). PGF 
r e le a se  in  v itr o  c o rre la te s  w e ll w ith  spontaneous u te r in e  c o n tr a c t io n s  
and both  a re  in h ib i t e d  by in d om eth acin  (W illia m s ,1973). PGs a re  n ot  
released  as a consequence o f u ter in e  c o n tr a c t i l i t y  as papaverine in h ib it s  
pregnant u ter in e  a c t iv i ty  w ithout a ffe c t in g  PGF re lea se  (Aiken,1974).
The low  r e le a s e  o f  PG on day 17 in  th e  r a t  i s  due to  th e  la c k  o f  
a v a i la b le  AA w ith in  th e  r a t  u ter u s  a s  a d d it io n  o f  AA and PLA2 i n  v i t r o  
e l i c i t s  u ter in e  con traction s w ith  a re lea se  o f PGF (Parnham, Sneddon & 
W ill ia m s ,1 9 7 5 ). A lthough t h i s  ex p erim en t has n o t been rep o rted  u s in g  
human myometrium i n  v itr o , fr e e  am niotic AA and PGF le v e ls  are markedly 
r a is e d  in  women in  labour (MacDonald, S h u ltz ,  D u en h o e lter , Gant, 
Jim enez, P ritchard , Porter & Johnston,1974). Human fo e ta l  membranes are 
enriched in  AA (Schwartz, Schultz, MacDonald & Johnston,1975) found in  
th e  2' p o s i t io n  o f  th e  g ly c e r o p h o s p h o l ip id s ( O k i t a ,  M acDonald &
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J o h n sto n ,1980) w hich i s  c le a v e d  by PLA2 (O kazaki, O k ita , MacDonald & 
J o h n sto n ,1 9 7 8 ). The AA c o n te n t  may be reduced du rin g  labou r (Schw artz  
e t .  a l . ,1975) but F i l s h i e  and A nstey  (1978) found no change in  f r e e  and 
e s t e r i f ie d  AA in  t is s u e s  obtained before and during labour in  women . I t  
must be noted here th a t p la cen ta l PGDH does not change before or during 
spontaneous or induced labour (K eirse, Hansenns, Hicks & Turnbull,1976; 
K e ir se , H icks & T u r n b u ll,1976) a lth o u g h  s im i la r  changes co u ld  be 
observed using s im ila r  methods in  sheep (K eirse, M itch ell & F lin t,1977). 
Thus a r ed u c tio n  in  PG c a ta b o lism  cannot a ccou n t fo r  th e  in c r e a se d  PG 
r e le a s e  a t  term  in  women. PGE and PGF a re  a ls o  s y n th e s is e d  by f o e t a l  
membranes (Keirse & Turnbull,1976).
PGE and PGF a re  both  p o w er fu l o x y to c ic  a g e n ts  in  th e  pregn an t 
u ter i of humans (Embre,1969; W iqvist, Bygdemann & Kirton,1971) and ra ts  
(Fuchs & Mok,1973) and thus may f a c i l i t a t e  the expulsion  of th e foetu s  
a t  term . PG a d m in is tr a t io n  in  women (Karim ,1971) and r a t s  (B uckle & 
Nathanielz,1973) induces labour and abortion . Whether th is  i s  due to  the  
o x y to c ic  a c t io n  o f  PGs or n o t was q u e s tio n e d  when Horton and P oyser  
(1976) found th a t PGF2 q, decreased serum progesterone le v e l s  in  various  
sp e c ie s , probably second arily  to  lu t e o ly s is  thus r e lie v in g  progesterone  
b lock  le a d in g  t o  an in c r e a s e  in  u te r in e  s e n s i t i v i t y  t o  o th er  s t im u l i  
(C sapo,1969). Further su p p ort fo r  t h i s  h y p o th e s is  com es from  th e  
observation th a t preadm in istration  o f progesterone a tten u ates the e f f e c t  
o f PGF2 (^ in  th e  r a t  (G utnecht, C o rn ette  & Pharr i s ,  1969; Fuchs & 
Mok,1973) .
A b ortion  induced by a m n io tic  i n s t i l l a t i o n  o f  s a l in e  , how ever, 
s t im u la t e s  th e  r e le a s e  o f PGF in t o  th e  a m n io tic  f lu id  o f  women 
(G ustavii & Green,1972) and th e tim e to  abortion  i s  prolonged w ith  the
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adm in istration  o f indomethacin and a sp ir in  before induction  (Waltman e t .  
a l . ,1972; 1973a). A sp ir in  a l s o  in c r e a s e s  g e s t a t io n a l  le n g th  in  women 
(Lew is & Schulm an,1973) and r a t s  (C h ester , Dukes, S la te r  & W alp o le , 
1972).
PG%2 i s  o x y to c ic  in  th e  non -p regn an t (Om ini, Moncada and Vane, 
1977) and pregnant ra t (W illiam s, ElTahir & M arcinciew icz,1979 ) u te r i  
in  v i t r o  b u t in  c o n c e n t r a t io n s  f a r  h ig h e r  th a n  PGE2 or PGF 
Subthreshold concentrations a lso  s e n s i t iz e s  the pregnant ra t uterus to  
cause a 3 -fo ld  p o ten tia tio n  o f oxytocin . However PGI2 i s  relaxant when 
adm inistered i n  v itr o  to  the human pregnant uterus (Omini e t .  a l .  ,1979) 
and a n ta g o n ise s  th e  e f f e c t  o f  o th er  PGs in  th e  non -p regn ant human 
myometrium (Sanger & Bennet,1980). These r e s u lt s  have been contradicted  
by W iqvist and h is  group who showed an oxytocic  a c tio n  o f PGI2 on human 
non-pregnant myometrium and u te r o tu b a l ju n c t io n  (W iq v ist , Lindblom & 
W ilIhelmsson,197 9 ) .
1.6 ) Qxyt-Ogjg and tocolytic drugs and uterine prostaglandin synthesis
The p o s s ib i l i t y  th at oxytocic  drugs, including oxytocin , may a c t by 
s t im u la t in g  u te r in e  PG s y n t h e s is  has been q u e s tio n e d . Indom ethacin  
a n ta g o n is e s  th e  e f f e c t  o f  o x y to c in  on th e  i n  v i t r o  non -p regn an t r a t  
u ter u s  but f a i l e d  t o  do so  c o m p le te ly  in  8 /1 0  p regn an t u t e r i  (Vane & 
W illiam s,1973). Indom ethacin and m eclo fen am ate  i n h ib i t  th e  e f f e c t  o f  
b rad yk in in  and 5 -h yd roxytryp tam in e  (5-HT) (S o rr e n tin o , C epasso & 
DiRosa,1972) and an g io ten sin  I I  (Baudouin-Legros, Meyer & W orcel,1974). 
Indomethacin a lso  delays oxytocin  induced p a r tu r it io n  in  ra ts  (Fuchs, 
S m it a s ir i  & C h a n th a ra k sr i,1 9 7 6 ). O xytocin  in  women i s  i n e f f e c t i v e  a t  
in d u c in g  labou r or u te r in e  c o n tr a c t io n s  b e fo r e  week 2 0  , a f t e r  w hich  
there i s  an increase in  s e n s i t iv i t y  (Anderson & Turnbull, 1968). A lso o f
2 0
g r e a t  i n t e r e s t  i s  th e  f in d in g  th a t  o x y to c in  i s  n o t e f f e c t i v e  fo r  
induction o f labour in  women w ith  hydatidiform  m ole, in trau terin e  death 
or ser io u s  fo e ta l  abnorm alities -  un like PGs. I t  seems th erefore  th a t  
adequate preparation of th e myometrium i s  important for  the a ction  of 
oxytocin  but not PGs. This i s  borne out by the fin d in g s th a t am niotic PG 
l e v e l s  in  p a t i e n t s  c a rr y in g  an a n e n c e p h a lic  fo e tu s  c o n ta in  low  or 
u n d e t e c t a b le  PG l e v e l s  b e f o r e  and d u r in g  la b o u r  (T u r n b u ll & 
A nderson ,1 978). PGs p o t e n t ia t e  th e  a c t io n  o f  o x y to c in  on th e  human 
pregnant u te r u s  ( G i l le s p ie  & B ea zely ,1972) in  a manner s im i la r  to  th e  
r a t .
The r o le  o f PGI2 sy n th es is  in  the pregnant ra t myometrium has been 
o f g r e a t  i n t e r e s t .  The p o s s i b i l i t y  th a t  o x y to c ic  drugs may s t im u la te  
u te r in e  PGI2 s y n t h e s is  has been  in v e s t ig a t e d .  O xytocin  c e r t a in ly  
stim u la tes  ra t pregnant myométrial PGI2 sy n th es is  as does angioten sin  
I I ,  b rad y k in in  and erg o m etr in e  (W illia m s , E lT ah ir  & Seed , 1983). PLA2 
and AA a lso  s tim u la te  PGI2 sy n th es is  and th is  stim u la tio n  i s  in h ib ited  
by m epacrine s u g g e s t in g  th a t  PLA2 p la y s  a p a r t  in  t h i s  s t im u la t io n  o f  
PGI2 sy n th es is . The e f f e c t  of drugs on human myométrial PGI2 sy n th esis  
has not been stu d ied .
H ista m in e  and r e la x in  i n h ib i t  r a t  p regn an t m yom étria l PGI2 
s y n th e s is  (W illia m s  e t . a l . ,1 9 8 3 ). R e la x in  i s  a p i t u i t a r y  p o ly p e p tid e  
r e le a s e d  d u rin g  l a t e  pregnancy (O'Byrne & S t e in e z ,  1976) and i s  a 
pregnant u t e r in e  r e la x a n t  a s  i s  h is ta m in e  (Kameswaran, P en n efath er  & 
West, 1962). -adrenoceptor s tim u la tio n  r e s u lt s  in  the rela x a tio n  of  
th e  r a t  u te r u s , b e in g  a n ta g o n ised  by p r o p r a n o lo l and t o  a much l e s s e r  
e x t e n t ,  p r a c t o lo l  (Wasserman & L evy ,1 972). Sa lb u tam ol , a s e l e c t i v e  
2"^di^Gnoceptor s t im u la n t , i s  used  t h e r a p e u t ic a l ly  t o  p rev en t or
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r e v e r se  prem ature or o x y to c in - in d u c e d  labour in  women (L ip s c h itz ,  
B a i l l i e  & D a v e y ,1976; L ig g in s  & V au gh an ,1973) s in c e  /3 2 r e c e p to r s  
a re  th e  predom inant ty p e  (Bowman & Rand, 198 0 ). S in ce  th e  a c t io n s  o f  
salbutam ol and 5-HT are receptor m ediated, and receptor an tagon ists are 
rea d ily  a v a ila b le , th ese  two drugs would be id ea l to  t e s t  the hypothesis  
th a t  o x y to c ic  and r e la x a n t  drugs may a f f e c t  p r o s ta c y c l in  r e le a s e  by 
receptor mediated con tro l o f p ro sta cy clin  sy n th es is .
1.7 ) Prostaglandins and u ter in e  blood f lo w
U te r in e  b lood  f lo w  i s  g r e a t ly  in c r e a se d  (by over 30 t im e s )  in
pregnancy (M etcalfe, Romney, Swartwout, P itcarim , Lethin & Barron,1959).
There i s  a la c k  o f  r e a c t i v i t y  t o  v a r io u s  d i l a t o r s  such as  exogenous
o e s t r a d io l ,  a d en o sin e  or b rad y k in in  w hich has been lik e n e d  t o  a
The u ter in e  vascu lar bed 
" p h y s io lo g ic  hyperaem ia" (C le w e ll ,1 9 7 9 ) . ^ con stricts  in  response to
a d r e n a lin e  and n o r a d r e n a lin e  w ith  th e  same s e n s i t i v i t y  in  th e  non­
pregnant and pregnant ewe (Barton, Killam & Meschia,1974) but d i la te s  in  
r e s p o n s e  t o  a n g i o t e n s i n  I I  (T e rr a g n o , T e r r a g n o , P a c h o lc z y k  & 
McGiff,1973) in  th e pregnant dog. In h ib itio n  o f PG sy n th es is  decreases  
b lo o d  f lo w  in  p regnant dogs (T erragno, T erragno,P acholczyk  & M cG iff, 
1 9 7 4 ), r a b b it s  (Venuto, O 'D o r is io , S te in  & F e r r i s ,1975) and ew es  
(McLaughlin, Brennen & Chez,1978). AA in creases blood flow  in  pregnant 
dogs and t h is  i s  in h ib ited  by indomethacin (Terragno e t .  a l . ,1974)
Attempts to  c la r i f y  th e type o f PG involved have been concentrated  
on th e  v a s o d i la t o r ,  PGE2 (C lark & Brody,1977) w hich d oes n o t t o t a l l y  
r e s to r e  b lood  f lo w  a f t e r  PG s y n t h e s i s  i n h i b i t i o n  (T erra g n o  e t .  
a l . ,1 9 7 4 ). Terragno has e lu c id a te d  in  r e t r o s p e c t  th a t  6 -OXO-PGF2 q; i s  
released  in to  u ter in e  venous blood in  la t e  pregnancy a fte r  separating 6-  
o x o - P G F ^ q , and PGE2 w hich behaved s im i la r ly  in  th e  TLC sy stem  used
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(Terragno & T erragn o,1 980). Thus f lo w  may be c o m p le te ly  r e s to r e d  on 
addition  of PGI2 .
There i s  no data a v a ila b le  on u ter in e  blood flow  comparing pregnant 
and non-pregnant women, however compromised system ic  vascular r e a c t iv ity  
in  pregnant women has been described (A ssali,1961). Angiotensin II  has a 
reduced p r e sso r  a c t i v i t y  w hich can be r ev e r se d  by tr e a tm e n t w ith  
indomethacin (E verett, Worley, MacDonald, Chand & Gant, 1978), however 
the type of PG involved has not been elu cid ated .
Compromised u ter in e  blood flow  in  preeclam psia i s  a major cause of 
fo e ta l  hypoxia and death. System ic v a so d ila ta tio n  using hydralazine i s  
an e s t a b l is h e d  tr e a tm e n t fo r  p r e ec la m p sia  (Berkow, 1977). The a n t i ­
hypertensive action  o f hydralazine in  renal hypertensive ra ts  has been 
shown t o  be dependant on PG s y n t h e s is  s in c e  i t  i s  p rev en ted  by 
indomethacin (Cangiano, Rodriguez-Sargent & M artin ez-M artin ad o , 1978). 
The a c t io n  o f  v a s o d i la t o r s  on m yom étria l PGI2 would th e r e fo r e  be o f  
in te r e s t .
1 .8 ) A ssay o f  PGIn
M easurement o f PGI2 s y n th e s is  in  u t e r in e  t i s s u e s  i s  th e  aim o f  
t h i s  stu d y  and th u s  a d is c u s s io n  o f  th e  a s sa y  m ethods a v a i la b le  i s  
necessary .
1.8 i) B io lo g ica l as s ay
PGI2 p r e se n t  in  aqueous sam p les can be a ssa y ed  by in h ib i t io n  o f  
p l a t e l e t  a g g r e g a tio n  (Moncada e t . a l . ,1976) ; r e la x a t io n  o f  su p er fu sed  
b o v in e  coron ary  a r te r y  (Moncada e t . a l . ,1976) or th e  in h ib i t io n  o f  
p l a t e l e t  adherence t o  v iv o  b lo o d -su p e r fu se d  tendon (G ryg lew sk i,
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Korbut, I O cetkiew icz, 1978).
1.8 i i )  Radioimmunoassay
T his tech n iq u e  has been rev iew ed  by Granstrom (1981). As PGI2 i s  
u n s ta b le , a n t i - s e r a  t o  i t s  h y d r o ly s is  prod u ct e-oxo-PGF^c^ have been  
used . With radioim m unoassay (RIA) th e  in h ib i t io n  o f  b in d in g  o f  
rad io lab elled  G-oxo-PGF^ by t e s t  samples i s  measureable. This binding 
can be a f f e c t e d  by compounds o f  s im i la r  s tr u c tu r e  a s  w e l l  as pH, 
p r o te in s ,  l i p i d  and a l t e r a t io n  o f  io n ic  s tr e n g th  o f  th e  medium 
(Granstrom , 1 9 8 1 ). Other d e tr im e n ta l fa c to r s  may include in terferen ce  
from the separation  methods, fo r  exam ple A m b er lite  XAD-2 d eg ra d a tio n  
products compete for anti-PGF or anti-TxB sera . Ihe s p e c i f ic i t y  of a n t i­
se r a  r a is e d  a g a in s t  6 - 0 x0 - PGF^ ^^  i s  in  doubt s in c e  i t  c r o s s  r e a c ts  
t o t a l ly  w ith 6-OX0 -PGE2 (Lee, McGiff, Housholder, Sun & Wong, 1979).
1.8 i i i )  Rad ioçhemi çal  assay
L a b e lled  AA (^H or ^^C) i s  in cu b ated  w ith  th e  t i s s u e  and th e  
products ex tracted , concentrated and separated by ILC. S p e c if ic  so lv en t  
system s have to  be used as PGE2 and 6-OXO-PGF2QJ have the same r f . va lues  
in  many sy stem s (C o ttee , F low er , Moncada, Salmon & Vane, 1977 ; Sun, 
Chapman & McGuire, 1977). T h is tech n iq u e  d e t e c t s  r a d io la b e l le d  
m etab o lites  o f AA. Very l i t t l e  conversion i s  seen in  chopped t is s u e  as 
th e la b e lle d  su b stra te  has to  compete w ith  endogenously released  AA for  
c o n v e rs io n  by c y c lo -o x y g e n a se . T h is can be overcom e by u s in g  th e  
microsomal fr a c tio n  o f the t is s u e  which concentrates synth etase a c t iv i ty  
and the lib er a te d  AA i s  discarded in  the microsomal supernatant. However 
u terin e  microsomes require the added co fa cto rs  for  expression  o f maximal 
a c t i v i t y  (Downing & W illia m s , 1981). T h is  can a l t e r  th e  p r o f i l e  o f  AA
24
m etab o lites  formed and g iv e  a m isleading p ic tu re  of products syn th esised  
in  the whole c e l l .
This technique i s  tim e-consuming and r e la t iv e ly  expensive to  run.
1.8 iv) SâS Chromatography-Mass gpeotrometXY (SCMjSl
T h is  m eth od  r e q u ir e s  d e r i v i t i s a t i o n  o f  G-oxo-PGF^ a f t e r
extraction . The O m ethyl-oxim e, methyl e s te r  o f G-oxo-PGF^^ i s  measured
and th e  r e s u l t s  o b ta in ed  a re  e x tr e m e ly  a c cu ra te  and s p e c i f i c .  The
advantage o f  GCMS i s  th e  v a r ie t y  o f compounds w hich can be a ssa y ed
w ithout confusion w ith  in ter fe r in g  substances. The s e n s i t iv i t y  i s  very
i t
h ig h  (50-250  pg) (G ranstrom , 1981) a n o ^ is  regarded  a s  a r e fe r e n c e  
method.
1.8 v) High Performance Liquid ChcpmatogiaEhY (hpiQ ..
PG%2 can be m easured d i r e c t l y  by t h i s  method a s  w e l l  as 6 -o x o -  
PGFjq  ^ ( H i l l ,  1979; W ynalda, L in co ln  & F it z p a t r ic k ,  1979). However a t  
present s e n s i t iv i t y  i s  poor and furthermore the equipment i s  expensive.
1.8 v i) Assay choice
As already d iscu ssed  (Section 1.3v) PG%2 i s  m etabolised to  severa l 
com pounds o th e r  th a n  G-oxo-PGF^^^ and i t  i s  an a s s u m p tio n  o f  
radiochem ical, radioimmunoassay and GCMS methods th a t PGI2 i s  hydrolysed  
to  6 -oxo-PGF2a* These m ethods, in c lu d in g  HPLC, in c lu d e  le n g th y  
e x t r a c t io n ,  p u r i f i c a t io n  and d e r iv a t i s a t io n  p roced u res a s  w e l l  a s  
su b sta n tia l investm ent in  c a p ita l equipment. U nless expensive k it s  are  
a c c e p t a b le ,  r a d io im m u n o a ssa y  a l s o  i n v o l v e s  le n g th y  and c o s t l y  
preparative s t e p s .
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Bovine coronary a r te r y  b io a ssa y  r e q u ir e s  e q u i l ib r a t io n  fo r  4 -7  
hou rs t o  e s t a b l i s h  r e s t in g  to n e , and even though r e f r ig e r a t o r  s to r a g e  
can reduce th is  tim e (Dusting, Moncada & Vane, 1977) the recovery a fter  
PGI2 induced r e la x a t io n  i s  s lo w . There a ls o  may be in t e r fe r e n c e  from  
other PGs which contract the t is s u e  (Omini e t .a l . ,  1977).
The p l a t e l e t  a g g r eg a tio n  b io a s sa y  fo r  th e  e s t im a t io n  o f  PG%2 i s  
th e  most convenient as i t  d e te c ts  b io lo g ic a l a c t iv i t y  of the substance 
and does n o t m easure th e  h y d r o ly s is  p rod u ct. I t  i s  r a p id , cheap and 
assays nanogram q u a n tit ie s  o f PGI2 . In terference by both PGD2 and 6- 0x0 -  
PGFjq  ^ , w hich a re  a n t ia g g r e g a to r y  (Sm ith , S i l v e r ,  Ingerman & K o s s is ,  
1974; Lee, McGiff, Householder & Sun, 1979) can be abolished by carefu l 
contro l procedures.
1 .9 ) Aims
1) To c h a r a c t e r is e  th e  a n t i-a g g r e g a to r y  m a t e r ia ls  r e le a s e d  by human 
p lacenta  and myometrium in  v itr o .
2) To determ ine the e f f e c t  o f u ter in e  stim u lan t and relaxant drugs 
on th e  r e le a s e  o f  a n t ia g g r e g a to r y  m a te r ia l  from  th e  pregnant r a t  
myometrium.
3) To d e term in e  th e  e f f e c t  o f v a s o d ila to r  drugs on th e  r e le a s e  o f  
anti-aggregatory  m ater ia l from the pregnant ra t myometrium.
4) To d ev e lo p  and c h a r a c t e r is e  an a ssa y  fo r  PLA2 a c t i v i t y  w ith in  th e  
pregnant ra t uterus.
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2.0) METHODS -  Studies m  th £  production û f  an ti-aggregatory  a c t iv i t y  by  
the. pregnant human myometrium and p lacen ta , and the. production o f  ^  
the pregnant lat myometrium
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2 J ) Preparation o t  human myometria and placentae
Lower segm ent human m yom etria w ere o b ta in ed  a t  abdom inal 
hysterotomy or e le c t iv e  caesarian  sec tio n , before th e onset o f labour 
and b e fo r e  sy n to c in o n  was a d m in is te r e d . P la c e n ta e  w ere o b ta in ed  from  
p a t ie n t s  undergoing e l e c t i v e  c a e sa r ia n  s e c t io n  and ex p er im en ts  w ere  
paired w ith  myométrial samples taken from the same p a tien t. Samples were 
p la c e d  in  i c e - c o ld  T yrode's s o lu t io n  and used  w ith in  2 hou rs. Sam ples 
w ere b lo t t e d  dry and t r a c e s  o f b lood  and d e c id u a l t i s s u e  rem oved. The 
samples were then placed on ic e  in  T ris-b uffered  s a lin e  (TBS : pH 8.0 ; 
50 mM ).
2 .2 ) Pxepar^ ticn o L  pregnant x s t  myometrium and decidua
Fem ale w is ta r  r a t s  (200-250  g , Bath U n iv e r s ity  s tr a in )  w ere  
mated o v e r n ig h t and c e r v ic a l  p lu g s  n oted  over  th e  n ex t tw o d ays. The 
presence of p lugs were taken as evidence of su c ce ssfu l f e r t i l i s a t io n  and 
t h i s  denoted  as day 1 o f  pregnancy. A nim als w ere k i l l e d  on s e le c t e d  
days of pregnancy, the u terin e  horns d issec ted  out and placed in to  ic e -  
c o ld  T r is  b u ffe r e d  s a l in e  (TBS : pH 8 .0  ; 50 mM). The u te r in e  c o n te n ts  
were removed and the s i t e s  of n id ation  d issec te d  out s in ce  they do not 
s y n th e s is e  PGI2 . D ecid u a l t i s s u e  was sep a ra ted  from th e
myometrium by scraping w ith  a microscope s l id e  (W illiam s,1973). In some 
experim ents decidual t is s u e  was separated by tea sin g  w ith  a cotton  bud. 
The w e ig h t o f  th e  d ec id u a  was c a lc u la te d  from  th e  d i f f e r e n c e  betw een  
th a t of the whole uterus and th e  separated myometrium.
In some ex p er im en ts  r a t s  w ere a n a e s th e t is e d  w ith  e th e r  and th e  
u te r in e  horns exp osed  and kept m o is t  w ith  warm Krebs' s o lu t io n .  The 
a r t e r i a l  su p p ly  o f  one horn was clam ped a t  th e  u te r in e  and ov a r ia n
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a r t e r i e s  and th e  o th er  horn p e r fu se d  w ith  warm (37®C) Krebs' s o lu t io n  
v ia  th e  fem o ra l a r te r y  u n t i l  no b lood  was v i s i b l e  (| approxim ately 15 
m inutes). The vena-cava was sec tio n ed  to  a llow  perfusate  to  escape.
2.3) Incubation c ondit io ns
Human myométrial and p la cen ta l samples were suspended in  TBS 50 % 
w/v. Rat myométrial samples from day 19 to  22 pregnant r a ts  were b lo tted  
dry and suspended in  TBS t o  g iv e  a 25% (w/v) m ix tu re . The r e a c t io n  was 
i n i t i a t e d  by chopping th e  sam p les f i n e l y  w ith  d i s s e c t in g  s c i s s o r s .  
Incubations were performed a t  2cPc for 15 minutes (rat myometrium and 
human p la c e n ta  ) and 30 m in u tes  (human myometrium) . Sam ples w ere  
cen trifuged  a t  2,000 g for  30 seconds in  an Eppendorf m icrofuge (5412) 
to  sedim ent a l l  t is s u e  from th e incubation medium. Ihe incubation media 
were asp irated  and stored  on ic e . Portions o f the incubation media were 
removed and th e ir  anti-aggregatory  a c t iv i t i e s  a ssessed .
2.4) E stim ation o f .  p ro sta cy c lin  content a f  incubation media
i) Preparation q I  rabbit platelet-rich plasma
Blood was obtained from New Zealand White rab b its (2.5-4 kg) under 
e th e r  a n e s th e s ia  by c a rd ia c  p u n ctu re  u s in g  a 16-(gauge n e e d le  w ith  
s i l i c o n e  tu b in g  a tta c h e d . The b lood  was c o l l e c t e d  in t o  p l a s t i c  tu b es  
c o n ta in in g  3.8 or 3.16 % (w/v) t r i - s o d iu m c i t r a t e  (9 v o l  b lood  : 1 v o l  
c it r a te ) .  The tubes were g en tly  inverted  and cen tr ifu ged  a t  200g for 10 
m in u tes  a t  room tem p eratu re . The p l a t e l e t - r i c h  p lasm a (PRP) was th en  
a s p ir a te d  and p o o led  in t o  one p l a s t i c  tu b e . The PRP was th en  d iv id e d  
in t o  0.5 ml a l iq u o t s  in  3 ml p l a s t i c  tu b es  (Luckam PT/0944) or 0.2 ml 
a l iq u o t s  in  0.5 ml tu b es  (Luckam L P /2). Tubes w ere m a in ta in ed  a t  room
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temperature throughout th e experiment.
ii) Inhibition o t platelet aggregation
Each tube was placed in  an aggregometer (Bryson, EEL or Malin dual 
c h a n n e l) , warmed a t  37°C and s t ir r e d  a t  1100 rpm. The aggregom eter  
ou tp u t was co n n ected  t o  a 'JJ' pen reco rd er . The s m a l le s t  d ose  o f ADP 
th a t  produced an i r r e v e r s ib l e  a g g r eg a tio n  was found (2 .5 -1 0  uM f i n a l  
concentration) and used for th e  duration o f th e  experim ent. Samples o f  
in c u b a tio n  m edia (m yom étria l : 1 .2 5 -2 0  u l ; p la c e n ta l  ; 2 0 -8 0  u l) w ere  
added t o  th e  c u v e t te  one m in ute b e fo r e  ADP and th e  a n t i-a g g r e g a to r y  
e f f e c t  record ed . The PGI2 c o n te n t o f th e  sam ple was e s t im a te d  u s in g  a 
2+2 doses assay a ga in st authentic  PGI2 and production expressed as ng/mg 
wet w eight o f t is s u e  over the s p e c if ie d  incubation tim e.
i i i )  Papaverine pre-treatm ent qJL S M
In order to  in crease p la t e le t  s e n s i t iv i t y  to  PGI2 some experim ents 
were carried  out using p la t e le t s  pretreated  w ith  the phosphodiesterase  
in h ib i t o r ,  p a p a v er in e . Sam ples (0.5 m l)o f PRP w ere p la ced  in  an 
aggregometer as sp e c if ie d  above. In t e s t  sam ples, papaverine, PGI2 and 
ADP w ere added a t  c o n s e c u t iv e  one m inute in t e r v a l s ,  a f t e r  one m in ute  
pre-incubation . Papaverine was om itted in  the con tro l group leav in g  a 
two minute pre-incubation  period (see Table 1.)
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Table I I  Time course q L  SSL2 assay with QL without popaverinot
Time Control Test
Mins
0  pre-incubation  pre-incubation
1 pre-incubation  papaverine added
2 PGI2 added PGI2 added
3 ADP added ADP added
iv) D eterm ination pf assaY oooffioionta pf variation
Specimens o f lower segment u ter in e  t is s u e  were obtained from three  
p a t ie n t s .  These w ere p o o led  and a 50% w /v  m ix tu re  in cu b ated  as  above. 
The in c u b a tio n  m ix tu re  was then c e n tr ifu g e d  a f t e r  th e  30 m in ute  
in c u b a tio n  p e r io d . The pH o f  th e  a s p ir a te d  in c u b a tio n  medium was 
a d ju s te d  t o  pH 6 .5  by th e  a d d it io n  o f  O.IN HCl, and p la c e d  in  a w ater  
bath a t  37°C for  60 minutes to  destroy a l l  endogenous PGI2 . The a sp ira te  
was th en  p la c e d  on i c e ,  r ea d ju ste d  t o  pH 8 .0  u s in g  0.1 N NaOH, d iv id e d  
in t o  fo u r  eq u a l p o r t io n s  and s to r e d  a t  -20®C u n t i l  req u ired . PG%2 was 
added t o  th e  a s p ir a t e  t o  make a c o n c e n tr a t io n  o f  250 n g /m l (prepared  
fr e s h  each  day) and k ept on i c e .  Standard s o lu t io n s  w ere a l s o  made up 
fresh  each day in  TBS.
The PGI2 content o f each portion  was then assayed a g a in st authentic  
PG%2 using PRP from four d if fe r e n t rab b its. In each experim ent four 2+2 
dose assays were performed for both con tro l and pretreated  groups. The 
c o e f f ic ie n t s  o f v a r ia tio n  o f th e  d i f f e r e n t  c o n c e n tr a t io n s  a ssa y ed  (x) 
were ca lcu la ted  from equation 1 :
Equation 1)
( s tan d ard  d e v ia t io n  o f  x /  mean o f  x ) * 1 0 0  %
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2J5) Thp effect pi m  tbs stability pf bumsn myoïïietrial and placental 
antinaggcegatQCY activity
M yom étrial and p la c e n ta l  sam p les w ere in cu b ated  a s  norm al. The 
in c u b a tio n  m edia w ere a s p ir a te d  and th e  a n t i-a g g r e g a to r y  e f f e c t  o f  a 
a l iq u o t s  w ere a s s e s s e d  a g a in s t  ADP-induced aggregation o f rabbit PRP. 
Other p o r t io n s  w ere th en  a d ju ste d  t o  pH 12 .0  w ith  O.IN NaOH and 
m ain ta in ed  fo r  60 m in u tes  on i c e  and r e a c id i f i e d  t o  pH 8 .0  w ith  O.IN 
HCl. The a n t i-a g g r e g a to r y  a c t i v i t y  was th en  r e a s s e s s e d . Sam ples o f  
authentic PGI2 , PGD2 and PGE2 were trea ted  s im ila r ly .
Further experim ents were undertaken to  compare the s t a b i l i t y  o f  
th e human myométrial and p la cen ta l a c t iv i t i e s  a t  low er pH. T issues were 
in cu b a ted  a s  norm al and th e  in c u b a tio n  m edia a sp ira ted .T h e  a n t i ­
a g g reg a to ry  e f f e c t  o f  a p o r t io n  was a s s e s s e d  and o th er  a l iq u o t s  w ere  
a d ju s te d  to  pH7.5 or pH 8.5 and th en  in cu b ated  a t  room tem p eratu re  fo r  
30 m in u tes . These p o r t io n s  w ere th en  r e a s s e s s e d  fo r  a n t i-a g g r e g a to r y  
a c t iv i t y  a fte r  readjustm ent to  pH 8.0.
2.6) E ffec t M  ecechidon ic ac id  and phospholipaseAn pu  human myométrial 
PQI2 synthesis
These substances were added a fte r  pre-incubation  o f the t is s u e s  a t  
37°C fo r  te n  m in u te s . The t i s s u e s  w ere th en  chopped and in cu b ated  a t  
room tem p eratu re  fo r  30 m in u tes and th e  PGI2 c o n te n t  o f th e  m edia  
assayed.
2.7) Ef f e c t  ûf Uterine s t im u la n ts  and r e la x a n ts  pn r a t  and human 
m yom étrial anti-aggregatory  a c t iv ity
To study the e f f e c t s  of drugs th a t a f f e c t  u ter in e  c o n tr a c t i l i ty  the
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methods o f ElTahir and W illiam s (1980) were fo llow ed .
The t is s u e  was pre-incubated w ith  the drug for  10 m inutes a t  37®C 
p r io r  to  chopping. The t i s s u e  was th en  chopped a f t e r  c o o lin g  and 
in cu b a ted  a t  room tem p eratu re  fo r  15 m in u tes ( r a t ) ,  30 m in u tes (human 
myometrium and 15 m in u tes human p la c e n ta ) .  The PG%2 c o n te n t  was th en  
determined . In con tro l samples pre-incubation  was carried  out w ithout 
drug add ition .
In ex p er im en ts  u s in g  r a t  myometrium w here a n ta g o n is t s  t o  th e  
stim u lan t or relaxant drugs were used, con tro l samples were preincubated  
fo r  2 0  m in u tes  w ith  th e  a n ta g o n is t  p r io r  t o  chopping w hereas in  t e s t  
samples the ag o n ist was added a fte r  1 0  m inutes pre-incubation  w ith  the  
a n ta g o n is t  and p r e - in c u b a t io n  co n tin u ed  fo r  a fu r th e r  1 0  m in u tes . 
Samples were then cooled , chopped and incubated a t  20°C for  15 m inutes.
2.8) Elimination oL .cariy-ovei: effects of drugs used in flu en ce  PGI2 
smthesis
On incubation o f myométrial t is s u e  w ith  drugs, the p o s s ib i l i t y  th a t  
such drugs may a f f e c t  p l a t e l e t  a g g r e g a b i l i t y  m ust be c o n s id e re d . To 
con tro l for  th ese e f f e c t s ,  each drug or m ixture was added w ith  the PGI2 
stan d ard  in  a volum e and c o n c e n tr a t io n  eq u a l t o  th a t  in  th e  unknown 
incubation medium being te s ted .
2.9) Assessment a f  adenosine diphosphatase (ADPase) a c t i v i t y
A s e r i e s  o f  ex p er im en ts  w ere c a r r ie d  o u t t o  d eterm in e  i f  a n t i ­
aggregatory m ateria l (s) in  the human myométrial and p la cen ta l incubation  
m edia was due to  ADPase a c t i v i t y .  For t h i s  p u rp ose , sam p les o f  th e  
myométrial and p la cen ta l incubates were heated to  37®C for  30 m inutes to  
d e s tr o y  endogenous PGI2 . ADP was th en  added t o  a l iq u o t s  o f  t h i s  PGI2 -
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f r e e  in c u b a tio n  medium (2.3 mM f i n a l  c o n c e n tr a tio n ) and in cu b a ted  a t  
room tem p eratu re  fo r  20 m in u tes . The a g g reg a to ry  resp o n se  induced by 
a l iq u o t s  o f  th e s e  s o lu t io n s  w ere compared w ith  th a t  o f  ADP s to c k  
so lu tio n .
2 J 0 ) Effect q L  B 2I2 ^  isolated pregnant human myometrium
Segments were c o lle c te d  a t  caesarian  sec tio n  and placed in  ic e -c o ld  
T yrode's s o lu t io n .  2 X 0.5 X 0.1 cm s e c t io n s  w ere d is s e c t e d  from each  
specimen and mounted in  a 10 ml organ bath and bathed in  Krebs' so lu tio n  
a t  37°C, oxygenated  w ith  95% O2 & 5% CO2 . I s o to n ic  c o n tr a c t io n s  w ere  
record ed  under a Ig  lo a d  u s in g  a 'JJ' pen reco rd er . Sam ples were  
e q u il ib r a te d  fo r  1 hour w ith  w ash ing ev ery  15 m in u tes . Only th o se  
sam ples ex h ib itin g  spontaneity  were used. Samples were challenged w ith  
2 0 0 n g/m l a c e t y lc h o l in e  t o  en su re  v i a b i l i t y ,  p r io r  t o  th e  a d d it io n  o f  
PGI2 . PGI2 was added t o  th e  organ bath  fo r  a c o n ta c t  tim e  o f  8 m in u tes  
w ith  8 minutes recovery a fte r  washing.
3 4
3.0) METHODS -  Assay ûf pregnant xât u ter in e  PL&2 a c t iv i ty
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3J.) Liquid scintillation counting
A LKB 1215 liq u id  s c in t i l la t io n  counter was used to  d e tec t radio­
a c t i v i t y  from  t r i t i a t e d  (^H) and carb on-14  (^^C). Quench cu rv es  w ere  
c o n s tr u c te d  u s in g  th e  e x te r n a l ch a n n e ls  r a t io  v s  e f f  ic e n c y  due t o  th e  
ea se  w ith  which i t  may be constructed  w ith  t h is  equipment. A ll samples 
w ere counted  fo r  1 0  m in u tes or t o  1 0 0 ,0 0 0  c o u n ts , w hich ever  occured  
f i r s t .
i) S c in t i l la t io n  cocktails
'Aqua Luma' (Lumac Systems Inc.) was used for  determ ining a c t iv i t y  
in  aqueous sam p les and a secon d ary  s c i n t i l l a n t  (2 ,5 -d ip h e n y lo x a z o le ,  
0 .3g; l ,4 -d i(2 - (5 -p h e n y lo x a z o ly l) )b e n z e n e , 0.2g; Triton-X114, 25ml and 
xylene, 75ml) for a l l  other sam ples.
i i )  Construction g f  quench curves
Quench cu rv es  w ere c o n s tr u c te d  u s in g  c a p s u le s  c o n ta in in g  known 
am ounts o f  (LKB c a t  N° 1210-120  : 101100 dpm) and (LKB c a t  N° 
1210-122  : 121100  dpm). 8ml o f carbon te tra ch lo r id e  was added to  100ml 
o f  s c i n t i l l a n t  and d i l u t e d  f o r  e a ch  p o i n t .  Quench c u r v e s  w ere  
constructed for a lone, alone and w ith  for dual la b e llin g .  
A ll  sam ples co n ta in ed  4ml o f  quenched c o c k t a i l  in  p l a s t i c  v i a l s  and 
loaded in to  the counter which had been programmed to  count and construct 
th e  quench cu rv e . The d ata  was s to r e d  in  th e  co u n ter  memory and th e  
e f f ic ie n c y  ca lcu la ted  au tom atica lly  from th ese  curves for a l l  subsequent 
experim ents.
For dual la b e l le d  sam p les th e  s p i l l o v e r  o f  co u n ts  from th e  h igh  
energy channel (^^C) to  the low energy channel (^H), and v ic e  versa , i s
Diagram 1) Flow diagram  i l l u s t r a t i n g  th e  seq u en ce ûf. p r e p a r a tio n  û f  
incubation media, ex tra ctio n  and separation  o L  o le ic  ac id  from d2Q fûL  
assay o î .  ra t u ter in e  HA2 .
TISSUE EXCISION (4°C) ----------► HOMOGENISATION (4°C)
CENTRIFUGE ( 700 g ,  15 m ins, 4°C)
BOIL CONTROL TEST
ADD TO SUBSTRATE MIXTJRE, VORTEX
INCUBATE 37°C
MINICOLUMN BLIGH & DYER (1959)
EXTRACTION





ca lcu la ted . The disadvantage of th is  procedure i s  th a t i f  there i s  very  
lo w , or n e g l i g i b l e ,  a c t i v i t y  in  one ch an n el and h igh  a c t i v i t y  in  th e  
oth er , then the amount of s p il lo v e r  ca lcu la ted  i s  subtracted and r e su lts  
in  a n e g a t iv e  v a lu e  in  th a t  chann el w ith  low  a c t i v i t y .  T h erefore  t h i s  
method was only used for the ca lib r a tio n  o f m ini-colum ns to  i l lu s t r a t e  
separation  o f th ese two la b e ls .
3 .2 ) Preparation o f u ter in e  t is s u e
Rat pregnant w hole  u te r u s  was e i t h e r  p la c e d  in  one o f  th r e e  i c e -  
co ld  media:
a) Tris-HCl buffer (lOQmM ; pH7.5 ; 5mM CaCl2 )
b) T ris-H d  buffer (lOQmM ; pH7.5 ; 5mM CaCl2) w ith  tween-80 (0.1% v/v)
c) Sucrose so lu tio n  (0.25 M)
T issu e  was added t o  make 25% (w/v) m ix tu res  and chopped f i n e l y  
before hom ogenisation on ic e  w ith  an 'U ltra Turrax' homogeniser for 20 
sec o n d s . The hom ogen iser b la d e  was k ep t in  i c e - c o ld  b u ffe r  u n t i l  
im m ediately before use. The homogenate was then cen trifuged  a t  700g in  a 
MSE 'C h ilsp in ' fo r  15 m in u tes a t  4®C to  sed im en t n u c le i  and la r g e  
elem ents o f c e l l  debris. The supernatant was then asp irated  and stored  
on i c e .
37
3.3) S y n th e s is  û f  1 '- o l e o v l ,2 'f^ 1 H oleoyl-phosphatidvlcholine ( ï^H3PCL
^H-dPC was kindly donated by Dr. G.J.Blackwell (Wellcome research  
la b o r a to r ie s) . Synthesis was carried  out using the method o f B lackw ell, 
Duncombe, Flower, Parsons and Vane (1977).
2mg ca rr ier  o le ic  ac id  and % -o le ic  ac id  (<10 Ci/mMol) w ith  20mg 
o f 1-a c y 1-p h osp hatidy lch olin e were added to  a reaction  f la sk  and organic  
so lv e n ts  removed. The m ixture was son icated  w ith  150ml phosphate buffer  
(0.1M ; pH 7.5) and 200ul adenosine triphosphate (ATP), 200umols MgCl2 r 
2uM ols Co-enzym e-A, and 3ml 0 .2 5 M su c r o se  c o n ta in in g  r a t  l i v e r  
m icrosom es ( l l g  r a t  l i v e r  w et w e ig h t hom ogenised in  9ml s u c r o s e ) .  
In cu b a tio n  was c a r r ie d  ou t a t  37°C w ith  sh ak in g  and fu r th e r  equal 
am ounts o f  ATP, MgCl2 f ^oA and m icrosom es added a t  30 m in u tes and 120  
m in u te s . A fte r  3 hours in c u b a tio n , th e  m ix tu re  was e x tr a c te d  w ith  
chloroform  : m eth anol (2 : 1 ) and th e  ch loro form  phase d r ie d  over  
anhydrous MgSO .^ The concentrated ex tra ct was applied to  a column o f 16g 
s i l i c i c  a c id  w ith  4g H y flo , s lu r r ie d  w ith  10 % (v /v ) m ethanol : 
chloroform . Unreacted fa t ty  acid s were e lu ted  w ith  10% (v/v) methanol : 
ch lo ro fo rm  and ^H-dPC w ith  m ethanol : ch loro form  (40 : 6 0 ). 50ml 
fr a c tio n s  were c o lle c te d  and th e rad ioactive  peak iso la te d .
3.4) Substrate preparation incubation
Amounts o f  ^H-dPC (sp .a c t . <10 Ci/mMol) and ^ ^ C -o lea te  (sp .a c t .  
59.9 mCi/mMol)) were dispensed as described in  th e relevan t sec tio n .
^H-dPC was p la ced  in  p l a s t i c  S a r s te d t  tu b es  (72.690) and d r ie d  
under n itr o g e n  g a s  w ith  u n la b e lle d  1 , 2 - d io le o y  1-p h o s p h a t id y lc h o lin e  
(dPC; con cen tration s as sp e c if ie d ) . Crude enzyme (in Tris-HCl [so lu tio n  
1] ; or T ris-H C l w ith  Tween-80 (0.1%) [ s o lu t io n  2] was added and
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v o r te x ed  fo r  1 m in u te. The s o lu t io n s  w ere in cu b ated  a t  37®C fo r  th e  
tim es sp e c if ie d .
The th ird  medium (so lu tio n  3) was adapted from the method o f Dey, 
H oversland and Johnson (1982). ^H-dPC and dPC was d r ie d  in  g la s s  tu b es  
under n itrogen. Solu tion  3 was prepared w ith  N -2-hydroxyethylpiperazine- 
N'-2-ethanesulphonic acid  (HEPES ; 50mM, pH and calcium  concentration  as 
sp e c if ie d ) , HEPES w ith  0.2% T riton  X-100 and th e  u terin e  homogenate in  
su c r o se  in  th e  r a t io  5 : 3 :  1.7 . Thus i f  th e  t o t a l  in c u b a tio n  m ix tu re  
had a volume of 300ul, th is  would contain  ISOul HEPES, lOOul HEPES w ith  
T rito n  X-100 (0.2%) and 5 0 u l o f  u te r in e  hom ogenate. B efo re  th e  
homogenate or blank sucrose was added, the m ixture was placed in  b o ilin g  
water for  1 m inute, im m ediately cooled in  iced  w ater, and bovine serum 
albumin (BSA: Img/ml f in a l  concentration) was added to  bind released  ^H- 
o le ic  acid  and thus prevent reacy la tion . The m ixture was then son icated  
a t  4°C w ith  20 second b u rsts separated by 5 seconds for  two m inutes in  
order to  crea te  T riton m ic e lle s . S olu tion  3 was then incubated a t  37®C 
for varying periods.
3.5) Solubility oL l,2 -d io leo y l-p h o sp h a tid y lch o lin e  (dPC) and o le ic  acid  
in iho throo substi.ate solution?.
The three incubation m ixtures were prepared as above, each 150ul 
sam ple c o n ta in in g  50nM ols ( i . e .  333uM) dPC and ^H-dPC (1 0 ,0 0 0 -2 5 ,0 0 0  
DPM) a t  pH 7.5 w ithout u ter in e  t is s u e  but w ith  0.25M sucrose su b stitu ted  
fo r  th e  u te r in e  hom ogenate in  s o lu t io n  3. A fu r th e r  group o f  m ix tu res  
were prepared w ithout dPC and ^H-dPC (10,000 -  25,000 DPM) but w ith  ^^C- 
o le a te  (10,000 -  20,000 DPM ). A fter preparation, aqueous sam ples were 
p ip e t te d  in t o  s c i n t i l l a t i o n  v i a l s  and tak en  up in  4ml Aqua Luma, th e  
a c t iv i ty  measured and compared w ith  co n tro ls  dispensed d ir e c t ly  in to  the
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s c in t i l la t io n  v ia ls  and evaporated under n itrogen. The percentage lo s s  
was then ca lcu la ted  .
3.6) Column chromatography
3 .6  i)  Preparation o f minicolumns
Mini-columns were prepared according to  th e method o f Cosentino  
and Le Grande (1981). G la ss  d is p o s a b le  P a steu r  p ip e t t e s  (130mm X 5mm) 
were plugged w ith  g la s s  wool and packed to  a h eigh t o f 5cm w ith  s i l i c a  
g e l  (Sigma 100-200 mesh) suspended in  hexane : dioxane : g la c ia l  a c e t ic  
a c id  (S o lv en t 1: 70 : 30 ; 1 , v /v /v ) .  The s i l i c a  g e l  was e i t h e r  h ea ted  
to  100°C for  1 hour or not heated, and was eq u ilib ra ted  in  so lv en t 1 for  
0 -1 4  days b e fo r e  u se . A n e g a t iv e  p r e ssu r e  fume cupboard was used  
throughout column preparation and use.
3 .6  i i )  E x tr a c t io n  and se p a r a t io n  o f  ^H-dPC and ^^C -o le ic  a c id  from  
aqueous samples using mini-colum ns
The advantage o f t h i s  proced u re i s  th a t  both  e x tr a c t io n  and 
separation  are achieved w ith in  the same step .
150ul a liq u o ts  of so lu tio n  2 contain ing ^H-dPC (333uM ; 75,000 DPM 
pH 7.5) and ^ ^ C -o le ic  a c id  (40 ,000  DPM) and s o lu t io n  3 c o n ta in in g  dPC 
(333uM : 48,000) and ^^C -oleic ac id  (40,000 DPM) were app lied  d ir e c t ly  
t o  th e  colum ns c o n ta in in g  1 0 0 - 2 0 0  mesh s i l i c a  g e l  w hich had been  
e q u il ib r a te d  fo r  7 days in  s o lv e n t  1 . 1 ml o f  s o lv e n t  1 was th en  
im m ed ia te ly  added. T h is  was g e n t ly  fo r c e d  in t o  th e  column pack in g  by 
a p p ly in g  p r e ssu r e  v ia  a p ip e t t e  bu lb  p la c e d  over  th e  colum n. The 1ml 
e lu a te  was c o l l e c t e d  in t o  a s c i n t i l l a t i o n  v i a l .  F iv e  fu r th e r  1ml 
a l iq u o t s  o f  s o lv e n t  1 w ere added t o  th e  column and s u c c e s s iv e  e lu a t e s
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(c o n ta in in g  or ^ H -o le ic  a c id  ) c o l l e c t e d  ( fo r  each 1ml sa m p le).
The ^H-dPC was th en  e lu te d  by th e  a d d it io n  o f  s i x  1ml a l iq u o t s  o f  
s o lv e n t  2 (C hloroform  : m ethanol : w a ter; 65 : 35 ; 4 , v /v /v )  and 
c o l l e c t e d  as b e fo r e . Both s o lv e n t s  1 and 2 w ere d r ie d  down under 
n itr o g e n  gas in  a w ater  bath  a t  37®C and th e  s c i n t i l l a t i o n  c o c k t a i l  
added.
Column r e t e n t io n  o f  ^H-dPC and ^ ^ C -o le ic  a c id  was c a lc u la te d  by 
comparing the t o t a l  ra d io a c tiv ity  e lu ted  w ith  150ul o f the same sample 
taken up in  Aqua Luma. Dual la b e lle d  s c in t i l la t io n  counting was used for  
th ese  procedures.
3.7) Thin layer chromatography 
3 .7  i) E xtraction q L  igC and o le ic  acid, from aqueous samples
a) Organic so lv en ts  and ^
150u l sa m p les  o f  s u b s tr a te  s o lu t io n  3 (pH7.5 ; 5mM CaCl2 ;333uM 
dPQ c o n ta in in g  e i t h e r  3 ,0 0 0  DPM o f  ^H-dPC or 3 ,0 0 0  DPM o f  ^ ^ C -o le ic  
a c id  w ere a d ju s te d  t o  pH 3 .0  or 1 1 .0  by th e  a d d it io n  o f  O.lN HCl and 
O.lN NaOH. These sam p les w ere v o r te x ed  w ith  1ml each  o f th e  fo l lo w in g  
s o lv e n t s :  ch lo ro fo rm , d ich io ro m eth a n e , n -h ep ta n e , d ie t h y le t h e r  and 
b u ta n - l-o l. A ll were compared to  150ul aqueous samples taken up in  Aqua 
Luma.
b) Method pf Bligh and Dyer (1959)
150u l sa m p les  o f  s o lu t io n  3 (pH 7.5 ; 5mM CaCl2 ; 333uM dPC) 
contain ing 4,5000 dpm ^H-dPC and 3,500 DPM ^^C -oleic acid  were prepared 
and added to  tubes contain ing 188ul chloroform and 375ul methanol and 
vortexed , forming a m isc ib le  chloroform : methanol : water system  (ratio  
1 :2 :0 .8  r e s p e c t iv e ly ) .  A fu r th e r  1 8 8u l o f  ch loro form  was added and
41
v o r te x e d  fo l lo w e d  by 1 8 8 u l o f  d i s t i l l e d  w ater  w hich sep a ra ted  th e  
so lu tio n  in to  chloroform  and m ethanolic la y ers . The lower (chloroform) 
layer  was a sp irated  in to  s c in t i l la t io n  v ia l s  and th e  m ethanolic layer  
fu r th e r  washed w ith  one volum e o f  ch lo ro fo rm . I t  was found th a t  th e  
a d d ition  o f 50ul o f methanol to  th e  chloroform layer ensured ^ o sp h o -  
l i p i d  s o l u b i l i t y .  The ch lo ro fo rm  was d r ie d  down and s c i n t i l l a t i o n  
c o c k t a i l  added. The r e s u l t s  w ere compared t o  1 5 0u l o f  co rresp on d in g  
aqueous sam ples added d ir e c t ly  to  Aqua Luma and % recovery ca lcu la ted . 
I f  th e  sam ple was t o  be a p p lie d  t o  TLC p l a t e s ,  th e  sam ple was d r ie d  in  
S arsted t tubes to  approxim ately 30ul and applied to  th e TLC p la te s .
3 .7  i i )  Preparation o f TLC p la te s
Whatman TLC p la te s  (LK6D) were heat a c tiv a ted  a t  100®C for  1 hour 
p r io r  to  u s e , and s to r e d  in  a d e s s ic a to r  c a b in e t  u n t i l  sa m p les w ere  
a p p lie d  t o  th e  p la t e s .  P la t e s  w ere run in  ch loro form  : m ethanol : 
g l a c i a l  a c e t i c  a c id  : w ater  (50 : 15 : 4 ; 2 , [S o lv e n t 3 ] ) .  The tan k s  
were eq u ilib ra ted  w ith  th e so lv en t system for 1 hour before use.
3 .7  i i i )  Separation o f. dP£ aM  o le ic  acid
^H-dPC (400 ,000  DPM in  ch loro from  : m ethanol [6 0 :4 0 ]) and ^^C- 
o le ic  ac id  (200,000 DPM in  toluene) were sp otted  onto separate la n es  and 
run to  lOcm. The p la te s  were then scanned using a Berthold TLC scanner 
(2X2 mm window) to  l o c a l i s e  peaks o f  a c t i v i t y .  Img o f  l ~ ly s o -  
ph osp hatid y lcholine was sp otted  onto one lane and th e p la te  run as above 
and v is u a lis e d  under iod in e vapour.
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3 .7  iv) E lution Q t dPQ s M  o le ic  acid  fiam  TL£. zones
^H-dPC (50 nM ols [140 ,000  DPM], e q u iv a le n t  t o  a 1 5 0 u l aqueous 
sample contain ing 333uMolar dPC ) and ^^C -oleic ac id  (80,000 DPM) were 
a p p lie d  to  se p a r a te  la n e s  o f  th e  TLC p la t e s  and d eve lop ed  t o  10cm. The 
zon es c o n ta in in g  ^H-dPC (o r ig in  -  8cm) and ^ ^ C -o le ic  a c id  (8 -  12cm) 
were scraped in to  s c in t i l la t io n  v ia l s .  S c in t i l la t io n  c o c k ta il was added 
w ith  or w ith o u t 1 ml m ethanol and th e  % reco v ery  compared t o  sam p les  
added d ir e c t ly  to  the s c in t i l la t io n  v ia ls .  The 30ul chloroform ex tra cts  
o f incubation media were app lied  to  separate lanes o f th e TLC p la te s  and 
developed to  10cm. The zones contain ing the ^H-dPC and released  ^H -oleic  
acid  were a lso  scraped in to  s c in t i l la t io n  v ia ls .
3.8) Protein  a ssa y
Protein  content o f rat u terin e  incubation media were assayed using  
an a d a p ta tio n  o f  th e  method o f Lowry, R osenbrough, Farr and R andall 
(1951). Since HEPES in te r fe r e s  w ith  the assay , rat u ter in e  homogenates 
w ere added t o  s a l in e  in  th e  same r a t io  (17 % hom ogenate v /v )  a s  th e  
in c u b a tio n  m ix tu r es . The a ssa y  was c a r r ie d  o u t u s in g  th e  fo l lo w in g  
so lu tio n s
A ; 5 % w/v CUSO4
B : 10 % w/v Na/k-Tartrate
C : 2 % w/v Na2C03  in  O.lN NaOH
D ; 1 v o l F olin -C iocalteau  reagent
& 2 v o l d i s t i l l e d  water 
E : 1ml A & 1ml B & 8ml water 
F : 1ml E & 50ml C
S o lu t io n s  E and F w ere prepared  im m ed ia te ly  b e fo r e  u se  and
43
so lu tio n s  A to  D stored  a t  4®C.
Incubation media were prepared contain ing 0.2ml samples (d ilu ted  1 
: 4 or 1 ; 8 a s  a p p r o p r ia te ) , 2 .0  ml F and 0.2 ml D. The sam p les  w ere  
mixed w e ll and allow ed to  stand for 30 minutes a t  room temperature in  
the dark. The absorbance was read a t  650nM aga in st a reagent blank and 
p r o te in  c o n c e n tr a t io n s  c a lc u la te d  from a c a l ib r a t io n  cu rve prepared  
using p u r if ied  bovine serum albumin as standard.
3.9) Calculation o L  ph.osEholipasezA2 ac.tlYity.
The amount o f  ^ H -o lea te  r e le a s e d  from  ^H-dPC was c a lc u la t e d  by 
subtractin g  the r a tio  o f DPM in  th e  o le ic  ac id  fr a c tio n  : to t a l  DPM of
the sample b o iled  blank sample (B), from th e r a tio  of o le ic  ac id  : to t a l  
DPM of the t e s t  sample (T) .This r a t io  o f o le ic  ac id  : dPC was then used 
to  c a lc u la t e  th e  a b s o lu te  amount o f  o l e i c  a c id  (nMols) r e le a s e d  by 
m u lt ip l ic a t io n  by th e  t o t a l  amount o f  dPC p r e se n t  (nM ols). nM ols o f  
o l e i c  a c id  r e le a s e d  was ex p r essed  a s  a fu n c t io n  o f  th e  t o t a l  p r o te in  
content in  mg (P) in  th e tube per hour o f incubation. (Equation 2).
Equation 2)
( (T -  B) X nMols dPO /  P X tim e = nMols o le ic  ac id  released  mg“  ^ hour”^
3.10) Açtion û f  â ü th g it ic  i^Q.gpholip a s e-A2 o r  l - o l e o y l  ,2 -  ( r ^ H1 - o le o y l )  -  
Phosphatidylcholine
Authentic porcine p acrea tic  PLA2 (5 U/ml) was incubated w ith  150ul 
sam p les o f  s o lu t io n  3 c o n ta in in g  333uM dPC (50 ,000  DPM, m in ico lu m n s : 
4 0 0 ,000  DPM, TLC) a t  37®C fo r  30 m in u tes . Sam ples w ere e x tr a c te d  and 
separated using m ini columns or the method o f Bligh & Dyer fo llow ed  by
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TLC. Samples were then compared by liq u id  s c in t i l la t io n  counting and th e  
TLC samples scanned using a Berthold TLC scanner (2X2 mm window).
3.11) Time co u rse  p f  ^H -o le ic  a c id  r e le a s e  and th e  com parison  p f  
separation  pf dPQ s a d  alsis. acid  by mini-column sjo û  TL£. after inoubation 
with rat uterine homogenate
S o lu t io n  3 (pH 7.5 ; 5mM CaCl2 ) was prepared by v o r te x in g  1ml 
HEPES and 0.66m l HEPES-Triton X -100 (0.2%) w ith  ^H-dPC (15 ,000  DPM per  
150 u l o f  f i n a l  in c u b a tio n  m ix tu re) and dPC (to  make 333uM). The 
s o lu t io n  was v o r tex ed  w ith  0.33m l o f  r a t  u te r in e  hom ogenate (19 day 
pregnant) and incubated a t  37°C . 150ul samples were taken in  d u p lica te  
from  0 -6 0  m in u tes  and e x tr a c te d  (B lig h  & Dyer 1959 ; s e e  s e c t io n  3.7 i .  
b) for ^ p l ic a t io n  to  TLC p la te s  for  separation  .
When TLC and mini-column separation  were compared, paired 150ul 
sam p les w ere p la ced  on m in i-co lu m n s and e x tr a c te d  fo r  TLC. Sam ples 
contain ing b o iled  homogenate were used as co n tro ls .
3.12) Incubation oL jzab utgiine hom ogenate w ith  p h osp h o lip aseA n 
inhibitors
Day 18 and 19 pregnant ra t u terin e  homogenates were incubated in  
so lu tio n  3 a t  pH 7.5 contain ing 5mM CaCl2 and 333 uM dPC (5,000 DPM per 
150 u l of f in a l  incubation m ixture). Mepacrine or te tra ca in e  was added 
to  s o lu t io n  3 p r io r  t o  th e  a d d it io n  o f  th e  hom ogenates t o  make 6.77  
uMolar and 1 mMolar f in a l  concentrations. D uplicate 150ul sam ples were 
taken over 60 m inutes and compared w ith  b o iled  protein  co n tro ls .
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3.13) Protein  dépendance
Three s u b s tr a te  m ix tu r es  ( s o lu t io n  3 , pH 7.5 ; 5mM CaCl2 ) w ere  
prepared by vortexing 3.0ml HEPES and 2.0 ml HEPES-Triton X-100 w ith  ^H- 
dPC (25,000 DPM per 150 u l o f f in a l  incubation mixture) and dPC (333uM) 
and sonicated . To three 1.5ml a liq u o ts  o f sub strate  so lu tio n  was added 
e ith e r  a) 0.75 ml b o iled  day 18 pregnant u ter in e  homogenate as blank, or
b) 0.75 ml u te r in e  hom ogenate, or c) 0.38 ml u te r in e  hom ogenate w ith  
0.38 ml sucrose so lu tio n . This was then vortexed and incubated a t  37®C . 
D u p lica te  sam p les w ere tak en  a t  5 , 10 and 20 m in u tes  and e x tr a c te d  
(Bligh & Dyer,1959) for sep aration  by TLC.
3.14) ^  dependence
A liq u o ts  o f  s o lu t io n  3 (5mM CaCl2 ; 333 uM dPC [2 5 ,0 0 0  DPM per  
150ul o f f in a l  incubation m ixture]) were prepared over a range o f 6 .75- 
8.5 by th e  a d d it io n  o f  vo lu m es o f  O.lN HCl or O.lN NaOH p r io r  to  
vortexing w ith  u terin e  homogenate. D uplicate 150ul samples were taken a t  
5 , 10 and 20 m in u tes  and th e  mean pH optimum found fo r  tw o day 20  
pregnant ra t u te r i.
3J5) Calcium dependence
S o lu t io n  3 (pH 8 .0  ; 333uM dPC [2 5 ,0 0 0  DPM per 150u l o f  f i n a l  
in c u b a tio n  m ix tu re] ) was prepared by v o r te x in g  300u l HEPES and 200u l 
HEPES-Triton X-100 w ith  ca lc iu m  in  c o n c e n tr a t io n s  from 0 -1 0  mMolar. 
lOOul o f rat u ter in e  homogenate (20 day pregnant) was added to  each tube 
and incubated over 20 m inutes. 150ul samples were taken in  d u p lica te  a t  
5 , 10 and 20 m in u tes  and e x tr a c te d  as  b e fo r e  fo r  s e p a r a t io n  by TLC. 
Samples contain ing b o iled  p rote in  were used as co n tro ls .
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3.16) Substrate dependence
S o lu t io n  3 (5mM CaCl2 ; pH 8.0; ^H-dPC 25 ,000  DPM per ISOul 
sam ple o f f i n a l  in c u b a tio n  m ixtu re) was prepared by v o r te x in g  300u l 
HEPES and 200ul HEPES-Triton X -100 w ith  50 , 7 5 , 100 , 200 , 400 and 800  
nM ols dPC w ith  ^H-dPC in  g la s s  tu b es  (to  make 41.6 -  1332 uM f i n a l  
concentrations) and son icated . lOOul of ra t u ter in e  homogenate (20 day 
pregnant) was added t o  each  tube and in cu b a ted  over 20 m in u te s . 150u l 
samples were taken a t  5 , 10 and 20 minutes and extracted  as b efore for  
s e p a r a t io n  by TLC. Sam ples c o n ta in in g  b o i le d  p r o te in  w ere used  as  
c o n tr o ls .
3.17) Statistics
A s t a t i s t i c s  program developed by T allarida  and Murray (1981) was 
m odified , loaded onto d isc  and run using a "Superbrain II" microcomputer 
( I n te r te c  Data S y stem s). A ll  s t a t i s t i c a l  p roced u res w ere c a r r ie d  ou t  
u s in g  t h i s  program. The p a ired  and unpaired  't '  t e s t s  w ere used  to  
compare t e s t  groups w ith  a s in g le  co n tro l, and Dunnet's t e s t  to  compare 
s e v e r a l  t e s t  groups w ith  a s in g le  c o n tr o l .  For f ig u r e s  18 and 19 
( s e c t io n s  4.13 & 4.14) r e s u l t s  w ere com paired by p a ired  't '  t e s t  a f t e r  
logjLQ transform ation. The Lineweaver-Burke p lo t  was used t o  c a lc u la t e  
Vmax and Km of th e ra t u ter in e  PLA2 (section  6J.5).
3 .18) Drug and so lu tio n s
a) Sources cf Chemicals and drugs 




D io leo y l-p h o sp h a tid y Ich o lin e  
2 '5 *-d ip h en y loxazo le  
1 , 4 - d i (2- ( 5 -p h en y loxazoy l))benzene 
Dipyridam ole (Persantin)
Ergometrine m aleate  
F orsk olin  
H ydralazine HCl
N -2-hydroxyethyl p ip era z in e -N '-2 -e th a n e-  
su lp h on ic  a c id  
Indome th acin  
Mepacrine HCl 
^ H -oleic  a c id  
^ ^C -oleic  a c id
l~ -o le o y l  phosphatidyl ch o lin e  
Oxytocin (sy n th e tic )
Papaverine HCl
Phospholipase (porcine pancreas) 
P rostagland in  D2 
Prostagland in  E2 




S i l i c a  Gel (Mesh 100-200)
T etracaine HCl
T ris  (hydroxymethy 1 ) amincmethane 









Merck, Sharpe & Dohme 
Sigma
Amersham In tern a tio n a l


















b) Sources a f  Solvents  
A cetic  acid  (G lacial) 
Chloroform 
D ieth yl ether  

















NaCl, 6.9 ; KCl, 0 .35 ; CaCl2 , 0.55 ; KHPO4 , ^.16 ; MgSO^.? H2O, 0 .16  ; 
G lucose, 1 .0  and NaHOOg, 2 .1  (g/dm^).
Tyrode's so lu tio n
NaCl, 8 .0  ; KCl, 0.2 ; MgCl2 , 0.1 ; NaHPO^, 0.05 ; NaHO^, 1 .0  ; CaCl2 , 
0 .2  and g lu co se , 1 .0  (g/dm^).
Arachidonic acid  and indomethacin
AA was s to r e d  in  benzene u n t i l  r eq u ired . Sam ples w ere th en  blow n dry  
under dry n itr o g e n  g as and resuspend ed  in  TBS and d is s o lv e d  w ith  an 
e q u iv a le n t  amount o f  NaHCOg. Indom ethacin  was added dry to  TBS and 
d isso lv ed  in  a sim ilar  manner.
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Dipyridamole
Dipyridamole was d isso lv ed  i n i t i a l l y  in  66% absolu te  ethanol and d ilu te d  
to  the required con cen tration .
Hydralazine
Hydralazine was d isso lv ed  in  TBS, kept on ic e  and used w ith in  one hour.
Other drugs
A ll other drugs were made to  th e required concentrations in  TBS un less  
otherw ise s p e c if ie d  and stored  on ic e  throughout th e  e x p e r im en ts .
P ro sta cy clin
P r o s ta c y c lin -N a  was s u p p lie d  by W ellcom e L a b o r a to r ie s  a s  th e  s o l i d  and 
stored  a t  -20®C in  OJ. N NaCH (pH 11.0 , lOmg/ml). A liquots o f t h is  so lu tio n  
were d ilu te d  to  lOOug/ml in  lOOmM T ris  bu ffer (pH 11.0) and stored  a t  -20°C. 
From t h i s ,  s ta n d a rd  s o lu t io n s  w ere prepared  f r e s h  each day in  50 mM T r is  
b u ffe r  (pH 8.0) and w ere s to r e d  on i c e  th rou ghout th e  ex p er im en t.
PG%2 was a l s o  p rep ared  in  u n gassed  Krebs' s o lu t io n  and s to r e d  on i c e  fo r  
a p p lica tio n  to  human pregnant myometrium i n  v itr o  (as described  in  se c tio n  
2 .10).
50
4.0) EE5ÜLT5 -  Studies en tb& production c f  an ti-aggregatory  m ateria l by  
the, pregnant human myometrium and p lacenta
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4J.) The e f f e c t  o L  papaverine m  ADP-jndusfid platelet aggregation
In order t o  in c r e a s e  th e  s e n s i t i v i t y  o f p l a t e l e t s  t o  th e  a n t i ­
aggregatory in flu en ces  o f PGI2 , PRP was pretreated  w ith  the phospho­
d ie s te r a se  in h ib ito r  papaverine. I n i t ia l ly  the e f f e c t  of papaverine on 
ADP induced p la t e le t  aggregation was observed in  order to  to  e s ta b lish  a 
th r e sh o ld  c o n c e n tr a t io n  o f  p ap a v er in e  w hich  co u ld  be used  fo r  t h i s  
purpose.
Papaverine was added to  PRP a fte r  1 m inute's s t ir r in g  a t  37®C and 
in cu b a ted  w ith  th e  p l a t e l e t s  fo r  2 m in u tes  b e fo r e  ADP a d d it io n .  
Papaverine exh ib ited  d o se-re la ted  an ti-aggregatory  a c t iv i ty  (see fig u re  
4). At 50uM th e  in h ib i t io n  was 6.26 + / -  1.4% (mean + / -  s .e .m .; n=6 ) , 
lOOuM (14.1 + /“ 1.9%); 200uM (32.9 +/-11.1% ), 400uM (72J. + / -  10.4%) and 
800uM (97.4 + / -  1.9%) in h ib i t io n  o f p l a t e l e t  a g g r e g a t io n ) . SOuM and 
lOOuM papaverine thus exh ib ited  l i t t l e  anti-aggregatory  a c t iv ity .  These 
doses were th erefore used to  study th e ir  in tera c tio n  w ith  PGI2 .
4.2) The. e f f e c t  a f  papaverine m  t b s  in h ib it io n  a f  platelet aggregation 
by PGI2
P la te le t s  were incubated and s t ir r e d  for  one minute prior to  the  
a d d it io n  o f  p a p a v er in e . PGI2 was added a f t e r  1 m in ute in c u b a tio n  w ith  
p ap a v er in e  and a g g r e g a tio n  induced w ith  ADP 1 m in ute la t e r .  Dose 
resp o n se  cu rv es  o f  th e  a n t i - a g g r e g a t o r y  a c t i v i t y  o f  PGI2 w ere  
c o n s tr u c te d  a lo n e  or in  th e  p resen ce  o f  5 0 , 100 and 200uM p ap averin e  
(see f ig u re  5). The concentration o f PGI2 required to  in h ib it  p la t e le t  
a g g r e g a t io n  by 50% (ID^q) was reduced from 7.2 + / -  0.7 ng PGI2 /m l  o f  
PRP (mean + / -  s.e .m .; n=4) t o  3.9 + /- 0 .4  by 50uM p ap averin e; t o  2.2 + / -  
0.6 n g /m l by lOOuM and t o  1.5 + / -  0 .4  ng PGI2 /m l  by 200uM papaverine. 



























Figure 4) The e f fe c t  of papaverine on ADP-induced p la t e le t  aggregation  
of c i t r a t e d  ra b b it p l a t e l e t - r i c h  plasm a. Papaverine (50 -  400uM) 
exh ib ited  a d ose-related  in h ib itio n  o f ADP-induced p la t e le t  aggregation. 
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Figure  5) The e f f e c t  of papaverine  (50,100,200 uM) on th e  a n t i ­
agg rega to ry  a c t io n  of PGI2  using  ADP-induced a g g reg a tio n  of r a b b i t  
p l a t e l e t - r i c h  plasma. Papaverine p o te n t i a t e d  th e  e f f e c t  of PGI2  in  a 
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Figure 6 ) The e f f e c t  of papaverine on the  dose of PGI2  requ ired  to  
i n h ib i t  ADP-induced p l a t e l e t  aggregation  by 25% {ID2 5 ). Papaverine 
reduced the ID2 5  in a dose-related fashion. Points represent mean +/- 
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F ig u re  7) The e f f e c t  o f  t im e  in t e r v a l  b etw een  c a e sa r ia n  s e c t io n  and 
in c u b a tio n  on human p regnant m yom étria l r e le a s e  o f  a n t i-a g g r e g a to r y  
a c t i v i t y .  A lthough th e r e  was no d i f f e r e n c e  in  th e  mean r e le a s e  , th e  
s.e.m . in c r e a se d  a t  8 hours but n o t s i g n i f i c a n t l y .  P o in ts  and v e r t i c a l  
bars in d ica te  mean + / -  s.e.m.
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was reduced from 2.69 + /” 0 .5 ng PGI2 /m l  t o  1 .68 + /“ 0.34 by 50uM 
p a p v er in e; 0.78 + / -  0 .2  (lOOuM) and 0.51 + / -  0.1 ng PGl2/m l by (200uM) 
(s e e  f ig u r e  6 ) . The s lo p e s  o f  th e  c u r v es  fo r  PGI2 a lo n e  or in  th e  
p r e se n c e  o f  th e  d i f f e r e n t  d o se s  o f  p ap averin e  w ere n o t s i g n i f i c a n t l y  
d if fe r e n t  ( t e s t  for p a ra lle lism ; T allarid a  & Murray, 1980)
4.3) The. e f f e c t  o t  time in t e r v a l  betw een  delivery and start nf 
in c u b a tio n  q r  the a n t i-a g g r e g a to r y  material released from human 
myometrium
Previous work in  t h is  laboratory has shown th a t maximal r e le a se  of 
a n t i-a g g r e g a to r y  m a te r ia l  i s  a ch iev ed  a f t e r  chopping and 30 m in u tes  
in c u b a tio n  a t  room tem p eratu re  . A l l  human m yom étria l samples w ere  
th erefore  trea ted  in  th is  manner to  generate an ti-aggregatory  m a ter ia l.
Figure 7 shows th a t th e re lea se  o f anti-aggregatory m ateria l from 
th ree  human myometria (weeks 38, 39, 40) i s  constant when stored  up to  8 
hours on ic e  in  Tyrode's so lu tio n . However th e  standard error was noted 
t o  in c r e a s e  over t im e , though n o t s i g n i f i c a n t l y ,  and th e r e fo r e  a l l  
sa m p les  w ere used  a s  soon  as  p o s s ib le  a f t e r  s e c t io n  (u su a lly  w ith in  2 
hours o f c o lle c t io n ) .
4.4) Preparation oL ££l2~free In.oubation medium from human p regnant 
myom étrial t is s u e
PGl2 - f r e e  medium was prepared in  order t o  t e s t  th e  e f f e c t  o f  
p a p averin e  on a u th e n t ic  PGI2 under th e  ex p e r im en ta l c o n d it io n s  w hich  
would be used.
A f t e r  c h o p p in g  and s u b s e q u e n t  in c u b a t io n ,  human pregnant 
myometrium produced anti-aggregatory a c t iv i t y .  Hie medium was incubated
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fo r  10 m in u tes and 60 m in u tes a t  pH6.5 a t  37°C T h is  a c t i v i t y  was 
m arkedly reduced a f t e r  10 m in u tes  in c u b a tio n  and a b o lish e d  a f t e r  60  
m inutes incubation (Figure 8). Pretreatm ent o f p la t e le t s  w ith  papaverine 
(lOOuM) confirmed th a t no resid u a l a c t iv i t y  remained, and showed th at  
PGl2“fr e e  medium does not a f fe c t  ADP-induced p la t e le t  aggregation in  the  
presence of papaverine.
4.5) Ths e f f e c t  af PGl2- f r e e  incubation medium from human myometrium on 
the anti-aggregatory activity of PGI2
The p o s s i b i l i t y  th a t  th e  PGl2“ f r e e  a s p ir a te  may a l t e r  p l a t e l e t  
s e n s i t iv i t y  to  PGI2 was in v estig a ted . PGI2 (2.5ng) was added one minute 
p rior to  ADP (5uM) w ith  or w ithout 20ul of PGl2“fr e e  human myométrial 
in c u b a te . PGI2 (1.25ng) was a ls o  added w ith  or w ith o u t 20u l o f  human 
PGl2- f r e e  myométrial incubate to  PRP pretreated  w ith  papaverine (lOOuM). 
F ig u re  9 shows th a t  th e  a n t i-a g g r e g a to r y  a c t i v i t y  o f  a u th e n t ic  PGI2 
remained the same in  th e presence o f PGl2“fr e e  human myométrial incubate  
w hether th e  p l a t e l e t s  w ere p r e - tr e a te d  w ith  p ap aver in e  or n o t . Thus 
a u th e n t ic  PGI2 may be used as a stan d ard  w ith o u t th e  concomitant 
add ition  o f PGl2- f r e e  incubate.
4.6) Assay coefficients oL variation
PGI2 was added to  PGI^-free human myométrial incubate to  make a 
c o n c e n tr a t io n  o f  250ng/m l and a ssa y ed  by a 2+2 d o ses  a s sa y . T h is  was 
compared using PRP from four rabbits w ith  and w ithout papaverine pre­
tr e a tm e n t and th e  a ssa y  rep ea ted  fou r t im e s  w ith in  each sam ple (see  
f ig u r e  10  fo r  exam p le). The a s sa y s  w ith o u t p ap aver in e  and w ith  
p ap averin e  (lOOuM) gave t o t a l  means o f  242.4 + / -  0.4 and 262.3 + / -  0.4  




Animal 1 2 3 4 X coeff
A 206-2 261-2 272-1 271-8 252-8 12-5%
B 2 58-A 2/32 237-0 231-5 242-5 4-8%
C 2232 230-7 263-3 252-3 242-4 7-7%
D 2727 216-9 241-8 1948 231-6 14-5%
X 2^ 0-1 2380 253-6 2376
coeff 128% 7-9 % 6-6% 13-9%
Papaverine Pretreated
Assay-PGbnq/ml
Animal 1 2 3 4 X c o e ff
A 199-8 277-5 295-0 310-0 270-6 18-1 %
B 194-6 2575 262-0 2720 246-5 143%
c 2279 295-0 315-6 241-0 2699 156%
D 264-0 256-0 2706 2576 262-1 2-5%
X 221-6 271-5 2888 2702
coeff 6 8% 8-5% 109%
T a b le  2) C o e f f i c i e n t s  o f  v a r i a t i o n  f o r  t h e  a s s a y
o f  PGI^ (2 5 0 n g /in l p l a c e d  i n  PGI^ f r e e  huinan myo­
m é t r i a l  in c u b a t e )  by  t h e  i n h i b i t i o n  o f  ADP -  
in d u c e d  p l a t e l e t  a g g r e g a t io n  w i t h  o r  w i t h o u t  p r e ­
t r e a t m e n t  w i t h  lOOuM p a p a v e r in e .  S a m p le s  w e r e  
a s s a y e d  u s in g  PRP fro m  f o u r  r a b b i t s  (A-D) and  
a s s e s s e d  f o u r  t im e s  p e r  r a b b i t  ( 1 - 4 ) .
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Figure 8) P rep ara tion  o f PGl2“ fr e e  medium a f t e r  in cu b a tio n  o f human 
pregnant myométrial t is su e . Myométrial incubate (MI) was incubated a t  
37®C fo r  10 and 60 m in utes a t  pH 6.5 and t e s t e d  fo r  a n ti-a g g r e g a to r y  
a c t i v i t y .  A ggregation  o f c i t r a t e d  r a b b it  p la t e l e t - r i c h  plasm a was 
induced by ADP (5uM, T ) . Papaverine (lOOuM, p) was used throughout . 
In cu bation  fo r  60 m in utes a t  37°C a b o lish e d  a l l  a n t i-a g g r e g a to r y  
a c t iv ity .
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Figure 9) The e f fe c t  of PGl2”free  myométrial incubate (MI) on the a n t i-  
aggregatory a c t iv ity  PGI2 . PGI^-free incubate was prepared by incubation  
of m yom étrial in cu b ate  a t  pH 6.5 at37°C fo r  one hour. A ggregation  o f  
c i t r a t e d  ra b b it  p l a t e l e t - r i c h  plasm a was induced by ADP (5 uM, ▼). MI 
had no e f fe c t  on the anti-aggregatory a c t iv ity  of PGI2 w ith or without 
papaverine (lOOum, p) pretreatm ent.
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Figure 10) The e f fe c t  of papaverine (p ; lOOuM) on the anti-aggregatory  
a c t iv ity  of PGI2 and PGI^-free human (39-40  week pregnant) m yom étrial 
incubate containing 250 ng/ml PGI2 in  a 2+2 doses assay. Papaverine did  
not a ffe c t  the response to  ADP (10 uM; g ) but p oten tiated  the e f f e c t  of 
PGI2 •
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p a p a v er in e  w ere 12,6 + / -  3.4 and 9.9 + / -  2.2% r e s p e c t iv e ly .  The in t e r ­
assay c o e f f ic ie n t s  o f v a r ia tio n  w ith  and w ith o u t p ap averin e  w ere 10.1  
+ /-  1.6 and 10.3 + / -  1.8 % r e s p e c t iv e ly  (se e  t a b le  2 ) . There w ere no 
s ig n if ic a n t  d ifferen ces  between the mean concentrations o f PG%2 f or the  
in te r -  or in t r a - a s s a y  c o e f f i c i e n t s  o f  v a r ia t io n  u s in g  p a ir e d 't*  t e s t .
4.7) !2qsl e f f e c t  nf. papaverine m  anti-aggregatory  activity produced by  
human myojnstrium
Hie p o ten tia tio n  o f the anti-aggregatory  a c t iv i t y  o f PGI2 released  
by human myometrium by lOOuM p ap aver in e  was e q u iv a le n t  t o  th a t  o f  
a u th e n t ic  PGI2 . T h is en ab led  th e  a s sa y  o f  o f  low  q u a n t i t ie s  o f  PGI2 
where la rg e  q u a n tit ie s  o f incubation media would be required t o  in h ib it  
p la t e le t  aggregation. Figure 11 i l lu s t r a t e s  th e  assay of PGl2“lik e  a n t i­
a g g reg a to ry  a c t i v i t y  in  TBS in  w hich a s e c t io n  o f  38 week pregnant 
myometrium was in cu b a ted . 5 and 10 u l o f  in c u b a tio n  medium e x h ib ite d  
l i t t l e  anti-aggregatory  a c t iv i ty  and th e volumes would have had to  be 
in c r e a se d  t o  20 and 40u l t o  be a ssa y ed . The in c u b a tio n  o f  PRP fo r  1 
m in u te  w ith  lOOuM p ap aver in e  p r io r  t o  th e  a d d it io n  o f  th e  in c u b a tio n  
medium p o te n t ia te d  th e  a c t i v i t y  so  th a t th e anti-aggregatory  a c t iv i ty  
co u ld  be a ssa y ed . The amount s y n th e s is e d  by t h i s  t i s s u e  was 0.654  
ng/mg/30 mins.
I t  was c o n s id e re d  th a t  t h i s  method p ro v id ed  s i g n i f i c a n t  and 
r e l i a b l e  p o t e n t ia t io n  o f  PGI2 a c t i v i t y  w hich  co u ld  be used  t o  a s sa y  
human myométrial PGI2 released  in to  TBS.
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Figure 11) The e f fe c t  of papaverine (p) on the anti-aggregatory a c t iv ity  
p r e se n t in  th e  in cu b a tio n  medium from human pregnant myometrium(40 
week). Aggregation of c itra ted  rabbit p la te le t -r ic h  plasma was induced 
by ADP (5uM). Papaverine (p;100 uM) p o te n t ia te d  th e  a c t i v i t y  o f th e  
anti-aggregatory  a c t iv ity .
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4.8) ThÊ e f f e c t  û f  c i t r a t e  c o n c e n tr a t io n  q r  b M  anti-aggregatQiy 
activity. oL E 2I2
S in ce  th e  c i t r a t e  c o n c e n tr a t io n  may a f f e c t  th e  a g g r eg a to r y 
a c t i v i t y  o f  ADP (O rch ard , 1 9 8 2 ) . The e f f e c t  o f  a l t e r i n g  th e  
concentration  on th e  anti-aggregatory a c t iv i ty  o f PGI2 w ith  or w ithout 
papaverine pre-treatm ent was a sse sse d  • The c i t r a t e  c o n c e n tr a t io n  was 
reduced from 3.8% to  3J6% (w/v) prior to  mixing w ith  rabbit blood (1ml 
c i t r a t e  : 9ml b lo o d ). The a g g r eg a t io n  o f  PRP ( p la t e l e t  count 700 ,000) 
was induced  w ith  ADP (lOuM) 1 m in ute a f t e r  PG%2 was added. F ig u re  12 
in d ica te s  th a t th e anti-aggregatory  e f f e c t  o f  PGI2 rem ained u n a lte r e d  
u s in g  PRP prepared  w ith  3.16% c i t r a t e  when com paired t o  3.8% c i t r a t e  
w ith  or w ithout papaverine (lOOuM).
4.9) In cu b a tio n  binm and th e  r e le a s e  o f . p la c e n t a l  antir-aggrega10ry. 
activity
S a m p les  o f  p la c e n t a  ( d e l i v e r e d  v a g i n a l l y  a t  term ) w ere  
in v e s t ig a t e d  fo r  th e  p ro d u ctio n  o f  a n t i-a g g r e g a to r y  a c t i v i t y .  The 
r e le a s e  o f  a n t i-a g g r e g a to r y  m a te r ia l was stud ied  during incubation in  
TBS (pH 8.0) a f t e r  chopping and a f t e r  p r e - in c u b a tio n  a t  37°C fo r  10  
m in u tes  p r io r  t o  chopping. No a n t i-a g g r e g a to r y  m a te r ia l was r e le a s e d  
du rin g  in c u b a tio n  over a 30 m in u te  p e r io d . However s i g n i f i c a n t  
r e le a s e  was ob served  a f t e r  p r e in c u b a tio n  a t  37®C fo r  10 m in u tes  w ith  
su b seq u en t chopping. There was a 32.7% in h ib i t io n  o f  ADP-induced  
p l a t e l e t  a g g r e g a t io n  a f t e r  10 m inutes incubation a t  room tem perature, 
34.5% a t  20 minutes but in h ib ito ry  a c t iv i t y  was markedly reduced a t  30 
m inutes to  10.7% and a t  45 minutes to  9.5%. For t h is  reason sam ples were 
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Figure 12) The e f f e c t  o f c i t r a t e  concentration  on th e anti-aggregatory  
a c t iv i t y  o f PGI2 in  the presence ( tr ia n g les ) and absence o f papaverine 
(l(X)uMf sq u a r e s). There was no d i f f e r e n c e  see n  when PRP was prepared  
u s in g  3.16% c i t r a t e  (c lo s e d  sym bols) a s  opposed t o  3 .8 % c i t r a t e  (open 
sym bols).
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tem p era tu re  fo r  15 m in u tes . The tim e  e la p se d  b etw een  d e l iv e r y  and 
assessm ent o f an ti-aggregatory  a c t iv i t y  had no e f f e c t  on the re lea se  of 
a n t i-a g g r e g a to r y  m a te r ia l  on s to r a g e  up t o  8 hours p o s t -d e l iv e r y ^  
however a l l  samples were used w ith in  2-4  hours o f c o lle c t io n .
4J0) Tbs e f f e c t  D f ^  m  an ti-aggregatory  a c t iv i t y  released  from human 
myometrium and p lacenta  and ra t myometrium
The s t a b i l i t y  o f th e s e  a c t i v i t i e s  w ere t e s t e d  under se v e r e  
a lk a lin e  con d ition s. The r e s u lt s  from two experim ents are summarised in  
f ig u r e s  13 and 14. Figure 13 in d ica tes  aggregation responses o f rabbit 
PRP induced by ADP (lOuM) . Samples o f PG%2 f PGD2 f and PGE2 were te s te d  
and a lk a lin ise d  to  pH 12.0 for  60 m inutes and r e a c id if ie d  to  pfl 8.0. Ihe  
anti-aggregatory  a c t iv i t y  o f PGI2 (lO ng/m l PRP) was id e n t i c a l  t o  th a t  
b efore a lk a lin is a t io n  w h ils t  those o f PGD2 (20 ug/ml) and PGE2 (60ug/ml) 
were abolished  on a lk a lin isa tio n .
The a lk a lin e  s t a b i l i t y  o f the an ti-aggregatory  m a ter ia ls  released  
by human and ra t pregnant myométrial t is s u e s  and human p la cen ta l t is s u e  
was s tu d ie d  in  a s im i la r  manner (F igu re 1 4 ). As shown th e  a c t i v i t i e s  
released  by the myométrial samples were a lk a lin e  s ta b le  and s im ila r  to  
PGI2 . However a lk a l in i s a t io n  m arkedly reduced th e  a n t i-a g g r e g a to r y  
a c t iv i t y  derived from the p lacenta.
I t  was th en  d ec id ed  t o  compare th e  s t a b i l i t y  o f  th e  human 
myom étrial and p la cen ta l a c t iv i t i e s  a t  low er pH s in ce  PGI2 i s  unstable  
a t  a c id  pH. As p r o te in s  a re  denatured  a t  low  pH, th e  in c u b a te s  w ere  
in cu b a ted  a t  pH 7.5 and 8 .5 .
The r e s u l t s  from one exp erim en t a r e  shown in  f ig u r e  15 . The 
t r a c in g  show s th e  a g g reg a to ry  resp o n se  o f  r a b b it  PRP induced by ADP 
(lOuM) . lO ig o f authentic  PG%2 , 4 0 i l  o f myométrial incubate and 60ul o f
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Figure 13) The e f fe c t  of a lk a lin isa tio n  on the anti-aggregatory a c t iv ity  
o f a u th e n tic  PG%2 , PGD2 , and PGE2 . The a n ti-a g g r e g a to r y  a c t i v i t y  o f  
these PGs was te sted  before and a fter  incubation a t  pH 12.0 (4°C) for 60 
m in u tes. PGI2 (lO ng/m l PRP), PGD2 (20ug/m l) and PGE2 (60ug/m l) a l l  
e x h ib ite d  a n ti-a g g r e g a to r y  a c t i v i t y  a g a in s t  ADP(10uM, |  ) -in du ced  
a g g reg a tio n  o f c i t r a te d  r a b b it  PRP. When a lk a l in is e d  to  pH 12 .0 , PGI2 
r e ta in e d  i t s  a c t i v i t y  u n lik e  PGD2 and PGE2 which l o s t  a l l  a n t i ­
aggregatory a c t iv i t y .
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Figure 14) The e f f e c t  of a lk a l in is a t io n  o f pregnant human (HI) and ra t  
(RI) m yom étrial and human p la cen ta l (PI) anti-aggregatory  a c t iv i ty .  A ll 
in h ib ited  ADP(10uM, |  )-induced aggregation o f c itr a te d  rabbit PRP. Both 
HI and RI reta ined  an ti-aggregatory  a c t iv i t y  when incubated a t  pH 12.0 
(a t 4°C; H l-a lk , R l-a lk )  fo r  60 m in u te s , how ever PI l o s t  some a n t i ­
aggregatory a c t iv i t y  under th ese  con d ition s (HPI-alk)
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Figure 15) The e f fe c t  of pH on the anti-aggregatory a c t iv i t i e s  o f PG%2 ,
human pregnant-myometrial (MI) and p lacen ta l (PI) incubates. The a n t i-
aggregation of
a ggregatory  a c t i v i t y  o f PGI2 , MI and PI were a s se s se d  u s in g /c it r a te d  
r a b b it  p la t e l e t - r i c h  plasm a induced w ith  ADP (10 uM, T ). The pH was 
a d ju sted  to  pH 8.5 and 7.5 or incubated  a t  room tem p erature fo r  1 hour. 
The anti-aggregatory a c t iv ity  of both PGI2 and MI a t pH 8.5 was s l ig h t ly  
reduced but a b o lish ed  a t  pH 7 .5 . The a c t i v i t y  o f PI was u n a ffe c ted  by 
th ese co n d itio n s.
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p la c e n ta l incub ate from a 40 week pregnant woman caused in h ib it io n  o f  
th e  ADP-induced aggregation . P ortio n s o f  th ese  media were then ad ju sted  
t o  pH7.5 and 8.5 and m aintained a t  room tem perature fo r  30 m inutes. The 
media were then read ju sted  t o  pH8.0 and th e  a n t i - a g g r e g a t o r y  a c t i v i t y  
t e s t e d  .
A uthen tic PG%2 l o s t  some a c t iv i t y  a t  pH8.5 a t  room tem perature and 
l o s t  a l l  a c t i v i t y  when in c u b a te d  a t  pH7.5. The a c t i v i t y  r e le a s e d  by  
pregnant myometrium behaved in  a s im ila r  manner, however th e  p la c e n ta l  
fa c to r  was u n a ffec ted  by th e se  incub ation  co n d it io n s  .
4J.1) Tbs e f f e c t  indom ethacin SQ i b s  release of. human myométrial and 
plagental antir-aggregatory activity
Human m y o m étr ia l and p la c e n t a l  t i s s u e  w as in c u b a te d  w ith  
indom ethacin (335uM,120 ug/m l) and i s  i l lu s t r a t e d  in  f ig u r e  16. 80ul o f  
p la c e n t a l  in c u b a te  in h ib i t e d  ADP (5uM )-induced  a g g r e g a t io n  and th u s  
9.6ug o f  indom ethacin was added w ith  th e  p la c e n ta l incubate to  determ ine  
any in t e r a c t io n  w ith  th e  a n t i - a g g r e g a t o r y  a c t i v i t y .  When 9 .6ug o f  
in d o m eth a c in  w as added a lo n e  t o  th e  PRP t h e r e  was no e f f e c t  on ADP 
induced aggregation . As 4CXil o f indom ethacin tr e a ted  m yom étrial in cu b ate  
was a s s e s s e d ,  4 .8ug o f  in d o m eth a c in  w as added w ith  th e  m y o m étr ia l  
in c u b a te  t o  a s s e s s  th e  in t e r a c t io n  w ith  th e  a n ti-a g g reg a to ry  a c t iv i t y  
p resen t.
Indom ethacin d id  n ot in te r fe r e  w ith  th e  a n ti-a g g reg a to ry  a c t iv i t y  
p r e s e n t  in  m y o m étr ia l in c u b a te  b u t p r e - in c u b a t io n  o f  th e  t i s s u e  w it h  
indom ethacin g r e a t ly  reduced th e  a n ti-a g g reg a to ry  a c t iv i t y  p resen t. Oi 
the o th er  hand, indom ethacin s l ig h t l y  p o te n tia te d  th e  a n ti-a g g reg a to ry  
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Figure 16) The e f f e c t  of indomethacin on human pregnant myométrial (MI) 
and p la c e n t a l  (PI) a n t i-a g g r e g a to r y  a c t i v i t y  in  in c u b a tio n  m edia. 
P la t e le t  aggregation of c itr a te d  rabbit p la t e le t - r ic h  plasma was induced 
by ADP (5 u M ;^ ). Addition of indomethacin (4.B-9.6 ug) had no e f f e c t  on 
ADP-induced aggregation o f the anti-aggregatory  a c t iv i t y  of MI and PI. 
Incubation of myometrium w ith  indomethacin (IND MI) reduced the re le a se  
of anti-aggregatory  m ateria l w h ils t  not a f fe c t in g  th a t by th e p lacenta  
(IND P I).
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reduce th e  r e le a se  o f a n ti-a g g reg a to ry  a c t iv i t y .
I t  w as t h e r e f o r e  e v id e n t  t h a t  a lth o u g h  b o th  th e  m yom etrium  and 
p la c e n ta  r e le a s e  a n t i - a g g r e g a t o r y  m a t e r ia l  (s) y th e y  a r e  n o t t h e  sam e. 
S in ce th e  m yom étrial, a c t iv i t y  i s  s ta b le  a t  a lk a lin e  pH, i s  a c id  la b i l e ,  
th e  r e le a se  in h ib ite d  by indom ethacin and i t ' s  a n ti-a g g reg a to ry  a c t iv i t y  
p o ten tia te d  by papaverine, th e  m a ter ia l w i l l  be referred  to  a s  PGI2 and 
th e  r e le a se  q u a n tif ied  as PGI2 eq u iv a len ts  per mg w et w eigh t o f t i s s u e  
p er  30  m in u te s  o f  in c u b a t io n . PGI2 i s  u n iq u e  amo ng th e  PGs in  
p o sse ss in g  a l l  o f th ese  p r o p e r tie s .
4.12) A ssessm ent qL  ADPase a c t iv i t y  i n  human m yom étrial and p la c e n ta l  
in cu b ation  media
Experiments were ca rr ie d  out t o  determ ine i f  th e  a n ti-a g g reg a to ry  
fa c to r  (s) in  th e  p la c e n ta l and m yom étrial in cu b ation  media were in  part 
due t o  th e  p r e se n c e  o f  an ADPase (F ig u re  1 7 ) . To t h i s  en d , sa m p le s  o f  
p la c e n t a l  and m y o m étr ia l in c u b a t io n  m edia  w ere  h e a te d  a t  37°C fo r  30  
m inutes t o  d estroy  any PGI2 p resen t and then incubated w ith  ADP (23mM) 
a t  room tem perature fo r  20 m inutes. The aggregatory a c t iv i t y  o f ADP from  
s to c k  or in c u b a te d  s o l u t i o n s  w ere  th en  com pared. 5 u l o f  ADP ( to  make 
23uM f in a l  PRP concen tration) induced ir r e v e r s ib le  aggregation . 5 u l o f  
PGl2“fr e e  m yom étrial and p la c e n ta l incub ates w ere added w ith  5u l stock  
ADP and each had l i t t l e  d ir e c t  e f f e c t  on th e  ADP induced aggregation . I f  
ADP was in c u b a te d  w ith  th e  PGl2“ f r e e  m y o m étr ia l in c u b a te , no l o s s  o f  
a c t i v i t y  w as n o ted  when com pared t o  th e  r e sp o n se  o b ta in e d  when th e  
incubate was added w ith  sto ck  ADP w ith ou t in cu b ation . Comparison o f  th e  
response produced by a liq u o ts  o f p la c e n ta l incubate compared .w ith  th e  
c o n tr o l  s to c k  s o lu t io n  show ed t h a t  57 .0  + / -  1.6% (mean + / -  s.e.m .; n=3) 




M I N S
Figure 17) Assessm ent o f ADPase a c t iv i t y  in  incubation  media from human
pregnant myometrium and p lacenta . The incubation  media were heated a t
37°C t o  h y d ro ly se  a l l  endogenous PGI2 . ADP (2.3mM) was in cu b a ted  in
PGl2“fr e e  myométrial (MI) and PGl2“fr e e  p la c e n ta l (PI) incubates fo r  30
m inutes a t  room temperature. The aggregatory a c t iv i t y  o f the remaining
ADP was a ssessed  by inducing a g g r eg a tio n  o f c i t r a t e d  r a b b it  p l a t e l e t -
r ich  plasma. PI had a markedly reduced cap acity  for inducing aggregation  
MI
compared tOj^and t h i s  e f f e c t  was a b o lish e d  by b o i l in g .  MI and PI had no 
e f f e c t  on ADP-induced aggregation when added a t  the same tim e. ADP did
not degrade over 30 m inutes a t  room tem perature.
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s u p e r n a ta n t . I f  th e  su p e r n a ta n t w as b o i l e d  and c e n t r i f u g e d  b e fo r e  
in cu b ation  w ith  ADP, then no lo s s  o f  a c t iv i t y  was seen .
4J.3) Tbs e f f e c t  M  m  human m yom étrial PSI2 s y n th e s is
Ih e e f f e c t s  o f  two co n cen tra tion s o f AA on human m yom étrial PGI2 
s y th e s is  i s  summarised in  f ig u r e  18. Treatment o f m yom étrial t i s s u e  w ith  
50uM AA had no e f f e c t  on PGI2 s y n t h e s i s  when com pared t o  th e  b a s a l  
s y n t h e s i s  (B a sa l : 0 .16  + / -  0 .05  ; AA [50uM] : 0 .2 0  + / -  0 .07 n g /m g /3 0  
m in s ; n=6) w h i l s t  99uM AA in c r e a s e d  s y n t h e s i s  from  0 .182  + / -  0 .05  t o  
0.581 + / -  0 .27 n g /m g /3 0  m in s (p<0.05 ; n = 7). AA c a r r ie d  o v er  in  th e  
in cu b ation  media d id  n ot a f f e c t  th e  a n ti-a g g reg a to ry  a c t iv i t y  o f PGI2 .
4J.4) I h s  e f f e c t  o f . P L ^  (2n m yom étrial PQI2 sy n th e s is
Ihe e f f e c t s  o f  two co n cen tra tion s o f PLA2 human m yom étrial PGI2 
s y n t h e s i s  i s  show n in  f i g u r e  19 . T reatm en t o f  th e  t i s s u e s  w ith  PLA2 
(lO U/m l) in c r e a s e d  g e n e r a t io n  from  0.17  + / -  0 .07  t o  0 .48  + / -  0 .2  
ng/m g/30 m in s (p<0.02 ; n = 5). PLA2 a t  a c o n c e n tr a t io n  o f  5U /m l d id  n o t  
a f f e c t  PGI2 s y n t h e s i s  (B a sa l : 0 .1 6 0  + / -  0 .0 5  ; PLA2 [5U /m l] ; 0 .12  + /“ 
0.04 ng/m g/30 m ins ; n=6).
4 .15) Tha e f f e c t  O t  OxyLO-Cin and  e r g o m e tr in e  q r  p reg n a n t human
m yem etrla l E 2I 2 sy n th e s is
The e f f e c t  o f  o x y to c in  (0.44uM) and e r g o m e tr in e  (61uM) on 
m y o m étr ia l PGI2 s y n t h e s i s  i s  sum m arised  in  f i g u r e  2 0 . In c u b a t io n  o f  
human m yom etrium  w ith  o x y to c in  or  e r g o m e tr in e  d id  n o t  a l t e r  PGI2 
sy n th e s is . The b a sa l sy n th e s is  o f 0.264 + / -  0.09 was in creased  t o  0.317 






















B 99 uM AA
F ig u re  18) The e f f e c t  o f a r a ch id o n ic  a c id  (AA) on th e  p r o d u c tio n  o f  
anti-aggregatory  a c t iv i t y  by human pregnant myometrium (36-39 week, B). 
In h ib itio n  of ADP-induced aggregation o f c itr a te d  rabbit p la t e le t - r ic h  
plasma by M was not increased by 49.5 uM AA (n=6) but was increased  in  
th e  presence of 99.0 uM AA (n=7). Columns and v e r t ic a l  l in e s  represent 
mean + / -  s .e .m . S ig n i f i c a n t  d if fe r e n c e s  b etw een  c o n tr o l  and t r e a te d  
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F ig u re  19) The e f f e c t  o f p h o sp h o lip a se -A 2 (PLA2 ) on th e  fo r m a tio n  o f  
human pregn ant (36 -39  w eeks g e s t a t io n )  m y o m étr ia l a n t i-a g g r e g a to r y  
a c t i v i t y  (M) in  th e  in c u b a tio n  medium. I n h ib i t io n  o f  ADP-induced  
a g g r e g a t io n  o f c i t r a t e d  r a b b it  p l a t e l e t - r i c h  p lasm a by M was n o t  
in c r e a se d  by 1 U/m l PLA2 (n=6) b u t was in c r e a se d  in  th e  p resen ce  o f  10  
U /m l PLAg (n=5). Columns and v e r t i c a l  l i n e s  r e p r e s e n t  mean + / -  s .e .m . 
S ig n if ic a n t  d if fe r e n c e s  between basal (B) and trea ted  groups are shown
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F igu re 20) The e f f e c t  o f o x y to c in  (OX) and ergom etr in e  (ERG) on human 
pregnant m yom étrial PGI2 s y n th e s is  (38-40 weeks g e s t a t io n ) .  Basal 
syn th esis  (B) of PGI2 was not s ig n if ic a n tly  influenced by oxytocin (0.44 
uM, n=8) or ergometrine (61uM n=5). Columns and v e r t ic a l bars in d icate  
mean + / -  s.e.m.
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tr e a tm e n t  d e c r e a se d  PG%2 p r o d u c t io n  from  0 .209  + / -  0 .07  t o  0 .157  + / -  
0.06 ng/m g/30 m ins (mean + / -  s.e.m.; n=5).
4.16) P r o sta c y c lin  production by human myometrium durilia PCegnançy
Hie v a r ia t io n  in  PG%2 s y n th e s is  th a t occurs in  m yom étrial t i s s u e  
d u r in g  g e s t a t i o n  i s  shown in  f ig u r e  2 1 . S y n th e s is  in  th e  seco n d  
tr im e s te r  (week 15) o f pregnancy was low  (0.093 + / -  0.038 ng/m g/30 mins; 
n=3) and s y n t h e s i s  in c r e a s e d  tw o  w eek s p r io r  t o  term . S y n th e s is  a t  37 
weeks was 0.939 ng/m g/30 m inutes (n=2)  ^ week 38 : OJ.29 + / -  0.018 (n=8), 
week 39 : 0 .2 6 2  + / -  0 .0 5 8  (n=10) p ea k in g  a t  term  (week 40) ; 0 .4 7 3  + / -  
0 .0826  (n=9). PG%2 s y n t h e s i s  from  tw o p a t i e n t s  who had n o t  s t a r t e d  
labour by week 42 had low  sy n th eses  a t  0.216 and 0.0343 ng/m g/30 m inutes 
r e p e c t iv e ly .
4 J.7) Tho. £ff££t pf PGI2 an. human loszan segment ntecua in yitin
Four m yom étrial s t r ip s  (weeks 38 -  40) were suspended under a Ig  
lo a d  in  lOm l Krebs* s o lu t io n  g a s se d  w ith  5% CO2 : 95% O2 . A fte r  1 hour 
e q u i l ib r a t io n  a l l  t i s s u e s  resp on d ed  t o  2 0 0 n g /m l Ach and e x h ib i t e d  
is o to n ic  co n tr a c tio n s . A fter 1 hour e q u il ib r a t io n  a l l  t i s s u e s  ex h ib ited  
is o to n ic  co n tr a c tio n s . 200 ng/m l PGI2 in h ib ite d  spontaneous a c t iv i t y  in  
th r e e  sa m p le s  and red uced  th e  b a s a l  to n e  in  tw o  ( s e e  f i g u r e  2 2 ) . Lower 
c o n c e n tr a t io n s  (20 and 2 n g /m l) d id  n o t  a f f e c t  a c t i v i t y  in  tw o o th e r  















GESTATION (w eek s)
Figure 21) The e f f e c t  o f g e s ta tio n  on human m yom étrial PGI2 sy n th es is . 
Synthesis was maximal a t  term. Production by myometria from p a tien ts  o f  
42 weeks g e s ta tio n  (not in  labour) was a t  a le v e l  s im ila r  1 s t  tr im ester  
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F igu re  22) The e f f e c t  o f PGI2 (200 ng/m l) on 2 p ie c e s  o f  human low er  
segment 40 week pregnant myometrium . Ihe t is su e s  were bathed in  Krebs' 
so lu tio n  a t  37°C. Spontaneous contractions were abolished in  each case 
and basal tone reduced.
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5.0) RESULTS -  S t u d ie s  q r  th e  p r o d u c tio n  q L  PGI2 th f i pregnant rat 
myometrium
8 2
5.1) ihs e f f e c t  q L  t i s s u e  h a n d lin g  q r  S Q I2 synthesis bz xat pregnant
Rat pregnant myometria from 5 an im als w ere s p l i t  in to  4 p ie c e s  
and ea ch  w as t r e a t e d  d i f f e r e n t l y .  The d e c id u a l t i s s u e  o f  2 p i e c e s  was 
s e p a r a te d  by s c r a p in g  w ith  a m ic r o sc o p e  s l i d e  and in  th e  o th e r  tw o  
p ie c e s  by g e n t le  te a s in g  w ith  a co tto n  wool bud. A ll sam ples were pre­
in c u b a te d  a t  37®C fo r  10  m in u te s . One sa m p le  from  each  group w as th en  
chopped p r io r  t o  in c u b a t io n  a t  room te m p e r a tu r e . The r e s u l t s  a r e  
i l lu s t r a t e d  in  f ig u r e  23.
Scrap ed  t i s s u e  s y n t h e s i s e d  g r e a t e r  am ounts o f  PGI2 th an  t e a s e d  
t i s s u e  (p<0.05; ANOVA a t  20  m in u te s ) .  Chopping in c r e a s e d  th e  r a t e  o f  
PGI2 s y n th e s is  by th e  scraped t i s s u e  reaching a maximum a t  20 m inutes  
com pared t o  40  m in u te s  w ith o u t  ch op p in g  . The PGI2 c o n te n t  o f  th e  
scraped and chopped media began t o  f a l l  a f t e r  28 m inutes.
5.2) TjûSi effect qL o x y to c ic  drugs o r rab myomatrial SQL2 sy n th e s is
5 .2  i )  5-HT
The e f f e c t  o f  in c u b a t in g  m y o m étr ia l t i s s u e  w ith  5-HT (21uM) on 
PGI2 s y n t h e s i s  i s  i l l u s t r a t e d  in  f ig u r e  2 4 . B a sa l PGI2 s y n t h e s i s  was 
assayed u sin g  a 2+2 d oses assay  a g a in st a u th en tic  PGI2 . However 5-HT may 
a f f e c t  th e  a g g r e g a b i l i t y  o f  th e  p l a t e l e t s  and th u s  c o n t r o ls  fo r  th e  
carry-over  o f 5-HT were ca rr ied  ou t. Hie maximum volume o f th e  incub ate  
from th e day 19 pregnant m yom étrial in cub ation  m ixture con ta in in g  5-HT 
u sed  in  th e  a s s a y  w as 5 u l .  T h is  i s  a c a r r y -o v e r  o f  0 .1  ug 5-HT (21uM , 
20 u g /m l) and t h i s  d o se  was added t o  PRP and i t s  e f f e c t  on ADP in d u ced  
a g g r e g a t io n  a lo n e  was exam in ed . T h is  am ount w as a l s o  added w ith  th e  
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F igure 23) The e f f e c t  o f han d lin g  o f ra t u te r in e  t i s s u e  (19-20  day 
pregnant) during sep a ra tio n  o f myometrium from deciduum on PGI2 
form a tio n . D ecidual t i s s u e  was removed by scrap in g  ( t r ia n g le s )  or 
te a s in g  ( c ir c le s ) .  The two groups were then e ith e r  chopped (c lo sed  
sym bols) a f t e r  10 m in utes p re in cu b a tio n  a t  37®C or l e f t  in t a c t  (open 
symbols). Scraping increased PGI2 syn th esis over teasin g , and chopping 
in c r e a s e d  th e  s y n t h e s i s  f u r t h e r .  ( | )  in d ic a te s  chopping where 
ap p licab le .
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F ig u re  24) The e f f e c t  o f  5-HT (21uM) on PGI2 s y n t h e s is  by r a t  pregn an t 
(day 19; B) myom etrium. A d d itio n  o f lOOng o f  5-HT in  5 u l T r is -b u f fe r e d  
s a l i n e  (50 mM,pH 8.0) had no e f f e c t  on ADP-induced a g g r e g a t io n  o f  
c i t r a t e d  r a b b it  p l a t e l e t - r i c h  plasm a nor on th e  a n t i-a g g r e g a to r y  
a c t i v i t y  o f  PGI2 . PGI2 s y n t h e s is  in  th e  p r e se n c e  o f  5-HT (5HTi) was 
markedly stim u la ted  from 1.625 to  3.732 ng/mg/15 mins.
85
w ould c o n ta in  0 .0 5 ug 5-HT and t h i s  was added t o  th e  a u th e n t ic  PGI2 to  
co n tro l for  the lower dose o f incubate.
5-HT a t  th ese  doses had no e f f e c t  on ADP-induced aggregation nor 
upon th e anti-aggregatory  a c t iv i t y  o f PGI2 . 5-HT more than doubled the  
PGI2 s y n th e s is  from 1.625 ng/m g/15  m ins t o  3 .732 ng/m g/15  m in s, 
n e c e s s ita t in g  a reduction in  the volume o f 5-HT trea ted  incubate added 
to  th e  p la t e le t s  from lOul and 5ul to  5ul and 2.5ul.
5-HT in c r e a se d  b a sa l PGI2 s y n t h e s is  in  a day 19 pregnant 
myometrium in  a do s e - r e la t e d  manner ( f ig u r e  2 5 ). B asal s y n t h e s is  o f  
2.449ng/mg/15 mins was increased  to  2.891 (+18J.%) by 5.3uM 5-HT; to  
4 .0 0  (+63.3%) by lO.SuM ; t o  4.639 (+89.4%) by 21uM and t o  5 .59  ng
(+128.3%) by 84uM 5-HT.
This graded in crease  suggested a receptor mediated e f f e c t  and in  
another experim ent ra t myométrial t is s u e  was incubated w ith  5-HT w ith  or 
w ithout m ethysergide (17.6uM ; see  fig u re  26). T issue was pre-incubated  
w ith  m ethysergide for  10 m inutes prior to  the ad d ition  o f 5-HT and then 
pre-incubated for a fu rther 10 m inutes before chopping. Controls during 
th e  a s sa y s  w ere i n s t i t u t e d  a s  i l l u s t r a t e d  in  f ig u r e  24 , and th o se  
sa m p les w ere a ssa y ed  a g a in s t  a u th e n t ic  PG%2 in cu b ated  w ith  th e  
appropriate drug m ixtures.
F iv e  pregnant r a t s  (day 20) w ere u sed . 5-HT (42uM) s t im u la te d  
b a s a l s y n t h e s is  from  3.167 + / -  0.45 t o  4.289 + / -  0.49 ng/m g/15 m ins 
(p<0.05). M eth yserg id e  reduced b a sa l s y n t h e s is  t o  2.191 + / -  0 .29  
n g/m g/15 m ins and no s t im u la t io n  o f  PGI2 s y n t h e s is  was seen  when 
myometrium was pre-incubated w ith  5-HT in  th e  presence o f m ethysergide.
5.2 ii) Angiotensin and oxytocin
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Figure 25) The e f f e c t  o f 5-HT on PGI2 sy n th es is  by the myometrium of a 
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Figure 26) The e f fe c t  of 5-HT on rat myométrial PGI2 production ( 19-20 
day pregnant) and i t s  b lockade by m eth yserg id e  (M). 5-HT (42uM) 
s t im u la t e d  b a s a l  (B) PG%2 s y n t h e s i s  w h ich  was a n ta g o n is e d  by 
m eth yserg id e  (17.6uM). Columns and v e r t i c a l  l i n e s  in d ic a te  mean + / -  

























Figure 27) The e f f e c t  o f an g ioten sin  II  on PGI2 sy n th es is  by myometrium 
from  a day 19 p regn an t r a t .  A n g io te n s in  I I  s t im u la te d  s y n t h e s is  in  a 
d o se -re la ted  manner.
8 9
n g /m g /1 5  m in s. T h is  w as s t im u la te d  in  a d o se  r e la t e d  manner by 
a n g io t e n s in  I I  t o  2 .0 2 8  (+0.82%) a t  O .6 3 u g /m l;to  2 .812  (+39.83%) a t  
1 .2 5 u g /m l; t o  3 .54  (+75.7%) by 2 .5 u g /m l and t o  5 .341  n g /m g /1 5  m in s  
(+165.6%) by 5 u g /m l.
O xytocin a ls o  s tim u la ted  day 18 r a t  m yom étrial sy n th e s is  in  a dose 
r e la t e d  manner (F ig u re  28) from  1 .648  (b a sa l r e le a s e )  t o  1 .837  (+11.6%) 
a t  O .lluM ; t o  2 .197 (+33.4%) a t  )0.22uM; t o  3 .389  (+105.8%) a t  0.44uM  
and t o  4.17 ng/m g/15 m ins (+153.0%) a t  0.88uM.
C ontrols were ca rr ied  out fo r  both oxytoc in  and a n g io ten sin  in  th e  
sam e manner a s  th o s e  u sed  f o r  5-HT t o  e l im in a t e  c a r r y -o v e r  e f f e c t s  on 
th e  p la t e l e t s .
5.3) Tbs q L  salbutflmol m  uterine SGL2 s y n th e s is
The in c u b a t io n  o f  m y o m étr ia l t i s s u e  w ith  sa lb u ta m o l (21.5uM) 
r e s u l t e d  in  an i n h i b i t i o n  o f  PGI2 s y n t h e s i s  (F ig u re  2 9 ) . 5 u l and 2 .5 u l  
o f  in c u b a te  w ere u sed  fo r  b io a s s a y . T hese v o lu m es , i f  ta k en  from  an 
in c u b a t io n  m ix tu r e  c o n ta in in g  sa lb u ta m o l w i l l  c a r r y -o v e r  0 .1  ug and 
0 .0 5 ug r e s p e c t i v e l y .  As th e  t r a c in g  sh o w s, 5 u l o f  TBS c o n ta in in g  O .lug  
sa lb u ta m o l d id  n o t  a f f e c t  A DP-induced a g g r e g a t io n  or th e  a n t i ­
aggregatory a c t iv i t y  o f PGI2 . Salbutam ol reduced sy n th e s is  from 4.0 to  
2 3 7  ng/m g/15 m ins.
Ihe e f f e c t  o f salbutam ol on m yom étrial PGI2 production  v a r ied  on 
d i f f e r e n t  d ays o f  p regn an cy  (F ig u re  3 0 ). S a lb u ta m o l (43uM) o n ly  
in h ib i t e d  PGI2 s y n t h e s i s  in  l a t e  p reg n a n t r a t s .  On day 21 ; b a s a l  PGI2 
p r o d u c t io n  o f  4 .414 + / -  0 .831 w as red u ced  by sa lb u ta m o l t o  1 .994  + / -  
0.31 ng/m g/15 mins ( p<0.05; n=5). However in  19 day pregnant m yom etria, 
w here b a s a l  PGI2 s y n t h e s i s  was 2 .548  + / -  0 .13  , sa lb u ta m o l had l i t t l e  
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Figure 28) The e f f e c t  of oxytocin on PGI2 syn th esis by myometrium from a 











Figure 29) The e f f e c t  o f sa lb u tam ol (21.5 uM, SI) on b a sa l (B) PGI2 
syn th esis  by rat pregnant (day 21) myométrial t is su e . Addition of lOOng 
o f sa lb u tam ol (S) in  Sul o f T r is  b u ffered  (50mM,pH8.0) s a l in e  had no 
e f fe c t  on ADP(lOuM,t)-induced aggregation of c itra ted  rabbit p la t e le t -  
rich  plasma nor the anti-aggregatory action  of PGI2 . PGI2 syn th esis in  
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Figure 30) The e f f e c t s  of salbutamol on rat myométrial PGI2 syn th esis. 
PGI2 s y n th e s is  by day 21 (B21, n=5) pregnant myometrium i s  m arkedly  
h ig h er  than day 19 (B19, n=4). Salbutam ol (43 uM) in h ib i t s  PGI2 
s y n th e s is  by 21 day pregnant myometrium (S21) but n o t 19 day pregnant 
myometrium. S ig n ific a n t d ifferen ces between the basal and treated  groups 
i s  in d ic a te d  (* p<0.05).
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re lea se  o f the day 21 pregnant myometrium to  th a t seen a t  day 19.
P re trea tm en t o f  r a t  myometrium w ith  p r o p r a n o lo l ( f ig u r e  31) 
reduced PGI2 s y n t h e s is  from 4.414 + / -  0.831 to  3.426 + /“ 0.85 ng/mg/15 
mins (n=5). This decrease was not s ig n if ic a n t . However in  the presence  
o f propranolol salbutam ol did  not reduce PGI2 form ation (3.234 + / -  0.66 
ng/mg/15 m ins).
5.4) Tbs e f f e c t  a f  v a so d ila to rs  qel Xât myométrial PQI2 synthesis
5.4 i)  Dipyridamole
Day 19-20 pregnant myometria were trea ted  w ith  dipyridam ole and 
th e  e f f e c t  on PGI2 p ro d u ctio n  i s  shown in  f ig u r e  32. D ip yrid am ole  
required d ilu t io n  in  ethanol to  ensure s o lu b i l i t y  in  TBS. Incubation of 
m yom étr ia l sa m p les in  e th a n o l was th u s req u ired  t o  en su re  a v a l id  
comparison o f basal sy n th es is  w ith  th a t of dipyridam ole. A ll ethan ol- 
contain ing incubation media contained s ig n if ic a n t ly  l e s s  PGI2 than basal 
c o n t r o ls  (p<0.05, Dunnets t e s t ) .  B asal r e le a s e  o f  2.357 + / -  0.52  
ng/mg/15 mins (n=4) was reduced to  1J.65 + / -  0.41 by 7.4% ethanol which 
was s t im u la te d  in  tu rn  t o  1.26 + / -  0.34 by 0.1 mM d ip y r id a m o le . 14.7% 
e th a n o l reduced b a sa l s y n t h e s is  t o  1.594 + / -  0 .22 (n=7) w hich  was 
s t im u la te d  t o  3.767 + / -  0 .69 by 0.2 mM d ip y r id a m o le  (p<0.05f p a ir e d  *t' 
t e s t )  and th e  reduced PGI2 s y n t h e s is  in  th e  p resen ce  o f  29.4% e th a n o l  
was s t im u la te d  from 1.52 + / -  3.34 (n=4) t o  2.791 + / -  1.1 ng /m g/15  m ins 
by 0.4mM dipyridam ole.
The appropriate doses o f dipyridam ole and ethanol were added w ith  
th e  a u th e n t ic  PGI2 s ta n d a rd s t o  accou n t fo r  th e  ca rry  o ver . The ca rry  
over from th e  sam p les c o n ta in in g  0.4mM d ip y r id a m o le  p o te n t ia te d  th e  











Figure 31) The e f f e c t  of propranolol (P) on basal (B) and salbutam ol (S) 
in h ib i t e d  s y n t h e s is  o f  r a t  m yom étria l PGI2 (day 21 p regnancy, n=5). 
S y n th e s is  o f  PGI2 was reduced by sa lb u ta m o l (43 uM) and p ro p ra n o lo l  
(38.6 uM). S d id  n o t  in h ib i t  PGI2 s y n t h e s is  in  th e  p resen ce  o f  
p r o p r a n o lo l. Columns and v e r t i c a l  l i n e s  in d ic a t e  means + / -  s .e .m . 
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F igu re  32) The e f f e c t  o f  d ip y r id a m o le  (DP) on r a t  m yom étr ia l PGI2 
s y n t h e s is  (day 1 9 -2 0  p regn an cy). B asa l (B) s y n t h e s is  was reduced by 
ethanol v e h ic le  (E) in  a l l  trea ted  groups. DP (0.2 & 0.4 mM) stim u lated  
sy n th es is  (n=7 and n=4 r esp e c tiv  ely) over ethanol co n tro ls  w h ils t  OJmM 
DP d id  n o t . Columns and v e r t i c a l  l i n e s  in d ic a t e  mean + / -  s.e.m . 
S ig n if ic a n t d ifferen ce  between basal v e h ic le  c o n tro ls  and trea ted  groups 
a re  shown (* p < 0.05).
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5.4 i i )  Hydralazine
H y d ra laz in e  when in cu b ated  w ith  20  day pregnant ra t myométrial 
t i s s u e  (n=4), reduced PGI2 s y n t h e s is  s i g n i f i c a n t l y  (F igure 3 3 ). B asa l 
sy n th es is  was reduced from 1.48 + / -  0.11 ng/mg/15 mins to  0.59 + /“ 0.13 
ng/mg/15 min by 1 mM hydralazine (P<0.05, Dunnets te s t )  to  0.2 + / -  0.05 
in  th e  p re se n c e  o f  2mM (p<0.05) and t o  0.1 + / -  0.04 by 4mM (p<0.01). The 
a p p ro p r ia te  d o se s  o f  h y d ra la z in e  w ere added w ith  a u th e n t ic  PGI2 
standards to  account for the carry-over o f hydralazine. Hydralazine did  
not a f f e c t  the anti-aggregatory  a c t iv i t y  o f PGI2 .
5.5) Tho. £ f f s £ t  qL  FpiUSkolin m  IS L  myom étrial B 2I 2 sy n th es is .
Day 21 pregnant ra t myometria were pre-incubated w ith  Forskolin  
fo r  10 m in u tes  p r io r  t o  chopping and a ssa y  fo r  PGI2 . F o r sk o lin  
p o t e n t ia te d  th e  a n t i-a g g r e g a to r y  a c t i v i t y  o f PGI2 and th u s  in c u b a te s  
from trea ted  myométrial t is s u e  were assayed a g a in st authentic  PGI2 added 
w ith  the equ iva len t amount o f fo r sk o lin . Figure 34 shows th a t fo r sk o lin  
(25uM) in h ib it e d  b a sa l PGI2 s y n th e s is  from 3.47 + / -  0.51 ng /m g/15  
m in u tes  t o  3.29 + / -  0.35 (N.S.); 50uM reduced p ro d u ctio n  t o  2.49 + / -  
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Figure  33) The e f f e c t  of hydra laz ine  on r a t  myométrial PGI2  sy n th e s is  
(day 20 pregnancy). Basal (B) sy n th e s is  of PGI2  was in h ib i te d  in  the  
presence of increasing doses of hydralazine. Columns and v e r t ica l  lines 
re p re se n t  mean + /-  s.e.m. S ig n i f ic a n t  d i f fe re n c e s  between b asa l  and 























Figure 34) The e f fe c t  of forsk o lin  on rat myometria! (21 day pregnant) 
PGI2 syn th esis . Forskolin reduced s y n th e s is  in  a d o s e -r e la te d  fa sh io n . 
V e r t ic a l  bars in d ic a te  mean + / -  s.e.m . S ig n i f ic a n t  d if f e r e n c e s  from  
basal re lease  are ind icated (* p<0.05 ; ** p < 0.02).
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6 .0 ) RESULTS -  Assay f if  pregnant x â t  Utérins PLA2 activity
1 0 0
6.1) C h a r a c te r is a t io n  of fhs proced ure fo r fbs a ssa y  of Xât utérins 
phospholipag.erA2
Three incubation media (see se c t io n  3.4) were assessed  for  th e ir  
s u i t a b i l i t y  for the assay o f PLA2 tak ing in to  account th e ir  behaviour in  
th e  e x tr a c t io n  and s e p a r a t iv e  p r o c e s s e s  u sed . dPC and o l e i c  a c id  w ere  
sep a ra ted  u s in g  e i t h e r  m in i-co lu m n s or th in - la y e r  chrom atography. 
E x tr a c t io n  was c a r r ie d  ou t w ith  e i t h e r  m in i-co lu m n s o r , p r io r  to  
separation  by TLC, the method o f B ligh and Dyer (1959).
6.2) Solubility  of ÛSQ and olsis acid In fbs fhcss incubation m ixtures
Samples contain ing dPC w ith  ^H-dPC and ^^C-oleic acid  in  e ith e r
s o lu t io n  1 , s o lu t io n  2 or s o lu t io n  3 w ere in cu b a ted  a t  37®C fo r  30 
m in u tes in  order to  m im ic th e  in c u b a tio n  c o n d it io n s  to  be u sed . The 
aqueous sam p les w ere th en  a s p ir a te d  and th e  reco v ery  c a lc u la te d  by 
com parison  w ith  ^H-dPC and ^ ^ C -o le ic  a c id  d isp e n se d  d i r e c t l y  in to  
s c in t i l la t io n  v ia ls  .
From t a b le s  3 & 4 i t  can be seen  th a t  b oth  Tw een-80 and T r ito n  X- 
100 m arkedly in c r e a s e  th e  s o l u b i l i t y  o f  both  dPC and o l e i c  a c id  in t o  
aqueous so lu tio n . Tween-80 increased th e s o lu b i l i t y  o f dPC from 67% to  
98% and o le ic  acid  from 18% to  67% w h ils t  so lu tio n  3 improved s o lu b i l i t y  
o f dPC from 67% t o  86% and o l e i c  a c id  from 18% t o  91%. However marked 
v a r ia b i l i ty  in  the s o lu b i l i t y  using so lu tio n  2 was evident when compared 
to  so lu tio n  3.
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Table 3) Recovery ûf. ^H-dPC from Sarstedt tubes âftÊL inoubatiOD â t  
fûL 3Q minutes (mean + / - . .s.,£..ni»L
Buf f e r
T ris (so lu tion  1)
T ris & 0.1% Tween 
-8 0  (so lu tio n  2)
HEPES & T riton X- 
100 (so lu tio n  3)
Control PPM Aqueous PPM
16672.4 + / -  209.6 11191.6 + /“ 204.7
10720.9 + /-  144.2 10519.2 + / -  103.3
26273.0 + /-  36 22814.0 + / -  40.2
1  Recoverv 
67 % n=4 
98 % n=4
86 % n=4
Table 4) Recovery of ^ ^C -oleic ac id  from Sarstedt tubes after incubation 
at for 20. minutes (mean +/ -
Buffer Control PPM Aqueous PPM % Recovery
T ris (so lu tion  1) 18308.3 + / -  1204.2 3372.6 + /“ 1714.3 18 % n=4
T ris & 0J% Tween 13914.8 + /-  574.0 12073.5 + /“ 1211.7 86 % n=6
-80  (so lu tio n  2)
HEPES & Triton X- 10639.0 + /-  102.3 9422.9 + /-  98.0 91 % n=4
100 (so lu tio n  3)
6.3) The e f f e c t  o f  eq u ilib ra tio n  e f  s i l i c a  g e l  w ith  so lv en t 1 over tim e, en  
th e  reten tio n  e f  dPC and o le ic  acid  by m ini-colum ns
I t  was found th a t  h e a t a c t iv a t io n  o f  th e  s i l i c a  g e l  fo r  over 30 
m in u tes fo llo w e d  by e q u i l ib r a t io n  in  s o lv e n t  1 fo r  p e r io d s  o f  over a 
w eek, r e s u lt e d  in  im proved reco v ery  o f  dPC and o l e i c  a c id  from  m in i­
colum ns. 150u l o f  T ris-H C l (pH 7.5) c o n ta in in g  50 nm ols ( i e  333uM) 
dPC,^H-dPC (150 ,000  PPM) and ^ ^ C -o le ic  a c id  (83 ,000  PPM) was added to  
minicolumns which had been prepared using s i l i c a  which had or had not 
been h ea t a c t iv a te d  and w hich had been e q u il ib r a te d  over a p e r io d  o f  
days in  s o lv e n t  1 . S i l i c a  r e ta in e d  more a c t i v i t y  when i t  was n o t h e a t
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a c t iv a t e d  (s e e  f ig u r e  35) and r e t e n t io n  was s u s ta in e d  t o  6 d a y s . 
R e te n t io n  o f  dPC and o l e i c  a c id  was red u ced  when th e  s i l i c a  g e l  was 
h e a te d  and t h i s  r e d u c t io n  in c r e a s e d  fu r th e r  o v er  t im e , ( s e e  t a b le  5 ) .
A ll columns used were thus e q u ilib r a te d  fo r  10 days or more in  s o lv e n t  1 
p rio r  to  packing in to  th e  m in i-colum ns.
T ab le  5) The e f f e c t  q L  h e a t  a c t iv a t io n  and e q u i l ib r a t io n  û f  l.QQr2QQ mesh 
s i l i c a  gsl i n  solvent 1 on the re ten tio n  of dPQ and oleio acid
(Days)
IB ;scovery jof activity from mini-columns
Lbration Heated Not Heated
dPC oleate dPC oleate
1 2.8 5.6 3.5 5 .2
2 34.1 37.2 20.0 26 J
6 20.6 61.8 3 .0 6.2
10 59.5 77.8 _ _
A ll colmuns were thus e q u ilib r a te d  fo r  over 10 days.
6.4) Separation and extraction of d£Q and o le ic  ac id  using  m ini-colum ns  
The advantage o f t h i s  technique developed by C onsentino & Legrand, 
(1981) i s  t h a t  i t  e x t r a c t s  and s e p a r a t e s  dPC and o l e i c  a c id  w it h in  one  
s t e p .  To c h a r a c t e r i s e  t h i s ,  fo u r  1 5 0 u l sa m p le s  o f  s o lu t io n s  2 and 3 
c o n ta in in g  dPC (333uM ), ^H-dPC and ^ ^ C -o le ic  a c id  w ere  p a sse d  th rou gh  
four m ini-colum ns which had been e q u ilib r a te d  fo r  7 days in  so lv e n t  1 . 
From f ig u r e  36 i t  can be seen  th a t e x tr a c tio n  o f dPC and o le ic  a c id  from 
s o lu t io n  2 in to  so lv e n ts  1 and 2 r e s p e c t iv e ly  was 106 + / -  6.9% and 63J. 
+ /” 1.6%. E x tr a c t io n  from  s o lu t io n  3 was 9 7 .0  + / -  10 .34  % (dPC) and 121 













r n r  ( dau  ^'
F igu re 35) The e f f e c t  o f tim e  o f e q u il ib r a t io n  o f 100-200  mesh s i l i c a  
g e l  in  h e x a n e :d io x a n e :g la c ia l a c e t ic  a c id  (70:30:1 , s o lv e n t  1) (and 
heating prior to  equ ilibration) on the reten tion  of ^^C-oleic acid (open 
symbols) and 1 -o le o y l,2 (^H -oleoyl)-phosphatidylcholine (c lo sed  sym bols) 
in  m in i-co lu m n s. S i l i c a  g e l was heated  to  100°C ( tr ia n g le s )  or not 
heated (c irc les) prior to  eq u ilib ra tion  in so lv en t 1. Ihe samples were 
a p p lie d  in  T r is  b u ffe r  (SOmM pH7.5). O lea te  was e lu te d  in  1ml sam ples  
(1-6) by s o lv e n t  1 and dPC in  ch loroform :m eth anol:w ater (65:35:1 , 
so lven t 2). Retention was reduced a t  10 days w ith  the heated columns but 
f u l l  recovery of o le ic  acid and dPC was not atta ined .
F ig u re  36) The s e p a r a t io n  and e x tr a c t io n  o f  ^ ^ C -o le ic  a c id  (A ) and 1 -  
o le o y l ,2 - (^ H -o leo y l)-p h o sp h a tid y lch o lin e  (^H-dPC, A ) suspended in  t r i s  
b u ffe r  (100 mM, pH 7.5) w ith  0.1% Tween 80 ( s o lu t io n  2 , f ig u r e  a) and in  
HEPES b u ffe r  (50 mM) w ith  0.2% Triton-XlO O ( s o lu t io n  3 , f ig u r e  b) u s in g  
m ini-colum ns contain ing heated 100-200 mesh s i l i c a  g e l eq u ilib ra ted  for  
10 days in  h e x a n e :d io x a n e :g la c ia l  a c e t i c  a c id  (70 :30 :1 , s o lv e n t  1 ). 
O le a te  was e lu te d  in  1ml sam p les (No's 1-6) by s o lv e n t  1 and dPC in  1ml 
samples (No's 7-12) in  chloroform:methanol:water (65:35:4). From so lu tio n  
2 106 .0  + /” 6.9 % o f  o l e i c  a c id  and 63.1 + / -  10.3% dPC was reco v ered . 
From s o lu t io n  3 121 .0  + / -  9.1% o f o l e i c  a c id  and 97.0  + / -  10.3% o f dPC 
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Separation of dPC and o le ic  ac id  was com plete w ith  both so lu tio n s . 
O le ic  a c id  was e lu te d  in  s o lv e n t  1 and dPC in  s o lv e n t  2 . 95.8 + / -  1.7% 
of dPC e lu ted  was present in  so lv en t 2 and 86.3 + /-  2.0% o f o le ic  acid  
e lu te d  was p r e se n t  in  s o lv e n t  1 when s o lu t io n  2 was u sed . Of th e  t o t a l  
dPC e lu te d  from th e  s o lu t io n  3 r 95 .0  + / -  1.3% dPC was in  s o lv e n t  2 
w h ils t  98.3 + /-  0.1% o le ic  acid  was in  so lv en t 1.
S o lu tion  3 was then used throughout a l l  subsequent procedures s in ce  
the s o lu b i l i t y  of dPC and o le ic  ac id  was more c o n s isten t and no dPC was 
reta ined  by the column when compared w ith  so lu tio n  2.
6.5) E xtraction q L  dPQ and o le ic  acid  p rior l a  separation byThC
Aqueous samples cannot be applied  to  s i l i c a  p la te s  for separation  
o f c o n s t i t u e n t s .  T h erefo re  s e v e r a l  m ethods w ere a s s e s s e d  fo r  s o lv e n t  
e x tr a c t io n  o f  dPC and o l e i c  a c id  from s o lu t io n  3 by v o r te x in g  w ith  a 
range o f  o rg a n ic  s o lv e n t s  (T ab les 6 & 7 ). R e su lts  w ere compared to  
paired aqueous samples added d ir e c t ly  to  Aqua Luma. n-Heptane a t  pH 11.0 
was the most e f f ic ie n t  a t  ex tra ctin g  the dPC and o le ic  ac id , however the  
ex tra ct s o l id i f ie d  on contact w ith  the HEPES bu ffer  and was th erefore  
n o t u sed .
T able 6) Ex t r a c t i on û f  % -dPC from  aqueous sam p les ( s o lu t io n  31 in t o  
organic so lv en ts  a t  #1  and 11.0
Soivent m  2jQ. pH l i û
n-Heptane 86.1 % 93.0 %
Chloroform 1.5 % 2.4 %
diChloromethane 1.9 % 3.3 %
d ieth y le th er 29.7 % 63.7 %
B u tan -l-o l 0.4 % 0.3 %
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Table 7) Extraction pf ^ -oleic acid from ageous samplss. .(solution 31 
into 1ml of organic solvents at 3.Q and 11.Q
Solvent m  àQ m  11,0
n-Heptane 44.9 % 98.1 %
Chloroform 0.7 % 8.4 %
diChloromethane 0.7 % 54.9 %
d ieth y le th er 1.9 % 38.8 %
B u tan -l-o l 0.5 % 0.5 %
6.6) E xtraction o£ d£Q and o le ic  acid  using tbs method of High and Dyer 
(1959)
This technique r e l i e s  on the f^ ase separation  o f chloroform from 
th e  m e th a n o lic  la y e r  on s a tu r a t io n  w ith  w a ter . E x tr a c t io n  a t  98 .0  % 
(n=4) o f  dPC and 93 .0  % (n=4) o f  o l e i c  a c id  was good , however i t  was 
noted th a t on the second washing w ith  chloroform th a t the l ip id s  o ften  
came ou t o f  s o lu t io n .  A d d itio n  o f  50 u l o f  m ethanol ensured  s o l u b i l i t y  
a fter  ex tra ctio n . This method o f ex tra ctio n  was used for  a l l  experim ents 
invo lv ing  subsequent TLC separation .
6.7) Separation p f  dPQ and o le ic  acid  using 2 ^
In order t o  a s c e r ta in  th e  p r o f i l e  o f  f a t t y  a c id  and g ly c e r o -  
p h o sp h o lip id  s e p a r a t io n  u s in g  TLC sam p les c o n ta in in g  ^H-dPC and ^^C- 
o le ic  ac id  in  to lu en e were applied to  TLC p la te s  and run in  so lv en t 3. 
P la tes  were then scanned (see fig u re  37). O leic  ac id  tr a v e lled  w ith  the  
s o lv e n t  fr o n t  and dPC was r e ta in e d  on th e  p la t e  ( r f  = 0.33 ) .  L~- 
lysophosphatidylcholine applied  in  a s im ila r  manner was a lso  reta ined  on 
the p la te  (rf = 0.15). On scraping and counting by liq u id  s c in t i l la t io n .
Figure 37) T h in -layer chromatograms from a Berthold TLC scanner (30 sec  
tim e co n sta n t , 50mV s e n s i t i v i t y  , scanning speed 30(>nnv^r). ILC p la te s  
were developed in  so lv e n t 3 (Chloroform : methanol : g la c ia l  a c e t ic  a c id  
: w a te r  , 50  : 15 : 4 : 2 , v / v / v / v  ) .
a) 200  nM ols dPC c o n ta in in g  ^H-dPC w as a p p lie d  t o  th e  o r ig in  (0) 
and developed fo r  10cm. r f= 0 3 3 .
b) ^^C -oleic  a c id  was a p p lied  to  th e  o r ig in  (0) and developed fo r  

















99.7% o f  ^ ^ C -o le ic  a c id  was p r e se n t  in  th e  f i n a l  2cm o f  th e  la n e  and 
99.0% o f ^H-dPC was present in  the f i r s t  8.0cm.
6.8) E lution  ^H-dPC and ^^C -o le ic  acid  from p la te s
^H-dPC and ^ ^ C -o le ic  a c id  w ere a p p lie d  to  se p a r a te  la n e s  o f  TLC 
p la te s  in  concentrations which would be used experim entaly and developed  
in  s o lv e n t  3. The s i l i c a  from each  la n e  was tak en  up in  m ethanol or 
d ir e c t ly  in to  s c in t i l la t io n  f lu id  and the a c t iv i t y  compared w ith  samples 
applied  d ir e c t ly  to  the s c in t i l la t io n  v ia l s .  45.6% ^H-dPC and 97.5% 
o l e i c  a c id  w ere reco v ered  w ith o u t m ethanol and 95.0% ^H-dPC and 94.0% 
l^ c -o le ic  acid  w ith  methanol. Further experim ents showed th a t 94.4% of  
^H-dPC (n=4) was recovered w ith  prior treatm ent w ith  methanol and 97.3% 
of the ^^C-oleic acid  (n=4) was recovered when the ^H-dPC was extracted  
u sin g  s c i n t i l l a n t  a lo n e . For t h i s  reason  dPC was e x tr a c te d  from  th e  
s i l i c a  in  methanol and o le ic  ac id  in  s c in t i l la n t  alone.
6.9) A ctio n  û f  a u th e n t ic  p h o sp h o lip a se -A n q r  -H-dPC
The action  o f authentic  porcine pancreatic PLA2 was determined to  
a sse ss  the performance of the two methods o f separation  and the p o s it io n  
of the la b e l on the ^H-dPC. Figure 38 shows the a ction  o f authentic PLA2 
(5 U/ml) on the su b strate  (so lu tion  3) and subsequently separated using  
m in i-co lu m n s. 5 U/m l PLA2 in  150u l o f s o lu t io n  3 r e le a s e d  82.5% o f  th e  
a c t iv i t y  in to  so lv en t 1 (figu re  38). Figure 39 shows samples under the  
same incubation con d ition s except separated using ILC a fter  ex tra ctio n  
by the method o f Bligh & Dyer (1959). 97.3% of a l l  a c t iv i t y  was released  
and ran w ith  the so lv en t fron t in d ica tin g  ^H-dPC cleavage.
The im p ortance o f s o n ic a t io n  o f  th e  s u b s tr a te  m ix tu re  i s  a l s o
109
S a m p l e  N o
F igu re 38) The e f f e c t  o f a u th e n tic  p h osp h o lip ase-A 2 [ PLA2 ^ o n  1 -  
c le o y l ,2 (^H -oleoyl)-phosphatidylcholine (dPC A  ; Mini-column separation). 
dPC and released  o le ic  acid  were separated on mini-columns packed with  
1 0 0 -2 0 0  m esh s i l i c a ,  1m l sa m p le s  in  tu b e s  1 -6  w ere  e lu t e d  in  
hexane:dioxane;glacial a c e t ic  acid (70:30:1 , so lven t 1) and tubes 7-12 
in chi or oform:methanol: water (65:35:4 , so lven t 2). PLA2 cleaved 85% of 
the ^H -oleic acid from the ^H-dPC.
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i l l u s t r a t e d  in  f ig u r e  39. S o n ic a t io n  o f  s o lu t io n  3 ensured co m p le te  
lib e r a t io n  by authentic PLA2 w h ils t  the absence o f so n ica tio n  resu lted  
in  only 41.2% conversion under th e  same con d ition s.
6.10) Time c o u r se  qL  ^H -o le ic  a c id  r e le a s e  and Ü2Ê com parison  o f  
separation  a f  ^  and o le ic  acid  bY: mini-column and T l£ . a fte r  incubation 
with xat u ter in e  homogenate
Rat u ter in e  homogenate was incubated w ith  333uM ^H-dPC and paired  
150ul samples were taken over tim e from the same v e s s e l  and separated by 
TLC and m in i-co lu m n . The r e s u l t in g  tim e  c o u r se s  ( f ig u r e  40) show 
c o m p le te ly  d i f f e r e n t  p r o f i l e s .  The accu m u la tio n  o f  ^ H -o le ic  a c id  
in d icated  by TLC i s  sharp and peaks a fte r  one hour a t  6.88nmols o le a te  
released  per mg o f p rote in  w h ils t  the mini-colum n ind icated  on ly  a slow  
accum ulation peaking a fte r  30 m inutes a t  2.91 nmols/mg p rote in .
The separation  o f re leased  o le ic  acid  by TLC i s  more com plete than 
by m in i-co lu m n  as th e  e x te n t  o f  c o n v e rs io n  o f  dPC by a u th e n t ic  PLA2 
in d icated  by m ini-colum n i s  incomplete^ un like ILC. This could lead to  
inaccuracies in  the c a lc u la tio n  o f PLA2 a c t iv i t y  and thus TLC was taken 
as the method o f ch oice  for a l l  fu rther experim ents.
6.11) Th& effect û f  phospholipase-Ao in h ib ito r s  m  th e  HA2 a c t iv i t y  i n  
pi.egnant x e t  uterine homogenates
In cu b a tio n  o f  pregnant r a t  u te r in e  hom ogenate (day 19) w ith  
s o lu t io n  3 in  th e  p resen ce  o f  m epacrine (6.77uM) and t e t r a c a in e  (ImM) 
r e s u lt e d  in  th e  co m p lete  in h ib i t io n  o f  ^ H -o le ic  a c id  r e le a s e  (see  
f ig u r e s  41 & 42) when compared w ith  u te r in e  hom ogenates in cu b ated  
w ithout mepacrine or te tra ca in e .
Figure 39) Thin-layer chromatogram scanned w ith  a Berthold scanner (30 
second  tim e  c o n s ta n t , 50mV s e n s i t i v i t y ,  sca n n in g  sp eed  SOOmm/hour), 
i l l u s t r a t i n g  th e  e f f e c t  o f  a u th e n t ic  PLA2 on l - o l e o y l ,2 - ( ^ H - o le o y l ) -  
phosphatidylcholine prepared w ith  or w ithout son ica tio n . ILC p la te s  were 
were developed in  so lv en t 3 (Chloroform ; methanol : g la c ia l  a c e t ic  acid  
: w ater  , 50 : 15 : 4 : 2 , v / v / v / v  )
a) 333uM dPC w ith  ^H-dPC incubated in  so lu tio n  3 (NOT SONICATED) 
a t  37°C w ith  authentic  PLA2 (5U/ml) for  30 m inutes.
b) 333uM dPC w ith  ^H-dPC in cu b ated  in  s o lu t io n  3 (SONICATED) a t  
37°C w ith  au th en tic  PLA2 (5U/ml) for  30 m inutes.
S o n ic a t io n  r e s u lt e d  in  th e  r e le a s e  o f  97.3% o f  ^ H -o le ic  a c id  from th e  
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Figure 40) Paired comparison of indicated conversion of l-oleoylf2-('^H - 
o le o y l) -p h o s p h a t id y lc h o lin e  (dPC) by th e  700g sup ern atan t o f a ra t  
u te r in e  homogenate (day 19 pregnant) u sin g  two m ethods o f product and 
s u b s tr a te  e x tr a c t io n  and sep a ra tio n . R eleased  ^ H -o le ic  a c id  was 
extracted by the method o f Bligh & Dyer (1964) and separated from dPC by 
th in - la y e r  chrom atography (TLC, a ) and compared to  e x tr a c t io n  and 
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F igure 41) The e f f e c t  o f m epacrine (6.77mM,A) on th e  r e le a s e  o f o l e i c  
acid by the 700g supernatant of a day 18 pregnant rat uterine homogenate 
( A ) ,  M epacrine a b o lish ed  th e  th e  r e le a s e  o f ^ H -o le ic  a c id  from 1 -
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Figure 42) The e f f e c t  of te tr a c a in e  (A;lmM) on th e  r e le a se  o f o le ic  
acid by the 700g supernatant of a day 19 pregnant rat uterine homogenate 
( A ) .  Tetracaine abolished the release of ^H-oleic acid from l-o leoy ly2 -
H -oleoyl)-phosphatidylcholine.
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6.12) Protein dépendance fif  ib s  relea se  û f  o le ic  acid  tb s  l a t  uterine 
homogenate
Three substrate mixtures (so lu tion  3) were prepared w ith d iffe re n t  
c o n c e n tr a tio n s  o f r a t  u te r in e  hom ogenate. The c o n c en tr a tio n s  were 
c a lc u la te d  as 1.488 (b o ile d  c o n tr o l and h igh  p r o te in  co n c en tr a tio n  
sample) and 0.744 mg/ml. %e incubation m ixtures were incubated a t  37°C 
fo r  30 m in utes and sam ples taken  a t  5 , 10 , 20 and 30 m in u tes. The 
release  of o le ic  acid  increased w ith  protein concentration (see figu re
4 3 ).
The enzyme r a te  was c a lc u la te d  fo r  0.744m g/m l s o lu t io n  as 2.468  
and fo r  th e  1.44m g/m l s o lu t io n  as  2 .410 nm ols/m g p ro te in /h o u r  (f ig u r e
44). Higher co n c en tr a tio n s  o f p r o te in  were n ot used as th e  b u ffe r in g  
capacity o f the substrate mixture may not have been s u f f ic ie n t  a t th is  
l e v e l .  The r a t io  o f 1 p a r t hom ogenate : 5 p a r ts  s u b s tr a te  ( i .e .  17% 
homogenate/substrate) was used for a l l  experiments.
6J.3) ^  optimum ^H -oleic  acid  re lease  from ^H-dPC pregnant l a t
u terine homogenate
Substrate m ixtures o f so lu tio n  3 were prepared over a range of pH 
6.75 to  8.5 and th e  r a te  o f r e le a s e  o f  ^ H -o le ic  a c id  a f t e r  in cu b a tio n  
w ith  th e  u te r in e  f r a c t io n  c a lc u la te d  over 20 m in u tes fo r  two 20 day 
p r e g n a n t r a t s .  A peak o f  29 .8 8  a t  pH 8 .0  a s  com pared t o  13 .6 2  
nmols/mg/hour a t  pH 7.5 (see fig u re  45). A ll subsequent experiments were 
c a r r ie d  out a t  pH 8.0.
6.14) Tbfi .effect û f  calcium on ^H -o le ic  a c id  r e le a s e  from ^H-dPC 
pregnant %ab uterine homogenate
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Figure 43) The e f f e c t  of p ro te in  co n cen tra tion  on th e r e le a se  of Ch­
o le ic  acid from l-o leoy l,2 -(^ H -o leoy l)-p h osp h atid y lch o lin e  by th e 700g 
supernatant o f a day 19 pregnant ra t u ter in e  homogenate. ( a : 1.48 





























Figure 44) The e ffe c t  of protein concentration on the rate of release of 
H -oleic acid from l-o le o y l,2 - (  H-oleoyl)-phosphatidylcholine per mg of 
p ro te in  by the 700g supernatant o f a day 19 pregnant ra t u ter in e  
homogenate over tim e of in cu b ation . The ra te  of conversion  per mg 
p ro te in  over tim e i s  not a f fe c te d  by p r o te in  co n cen tra tio n . (A : 1.48 














T- ! I H  I  I  I  I I  t  I  ' H  I I  : '  .  I I : I  I  I I  .  I  :7  .  T| T, . ! ,  ; , I , , ,
6 . 5 0  7 . 0 0  7 . 5 0
: p  M r TTTyTin tt : n  ]
1 . 0 0  8 . 5 0
pH
Figure 45) The e f fe c t  of pH on the rate of release  of H -oleic  acid  from 
1 -o leo y l ,2 - (^H -oleoyl)-phosphatidylcholine (dPC) by the 700g supernatant 
o f a day 20 pregnant r a t  u te r in e  hom ogenate. R elease  o f  ^ H -o le ic  a c id  
was maximal a t pH 8.0.
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prepared and 150u l sam p les taken a t  5 , 10 and 20 m in u tes. F igure 46 
in d ic a te s  th a t  a lth ou gh  th e r e  was no graded s t im u la t io n  o f a c t i v i t y  
related  to  calcium  concentration, the re lease  of o lea te  by rat uterine  
homogenate had an absolute requirement for calcium.
6J5) The e f f e c t  o f Substrate concentration m  th e  re lease  qL  ^H -oleic 
acid from ^H-dPC b%: pregnant x a t  uterine homogenate
S u b stra te  m ix tu res  (s o lu t io n  3) were prepared w ith  dPC ranging  
from 41.6 to  1332uM, and th e  r a te  o f con version  by day 20 pregnant ra t  
uterine homogenate was ca lcu lated  from progress curves constructed from 
sam ples taken  a t  5 , 10 and 20 m in u tes. The co n v ers io n  was s u b s tr a te  
dependant ten d in g  t o  reach a maximum above 1332uM (f ig u r e  47 ; Vmax= 
16.8 nmols/mg/hour, Km= 0.7845) and 1/2 Vmax a t  48CXiM dPC.
For a l l  fu tu r e  exp erim en ts d u p lic a te  sam ples were used a t  a 
substrate concentration o f 1/2  Vmax , co n sistin g  o f 17% homogenate : 83% 
substrate mixture (so lu tion  3) a t  01 8.0 . Duplicate samples were taken 
a t 20 minutes of incubation sin ce  the correla tion  c o e f f ic ie n t  for those 
values ca lcu la ted  from data using 5, 10 and 20 minute samples compared 
to  20 minutes samples was 0.99 (n=23).
6.16) Th& e f f e c t  o t  p e r fu s io n  qL  ih e  u te r in e  bed o r  t h e  c a lc u la te d  
enzyme a c t iv ity
I t  was noted  th a t  u t e r i  taken from l a t e  pregnant r a t s  con ta in ed  
s ig n if ic a n t amounts of blood trapped w ith in  the myometrium and deciduum. 
T h is  w ou ld  a f f e c t  th e  p r o t e in  a s s a y  t o  g iv e  a h ig h e r  p r o t e in  
concentration and thus r e su lt  in  a lower ca lcu la ted  enzyme a c t iv ity . One 
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Figure 46) The e f fe c t  of calcium concentration on the rate of release  of 
^H-oleic acid  from l-o le o y l,2 -(^ H -o le o y l)-p h o sp h a tid y lc h o lin e  (dPC) by 
th e  700g su p ern atan t of a day 19 pregnant r a t  u te r in e  hom ogenate. dPC 






























S u b s t r a t e  ( m M o l a r )
Figure 47) The e f fe c t  of substrate concentration on the rate of release  
of o le ic  acid from l-o le o y l,2 - (% -o le o y l) -p h o s p h a t id y lc h o lin e  (dPC) 
by the 700g supernatant of a day 20 pregnant rat u terine homogenate. The 
r a te  o f co n v ers io n  was dependant on th e  su b s tr a te  c o n c en tr a tio n .  
Vmax = 16.8 nMols/mg/hr, Km = 0.7845.
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described in  se c t io n  2.2 and th e PLA2 a c t iv i t y  assayed.
The c a lc u la te d  PLAg a c t i v i t y  was in c r e a se d  from  28.5 t o  40.3  
nm ols/m g/hour on p e r fu s io n . The p r o te in  c o n c e n tr a t io n  a ssa y ed  was 
reduced from 1.97 to  0.78 mg/ml. T h erefo re  a l l  fu tu r e  ex p er im en ts  used  
perfused u ter in e  t is s u e . The dry w eigh t/w et w eight r a t io  o f the u ter in e  
t is s u e  was a lso  reduced by perfusion  from 7.3% to  3.2%.
6.17) Ths. çQntributipn oL m yom étria l and decidual PM 2 to . t h e  w hole  
uterine PL&2
One u te r in e  horn from a day 19 p regn an t r a t  was p e r fu sed  w ith  
Krebs' so lu tio n  and d ivided in to  two p ortion s. One p ortion  was incubated  
a s  norm al and th e  d ec id u a  scrap ed  o f f  th e  o th er  u s in g  a m icro sco p e  
s l i d e .  The myometrium and th e  deciduum from  th e  same sam ple w ere  
in cu b ated  in  th e  volum e w hich th e  w h ole  t i s s u e  would r e q u ir e . The 
a c t iv i t y  was a ssessed  a t  20 m inutes incubation tim e.
The w hole u ter u s  had th e  c a p a c ity  t o  l ib e r a t e  o l e i c  a c id  a t  th e  
rate  o f 40.3 nmols/mg/hour. The myometrium and decidua released  18.3 and 
24.4 nmols ^ H -o le ic  a c id /m g /h o u r  r e s p e c t iv e ly  (a t o t a l  o f  42.7 
n m ols/m g/h ou r). The myometrium th e r e fo r e  c o n tr ib u te d  42.8% t o  t o t a l  
a c t iv i t y  when assessed  in  th is  way.
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7 .0 )  DISCUSSION
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O ptim al c o n d it io n s  fo r  th e  r e le a s e  o f  a n t i-a g g r e g a to r y  m a te r ia l  
from th e  human myometrium (Bamford e t  a l.y  1 9 8 0 ), p la c e n ta  (M yatt & 
Elder,1977) and ra t myometrium (ElTahir & W illiam s, 1980) have already  
b een  d e te r m in e d . The c o n d i t i o n s  f o r  m y o m é tr ia l  r e l e a s e  w ere  
corroborated, however th e con d ition s for  th e re lea se  from th e p lacen ta  
d i f f e r e d  s u b s t a n t ia l ly  from  th o se  r ep o rted  by M yatt & E lder (1977). 
A nti-aggregatory a c t iv i t y  was only  released  a fte r  preincubation a t  37°C 
for 10 m inutes fo llow ed  by chopping and further incubation a t  22®C for  
15 m in u te s , and no a c t i v i t y  was r e le a s e d  w ith o u t p r e in c u b a tio n  or  
chopping. T h is  co u ld  in d ic a te  th a t  in c u b a tio n  a t  37 °C r e s u l t s  in  
a c tiv a tio n  o f  or re lea se  o f th is  m ateria l in to  the in tr a c e llu la r  medium, 
and i s  then re leased  in to  th e incubation medium on chopping.
Rat myometrium separated from deciduum by scraping and incubated 
a f t e r  chopping produced s u b s t a n t i a l  r e l e a s e  o f  PG l2 ” l i k e  a n t i ­
aggregatory m ateria l reaching a maximum a t  15 m inutes incubation a t  22°C 
in  TBS. T h is a g r e e s  w ith  th e  r e s u l t s  o b ta in ed  by E lT ahir & W illia m s  
(1980) u s in g  Krebs' s o lu t io n .  However th e  r e le a s e  was ob served  to  be 
markedly a ltered  by t is s u e  handling , the method o f  removal o f decidual 
t is s u e  a ffe c t in g  maximal sy n th esis  and the ra te  o f r e lea se  being a ltered  
by chopping. The f a c t  th a t  chopping in c r e a se d  th e  r a te  o f o u tp u t o f  
PG%2- l i k e  m ateria l but not maximal re lea se  may in d ica te  the presence o f  
a n e g a t iv e  feed b ack  mechanism a s  m yom étria l PGI2 s t im u la t e s  cAMP 
fo rm a tio n  (V esin , Do Khac & Harbon, 197 9; O m ini, e t  a l . ,  197 9) and PGI2 
sy n th es is  may be a ltered  by in tr a c e llu la r  cAMP (see la te r ) . Removal o f  
decidual t is s u e  from the rat myométrial t is s u e  excludes in terferen ce  due 
t o  th e  a n t i - a g g r e g a t o r y  a c t i v i t y  o f  PGD2 and PGE2 w h ic h  a r e  
predominantly syn th esised  by th e deciduum (Hamey, Sneddon & W illiam s,
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197 4; W illia m s  & Downing, 1977; A bel & K e lly , 197 9; A lw a ch i, Bland & 
Poyser, 1980).
Rat and human myométrial an ti-aggregatory  a c t iv i t y  released  in to  
th e incubation medium behaved in  a s im ila r  manner to  authentic  PGI2 in  
th a t they were s ta b le  a t  a lk a lin e  pH, but acid  la b i le ;  p rop erties  known 
t o  be p e c u lia r  t o  PGI2 am ongst th e  PCs. Both PGD2 and PGE2 , a n t i ­
a g g reg a to ry  PGs known t o  be r e le a s e d  by th e  myometrium (Vane & 
W illiam s, 1973; K atori, Harada, Yamashita, Ish ib ash i & M iyazaki, 1978), 
r e ta in e d  a c t i v i t y  a f t e r  a c i d i f i c a t i o n  but t h i s  was l o s t  on s to r a g e  a t  
a lk a lin e  pH. This i s  presumably due to  the conversion o f PGE2 to  PGB and 
PGD2 t o  a more p o la r  su b sta n ce  (P a ce -A sc ia k , 197 6b). PG%2 - f r e e  human 
m yom étr ia l in cu b a te  d id  n o t a f f e c t  th e  a n t i-a g g r e g a to r y  a c t i v i t y  o f  
PGI2 . Furthermore, the anti-aggregatory  p o ten cies o f PGD2 and PGE2 were 
very low s in ce  rabbit p la t e le t s  are r e la t iv e ly  in s e n s it iv e  to  th ese  PGs 
when compared to  PGI2 , un like human p la t e le t s  (W hittle , Monacada & Vane, 
1978).
P la c e n ta l  a n t i-a g g r e g a to r y  a c t i v i t y  on th e  o th er  hand was n ot  
abolished on a lk a lin isa t io n  but attenuated. Mild a c id if ic a t io n  to  pH 7.5  
from pH 8 .0  w ith  in c u b a tio n  a t  22®C d id  n o t a l t e r  p la c e n ta l  a c t i v i t y ,  
unlike the myométrial a c t iv i t i e s  and authentic PGI2 which were reduced. 
P retrea tm en t o f  t i s s u e s  w ith  in d om eth acin  i n h ib i t s  th e  r e le a s e  o f  
a c t i v i t y  from  r a t  (E lTahir & W illia m s , 1980) and human (Bamford e t  
a l . ,1980  ) m yom étria l t i s s u e s  w h i l s t  le a v in g  p la c e n ta l  a c t i v i t y  
u n a ffe c te d  (M yatt & E ld er , 1977). W h ilst th e s e  r e s u l t s  show th a t  th e  
m a te r ia l r e le a s e d  from th e  m yom étria l t i s s u e s  i s  p rob ab ly  PGl2 r th e  
p la cen ta l substance (s) does not p ossess the same p rop erties  and e x h ib its  
a d if fe r e n t  tim e course o f anti-aggregatory  a c tio n  aga in st ADP-induced
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aggregation to  both th e myométrial a c t iv i t i e s  and PGI2 .
Chow, C r a ft , Dandona and H utton (1980) rep o rted  th e  r e le a s e  o f  an 
ADPase in t o  TBS from chopped p la c e n ta l  t i s s u e  when in cu b ated  a t  37°C 
w hich reduced th e  a g g reg a to ry  a c t i v i t y  o f  ADP . T h erefo re  ADP was 
incubated a t  room temperature w ith  myométrial and p la cen ta l e x tr a c ts ,  
v ery  l i t t l e  ADP degrad in g  a c t i v i t y  was n o ted  in  th e  human m yom étr ia l 
incubate un like the human p la cen ta l incubate which contained s ig n if ic a n t  
a c t i v i t y .  A lthough human m yom étr ia l in c u b a te s  have been rep o rted  t o  
contain  an ADPase (Hutton, Chow, Craft & Dandona, 1980) when incubated  
a t  37°C, the ADP degrading cap acity  o f  th e human myometrium was low a t  
22°C . I t  was th ought th a t  th e  c o n tr ib u t io n  o f  ADPase t o  human 
myom étrial PGI2 a n ti-a g g reg a to ry  a c t i v i t y  under th e s e  c o n d it io n s  was 
in s i g n i f i c a n t  fo r  th e  p u rp oses o f  t h i s  s tu d y . However th e  ADPase 
a c t i v i t y  p r e se n t  in  th e  p la c e n ta l  in cu b a te  would have c o m p le te ly  
overshadow ed any a n t i-a g g r e g a to r y  a c t iv i t y  exh ib ited  by PGI2 and th is  
was not pursued fu rther. Ihe a lk a lin e  la b i l i t y  o f th e p la cen ta l a c t iv i t y  
may have ind icated  an e f f e c t  by PGD2 or PGE2 , which are syn th esised  in  
q u a n t ity  by th e  p la c e n ta  (Demens & Gabbe, 1976; M itc h e l l ,  Kraemer & 
Strick land , 1982). However, s in ce  indomethacin did  not even reduce th is  
a c t i v i t y  a t  d o se s  th a t  in h ib it e d  th e  r e le a s e  o f  m yom étr ia l a n t i ­
aggregatory a c t iv i t y ,  th is  i s  u n lik e ly .
The f a c t  th a t  th e  a n t i-a g g r e g a to r y  a c t i v i t y  r e le a s e d  under th e s e  
con d ition s by the p lacenta  i s  not PGI2 does not preclude the p o s s ib i l i t y  
th a t  PGI2 i s  s y n th e s is e d  by th e  p la c e n ta . 6 - 0 x0 - PGF^  ^ s p e c i f i c  RIA 
su ggests th a t th ere i s  endogenous re lea se  o f PGI2 from p la cen ta l t is s u e  
(M itch ell, Bibby, Hicks & Turnbull, 1978).
The a ssa y  c o e f f i c i e n t s  o f  v a r ia t io n  fo r  th e  a ssa y  o f  th e  PGI2 
content o f human myométrial incubation media were low , as were th ose  for
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ra t myometrium (ElTahir & W illiam s, 1980). However sp ec ie s  d iffe re n c e s  
in  the s e n s i t iv i t y  of p la t e le t s  to  PGI2 has led  to  th e widespread use o f  
human p la t e le t s .  Since th ese  are 3-5 tim es more s e n s it iv e  to  PGI2 than 
r a t  or r a b b it  p l a t e l e t s  r e s p e c t iv e ly  (W h ittle  e t  a l . ,  1978) p l a t e l e t s  
pretreated  w ith  papaverine were used for samples contain ing low le v e ls  
o f  PGI2 .
P ap averin e was a n t i-a g g r e g a to r y  a t  high doses and p o ten tia ted  th e  
anti-aggregatory  a c t iv i t y  of au then tic  PGI2 in  a dose re la ted  fash ion . 
Maximal p o t e n t ia t io n  o f  PGI2 a c t i v i t y  by p ap aver in e  was found a t  th e  
subthreshold dose o f lOOuM. This a lso  p o ten tia ted  th e an ti-aggregatory  
e f f e c t s  o f myométrial and PGI2 anti-aggregatory  a c t iv i t i e s  to  th e same 
e x te n t  and d id  n o t r e v e a l any o th er  a c id  s t a b le  a n t i-a g g r e g a to r y  
a c t iv i ty  (eg. PGD2 and PGE2) .  This p o ten tia tio n  was used as an accurate  
and s e n s i t i v e  e x te n s io n  t o  th e  a s sa y  o f  a n t i-a g g r e g a to r y  a c t i v i t y  in  
human myométrial incubates s in c e  th e  c o e f f ic ie n t s  o f v a r ia tio n  were low  
and s im ila r  to  th o se  o f th e  u n m od ified  a s sa y . P ap averin e p rob ab ly  
p o te n t ia te d  a n t i-a g g r e g a to r y  e f f e c t s  by p ro v id in g  a sub-m axim al 
in h ib i t io n  o f p l a t e l e t  p h o sp h o d ie s te r a se , s in c e  50uM p a p a v er in e  i s  
rep o rted  t o  in h ib i t  human p l a t e l e t  p h o sp h o d ie s te ra se  by 50% (M il ls  & 
Smith, 1971). PGI2 e lev a tes  p la t e le t  cAMP le v e l s  (Tateson, Moncada and 
Vane, 1977; Gorman, Bunting & M il le r ,  1977) v ia  rec e p to r  a c t iv a t io n  
(M ills & M acfarlane, 1977). Thus the degradation o f the p u lse  of cAMP 
g en era ted  by PGI2 would n o t be so  e f f i c i e n t  and th e  a n t i-a g g r e g a to r y  
a c t i v i t y  th u s p o t e n t ia te d . The in h ib i t io n  o f  p l a t e l e t  a g g r e g a tio n  by 
PGE  ^ can be p o te n t ia te d  by s e v e r a l  p h o sp h o d ie s te ra se  in h ib i t o r s  
in c lu d in g  th e o p h y ll in e ,  p ap averin e  and d ip y r id a m o le  (M ills  & Sm ith , 
1971). In turn  th e  in h ib i t io n  o f  p l a t e l e t  a g g r e g a t io n  by PGI2 i s
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p o te n t ia te d  by PGE^, th e o p h y ll in e  and d ip y r id a m o le  (W h ittle  e t  a l . ,  
1978) using doses which in  them selves are not anti-aggregatory .
F u rther e v id en ce  th a t  th e  a n t i-a g g r e g a to r y  a c t i v i t y  r e le a s e d  by 
human myometrium i s  an AA m etab o lite  was found on incubation o f human 
m yom étria l t i s s u e  w ith  AA or PLA2 . Both su b s ta n c e s  s t im u la te d  PGI2 
fo rm a tio n  t o  a s im ila r  d eg ree . T h is su p p o rts  th e  t h e s i s  t h a t  PG 
s y n t h e s is  i s  l im i t e d  by AA a v a i l a b i l i t y  (Kunze & V ogt, 1 9 7 1 ), and th e  
rep o rt th a t  AA and PLA2 s t im u la t e  PG%2 s y n t h e s is  by th e  r a t  p regn an t  
myometrium (ElTahir & W illiam s, 1980). Thus th e ra te  o f PGI2 sy n th es is  
i s  not dependent on low cyclo-oxygenase or PGI2 synth etase a c t iv i t i e s  or 
th e  la c k  o f  p r e c u r s o r  b u t a t  an e a r l i e r  s t e p ,  p r o b a b ly  PLA^. 
Indomethacin a ls o  in h ib ited  human myométrial PGI2 sy n th es is  presumably 
by the in h ib it io n  o f cyclo-oxygenase (Ahem & Downing, 1970; Vane 1971). 
High concentrations were used as reported in  previous work (Bamford e t  
a l . ,  1980) and would in d ic a t e  th e  p resen ce  o f  a cyclo-oxygenase enzyme 
w ith  low  a f f i n i t y  fo r  in h ib i t io n  by n o n -s te r o id a l  a n t i- in f la m m a to r y  
d ru g s  (NSAID). F lo w e r  and Vane (197 4) h a v e  r e p o r te d  d i f f e r e n t  
s u s c e p t ib i l i t ie s  o f the cyclo-oxygenase enzymes in  d if fe r e n t  t is s u e s  to  
in h ib i t o r s .  The p o s s i b i l i t y  o f  a low  a f f i n i t y  fo r  NSAID by u t e r in e  
cyclo-oxygenase in  la te  pregnancy has already been suggested (Terragno & 
Terragno, 1981). The potency o f indomethacin in  in h ib it in g  dog u ter in e  
PG fo rm a tio n  i s  reduced t e n - f o ld  from  th a t  req u ired  t o  in h i b i t  non­
pregnant u terin e  form ation (Terragno e t  a l . ,  1974; Terragno, Terragno & 
McGiff, 1976). A lso the dose o f indomethacin required to  ! in h ib it  t o t a l ly  
non -pregnant r a t  m yom étria l PGI2 s y n t h e s is  i s  <5 u g/m l w h i l s t  th a t  
req u ired  to  in h ib i t  pregnant r a t  m yom étr ia l PGI2 r e le a s e  by 50 % is 20  
ug/m l (ElTahir & W illiam s, 1980) under th e same incubation con d ition s.
Ihe p r o life r a tio n  o f an enzyme ch aracterised  by low NSAID a f f in i t y
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may account for th ese  d ifferen ces . Cyclo-oxygenase a c t iv i t y  i s  known to  
in c r e a s e  pregnancy in  r a t  u te r in e  t i s s u e  (W illia m s & Vane, 1973) 
and myometrium (W illiam s & El Tahir, 1980a) presumably in  preparation  
for  th e a c tiv a tio n  o f PLA2 a t  term.
As w e l l  a s  b e in g  s y n th e s is e d  by th e  m yom etrium , PGI2 was found t o  
a lte r  human myométrial c o n tr a c t i l i t y .  PGI2 i r r e v e r s ib ly  in h ib i t e d  th e  
sp on taneous c o n t r a c t i l i t y  and reduced th e  b a sa l to n e  o f  th e  lo w er  
segment myometrium in  v itr o . Omini e t  a l .  (1978, 1979), Sanger & Bennett 
(1980) and W ilh elm sson , W ikland & W iq u ist (1981) have rep o rted  a 
r ed u c tio n  in  sp on tan eou s m o t i l i t y  and b a sa l to n e  in  both  p regn ant and 
non-pregnant human myometria. Even though com plete in h ib it io n  was not 
seen , Omini and coworkers (1979) e l i c i t e d  an in h ib ito ry  e f f e c t  a t  2-20  
ng/m l in  th e superfused pregnant myometrium w h ils t  20Oig/ml (Omini e t  
a l . ,  1978) was required in  superfused non-pregnant myometrium; lOOng/ml 
(Sanger & Bennet ,  1980) and 1000 n g /m l (W ilhelm sson  e t  a l . ,  1981) 
a b o lish e d  c o n t r a c t i l i t y  in  n on -p regn ant t i s s u e  bathed  in  Krebs' 
s o lu t io n .  The p r e se n t  stu d y  show s th a t  th e  in h ib it o r y  p o ten cy  o f  PG%2 
d i f f e r s  n o t b ecau se  o f  th e  p r e p a r a tio n  o f  th e  myometrium d u rin g  
pregnancy but b ecau se  o f  th e  i n  v i t r o  c o n d it io n s .  S u p erfu s io n  w ith  
T yrode's s o lu  t io n  and a c o n s ta n t  in f u s io n  o f  PGI2 t o  th e  su p e r fu s io n  
f l u i d  (Omini e t  a l . ,  197 8) a s opposed t o  b a th in g  in  Krebs' s o lu t io n  
probably r e s u lt s  in  a greater a v a i la b i l i ty  o f PGI2 t o  the t is s u e  prior  
to  h yd ro lysis  to  G-oxo-PGF^^. However in  th is  study the e f f e c t  o f PGI2 
was profound and ir r e v e r s ib le , whereas c o n tr a c t i l i ty  i s  resumed a fte r  
th e  in f u s io n  o f  PGI2 i s  stop p ed  (Omini e t  a l .  197 8 , 197 9 ). D u stin g , 
Angus and leD uc (1982) have n o ted  a s im i la r  i r r e v e r s ib l e  e f f e c t  w ith  
e p ic a r d ia l ly  super fu sed  PGI2 on c ircu m flex  coronary artery  blood flow
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which remains unexplained. The mechanism of a c tio n  o f PGI2 in  causing  
u ter in e  re la x a tio n  i s  probably v ia  an in crease  in  myométrial cAMP le v e ls  
(Omini e t  a l .  1979) w hich i s  a common fe a tu r e  w ith  o th er  u te r in e  
re la x a n ts .
PGI2 a l s o  e l i c i t e d  a s l i g h t  in c r e a s e  in  th e  c o n t r a c t i l i t y  o f  th e
pregnant myometrium in  2/4  preparations, prior to  re laxation . An i n i t i a l
report o f an oxytocic  a c tio n  of PGI2 on human myometrium (W ilhelmsson,
Lindblom & W iquist, 1979), was a ttr ib u ted  to  a 'batch* d ifferen ce  in  the
PGI2 . However Sanger & Bennet (1980) rep o rted  th a t  30% o f t i s s u e s
i n i t i a l l y  contracted to  PG%2 . Intravenous in fu sio n  o f PGI2 a t  low doses
(<10 n g /k g /m in ) in  n on -p regn ant women has no e f f e c t  on u te r in e
c o n t r a c t i l i t y  (Makainen & Y lik o r k a la , 1982) w hereas in t r a - u t e r in e
i n s t i l l a t i o n  o f  PGI2 (0.3 -  0.6 ug) cau sed  a grad u al s t im u la t io n  o f
a c t iv ity .  Ihese s tu d ies  probably i l lu s t r a t e  an o x y toc ic  ac tio n  o f PGI2
a t  high concen trations, and a to c o ly t ic  a c tio n  a t  lower concen trations.
Bolus or high doses o f PGI2 (1000 ng/ml) to  superfused human myometrium
e l i c i t e d  c o n tr a c t io n s  and lo w er  d o se s  reduced c o n tr a c t i l i ty  (Omini e t
a l . ,  1978). S im ila r  f in d in g s  have a ls o  been rep o rted  in  th e  human
u m b ilica l artery  (Pomerantz, S in te to s  & Ramwell, 1978), ra t (Levy, 1980)
the sv n th es is  o f
and rabbit th oracic  aorta v ia  ^  an unstable pro-aggregatory
vasocon str ictor  s im ila r  to  TXA2 (Borda, S te r in -Borda, Gimeno, Lazzarri & 
Gimeno, 1983).
The observation  th a t human myometrium has th e  a b i l i t y  to  sy n th es ise  
in creasin g  amounts o f o f PGI2 during the la s t  two weeks of pregnancy i s  
in  agreement w ith  s tu d ies  in  th e  ra t (W illiam s & ElTahir, 1980a) but the  
aam ounts a re  10  t im e s  low er  in  human t i s s u e  . The e x a c t  m echanism  fo r  
th is  increase i s  unknown, but th e r is e  in  ra t and human myométrial PGI2 
s y n t h e s is  i s  c o in c id e n t  w ith  a peak in  plasm a o e s t r a d io l  l e v e l s
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(Anderson, 1977; W ilson, S ta n isc , Kahn-Dawood & Dawood, 1982; Turnbull , 
P a tte n , F l i n t ,  K e ir se , Jerem y & A nderson, 1974). Plasm a o e s t r a d io l  
in c r e a s e s  du rin g  pregnancy in  women peak ing a t  weeks 3 0 -4 0  (Dawood & 
Ratnam, 1974; Turnbull e t  a l . ,  1974). Free and bound plasma progesterone  
in creases a lso  throughout pregnancy (Yannone, M ueller & Osborne, 1969) 
and has been rep o rted  t o  f a l l  b e fo r e  labour (Csapo, Poharka & K a ih o la , 
1974).
There i s  no data a v a ila b le  a t  p resen t on th e e f f e c t s  o f s te r o id s  on 
pregnant human m yom étria l PGI2 s y n t h e s is .  O e s tr a d io l has been found  
however t o  s t im u la t e  6 -oxo-PGF2  ^ r e le a s e  by c u ltu r e d  te r m -p la c e n ta l  
c e l l s ,  w h ils t  progesterone in h ib it s  t h is  a ction  (Myatt, Jogee & Elder, 
1983). The a c t io n  o f  o e s t r a d io l  was th ou gh t t o  be e i t h e r  by th e  
a c tiv a tio n  o f PLA2 and/or in h ib it io n  o f PGDH a t  higher doses. Oestrogens 
a ls o  in c r e a s e  th e  s y n t h e s is  o f  PGs in  r a t  u t e r in e  t i s s u e  (Ryan, C lark , 
Van Orden & Brody, 1974) and p a s s iv e  im m u n isa tion  a g a in s t  o e s t r a d io l  
s ig n if ic a n t ly  reduces the concentration  o f PGE2 and PGF2Q in  ra t u ter in e  
venous b lood  in  labou r (Csapo, C u rr ie , Erdos & R esch , 197 8 ) ,  w h i l s t  
NSAID in h ib it  o e stra d io l-s tim u la ted  PG form ation by rat uterus (Jordan & 
Castracane, 1976). This s tim u la tio n  o f  PG sy n th es is  has been te n ta t iv e ly  
a ttr ib u ted  to  an increase in  PLA2 a c t iv ity .  In order to  in v e s t ig a te  the  
e f f e c t s  o f  s t e r o id s  and o th er  f a c t o r s  an a s sa y  fo r  r a t  u te r in e  PLA2 
a c t iv i ty  was ch aracterised .
Enzymic a c t iv i t y  which lib era ted  ^H -oleate from ^H-dPC was is o la te d  
in  the pregnant ra t uterus. Ihe methods o f separation  o f the h yd ro lysis  
products was found to  be c r i t i c a l .  Although mini-column separation  as 
d e sc r ib e d  by C on sen tin o  and Legrand, (1981) r e s u lt e d  in  a good  
s e p a r a t io n  o f  th e  r e le a s e d  f a t t y  a c id  from th e  g ly c e r o p h o sp h o lip id .
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conversion d etected  by th is  method was l e s s  than th a t found using TLC as  
th e  s e p a r a t iv e  p roced u re. L y so -p h o sp h a tid y lc h o lin e  can a f f e c t  th e  
m o b il i t y  o f  f a t t y  a c id s  in  s im i la r  sy stem s and co u ld  e x p la in  t h i s  
d isp a r ity . TLC was th erefore  used as  th e method o f choice.
The a c t i v i t y  w ith in  th e  p regn an t r a t  u te r u s  e x h ib ite d  a b s o lu te  
ca lc iu m  dépendance, an a lk a l in e  pH optim um , and was s u s c e p t ib le  t o  
in h ib it io n  by mepacrine and te tr a ca in e , both in h ib ito r s  o f phospholipase  
a c t i v i t y  (Marcus & B a l l ,  1969; Kunze e t  a l . ,  1974). These p r o p e r t ie s  
in fer  a j^ospholipase-dependent re lea se  o f o le a te  and severa l mechanisms 
should be considered: 1) r e lea se  o f o le a te  from th e sn l p o s it io n  by PLAj 
and m ig r a tio n  o f  th e  ly so -P C  w ith  th e  o le a t e  a t  th e  s o lv e n t  f r o n t ,  2) 
re le a se  o f o le a te  by PLAj from the sn l p o s it io n  w ith  subsequent breakdown 
o f th e lib era ted  lyso-PC by a lyso-ph osp holip ase, 3) th e a c tio n  o f PLC 
w ith  su b seq u en t l i b e r a t i o n  o f  ^ H -o le a te  by t h e  a c t i o n  o f  1 , 2 -  
d ia c y lg ly c e r o l - l ip a s e  on p h o sp h a tid ic  a c id  (PA), 4) th e  a c t io n  o f  PLC 
w ith  th e  l ib e r a t io n  o f  ^ H -o lea te  by a PA dependent PLA2 and 5) th e  
re lea se  by PLA2 from the sn2 p o s itio n .
To ta k e  th e  f i r s t  tw o p o in t s ,  PLA^, l i p a s e s  and p h o sp h o lip a se s  do 
n o t r e q u ir e  ca lc iu m  (McMurray & Magee, 1972; G a tts  & B a reb h o lz , 1973) 
and secondly bovine sem inal v e s ic le  l ip a se s  are in h ib ited  by high (lOmM) 
ca lc iu m  c o n c e n tr a t io n s  (Kunze e t  a l . ,  1974). A lso  th e  m o b il i ty  o f  th e  
lyso-PC lib era ted  by PLAj has a s im ila r  m o b ility  to  PC in  th e  TLC system  
used. T hirdly, PLC derived from p la t e le t  and human fo e ta l  membranes i s  
s p e c i f i c  fo r  PI (L apetina & C u a treca sa s , 197 9; D iRenzo, J o h n sto n e , 
Okazaki, Okita, MacDonald & B leasedale , 1981) and not PC which was used 
in  th is  s t u ^ .  I t  i s  th erefore  probable th a t th e  enzyme i s  PLA2 , and not 
P A -s p e c if ic  PLA2 s in c e  th e  l a t t e r  has a pH optimum o f  7 .0  ( B i l la h ,  
Lapetina, Cuatrecasas, 1981). More con clu sive  evidence would be to  use
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d u a l- la b e l le d  dPC in  order t o  i l l u s t r a t e  h y d r o ly s is  a t  e i t h e r  or both  
the sn l and sn2 p o sito n s and t e s t  fo r  in h ib it io n  or a c tiv a tio n  by EETA 
s in ce  EDTA in h ib it s  PLA2 but s tim u la te s  lip a se  a c t iv i t y  (Kunze e t  a l . ,  
1974). Examples o f th e use o f t h is  assay system  were then i l lu s tr a te d .
The re lea se  o f ^H -oleate by day 19 pregnant ra t uterus under optim al 
c o n d i t i o n s  w as h ig h  a t  40  n M o ls /m g /h o u r . U t e r i  ta k e n  from  
h yp oph ysectom ised  r a t s  c o n v e r t  2.2 nM ols/m g/hour (Dey e t  a l . ,  1982) 
w h i l s t  a t  day 1 o f  pregnancy t h i s  a c t i v i t y  i s  o n ly  4 .1 , p eak in g  a t  
im plantation  on day 4 a t  15.8 and returning to  6.61 nMols/mg/hour on day 
6 (Cox, Cheng & Dey, 1982). T h is  peak in  a c t i v i t y  corresp on d s w ith  a 
rep o rted  peak in  serum o e s t r a d io l  (Watson & Alam, 1976) and u te r in e  
o e s t r a d io l  r ec e p to r  c o n c e n t r a t io n  ( C la s s e r  & M cCormack, 1 9 8 1 ) .  
O e str a d io l p r e trea tm en t o f  h yp op h ysectom ised  r a ts  r e s u l t s  in  a 
c o n s id e r a b le  in c r e a s e  in  u te r in e  PLA2 a c t i v i t y  (Dey e t  a l . ,  1982) t o  
l e v e l s  s im i la r  t o  day 19 o f  pregnancy. The o e s t r a d io l  su rge  by 
in c r e a s in g  PLA2 a c t i v i t y  co u ld  th u s  e x p la in  th e  in c r e a se d  r e le a s e  o f  
PGI2 from the rat myometrium noted a t  day 21 over day 19.
The fa c t  th at o e stra d io l and progesterone are capable o f m odifying 
PG sy n th es is  may in d ica te  a receptor mediated a c t iv a t io n /in a c t iv a t io n  o f  
AA r e le a s e .  The u te r in e  s t im u la n ts  o x y to c in  and BK both  s t im u la t e  r a t  
pregnant myométrial PGI2 sy n th es is  (W illiam s & ElTahir, 1980 b) which i s  
in  i t s e l f  a stim u lan t o f rat u ter in e  c o n tr a c t i l i ty  (Omini e t  a l .  1977; 
E lT ahir e t  a l . ,  197 9 ). O xytoc in , a n g io te n s in  I I ,  e rg o m etr in e  and 5-HT 
a l l  increased the sy n th es is  o f PGI2 by ra t pregnant myometrium in  a dose 
rela ted  manner, and the e f f e c t  o f 5-HT was antagonised by m ethysergide, 
a 5-HT r ecep to r  a n ta g o n is t  (A w outers, L eysen , De C lerk  & Van N ueten,
198 2 ). The PLA2 in h ib it o r  m epacrine red u ces  th e  s t im u la te d  o u tp u t by
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th e s e  drugs w h i l s t  le a v in g  th e  s t im u la n t  a c t i v i t y  o f  AA u n a ffe c te d  
(W illiam s e t  a l . ,  1983) su ggestin g  th ey  are a c tin g  v ia  in creasin g  PLA2 
a c t iv i t y  . FLA2 i s  ac tiv a ted  by calm odulin (Walenga, C ^ s & F e in ste in ,  
1981), and as such could be co n tro lled  by in tr a c e llu la r  processes which 
m od ulate in t r a c e l lu la r  ca lc iu m  such as changes in  cAMP concen trations  
(rev iew ed  by B ar, 197 4 ). T h is  i s  su p p orted  by th e  f in d in g s  th a t  
b ra d y k in in  (A rold, Leibman, Roemer, Paegelow  & R eissm an, 1 9 7 6 ), 
oxytocin  (Bhalla, Sunborn & Foreman, 1972) and an g io ten sin  II  (D'Aurac, 
A n gles & Mayer, 1972) reduce r a t  u t e r in e  cAMP l e v e l s ,  w h i l s t  5-HT 
(Tereschenko, Kurski & Fedorov, 1972), an g io ten sin  II  (Blackmore, Dehaye 
& E xton, 197 9 ) , o x y to c in  (C arsten , 197 4) and erg o m etr in e  (G iovanni & 
A lb ero , 1966) reduce Ca'*”*' uptake and b in d in g  by m yom étria l f r a c t io n s ,  
which causes an increase  in  in tr a c e llu la r  calcium .
On th e  o th er  hand, sa lb u ta m o l, a s p e c i f i c  p. 2 a d ren o recep to r  
a g o n ist, reduced PGI2 sy n th esis  by th e 20 day rat pregnant myometrium. 
Although propranolol tended to  reduce PGI2 sy n th es is , salbutam ol d id  not 
reduce s y n th e s is  fu r th e r  t o  th o se  l e v e l s  see n  w ith o u t p r o p r a n o lo l,  
in d ica tin g  receptor antagonism. However salbutam ol d id  not in h ib it  PGI2 
sy n th es is  by myometria from 19 day pregnant ra ts . Salbutamol reduced th e  
s y n t h e s is  o f  PGI2 in  th e  day 21 m yom etria t o  th a t  seen  on day 19 o f  
pregnancy. T h is co u ld  in d ic a t e  e i t h e r  an a c t io n  on s t im u la te d  PGI2 
s y n t h e s is  in  th e  o e s tr o g e n  dom inated myometrium or be a r e s u l t  o f  an  
in crease in  p receptor dependent cAMP production which i s  known to  
occu r in  l a t e  pregnancy (Rinard & Chew, 197 8 ). S in ce  r e la x in  and 
h is ta m in e , both  u te r in e  r e la x a n ts  (P o r ter , Downing, & Bradshaw, 197 9; 
Kameswaran e t  a l . ,  1 9 6 2 ), reduced PGI2 s y n t h e s is  by r a t  19 day  
p regnant myometrium (El T ahir e t  a l . ,  1983) i t  would seem th a t  th e  
la t t e r  i s  true.
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The in t r a c e l lu la r  e v e n ts  fo l lo w in g  b e ta  r ec e p to r  a c t iv  a t io n  a re  
w e ll known (Schultz & Jacobs, 1982). p 2 ad ren o recep to r  s t im u la t io n  
r e s u l t s  in  th e  r e la x a t io n  o f  th e  n on -p regn an t r a t  u ter u s  w hich  i s  
a n ta g o n ised  by p ro p ra n o lo l and t o  a much l e s s e r  e x te n t  p r a c t o lo l  
(Wasserman & Levy, 1972). U terine cAMP le v e l s  in crease  on ad m in istration  
o f  is o p r e n a lin e  w hich  i s  b lo ck ed  by p r o p ra n o lo l;  p o t e n t ia te d  by 
th e o p h y ll in e  and m im icked by dibutyryl-cA M P (R obinson, B utcher & 
Sutherland, 1968). Adrenaline and dibutyryl-cAMP both in h ib it  oxytocin  
induced con traction s (Triner, Overweg & Natas, 1970) w h ils t  d ib u ty ry l-  
cAMP a b o lish es  calcium -induced con traction s (Mitznegg, Heim & M eythaler, 
1970). Such s t im u la t io n  o f  P 2 r e c e p to r s  o f  th e  r a t  u te r u s  i s  
accom panied by a p a r a l l e l  in c r e a s e  in  th e  in t r a c e l lu la r  cAMP b in d in g  
(Harbon, Do Khac & V e s in , 1976) and p r o te in  k in a se  a c t iv a t io n  (Harbon, 
V esin , Khac & L eiber, 197 8).
Vascular tone i s  con tro lled  in  a s im ila r  manner (Bohr, Greenberg & 
Bonaccarsi, 1978). Hydralazine, a p o te n t  h y p o te n s iv e  a g en t (W ilk in so n , 
Backman & Hecht, 1952) was a lso  found to  in h ib it  pregnant ra t myométrial 
PGI2 sy n th es is . The fa c t  th a t hydralazine has been reported to  re lax  rat 
myometrium a t  concentrations over ' 10”^M (Worcel, Saiag & C hevillard ,
1980) and i s  th era p eu tica lly  b e n e f ic ia l  as a to c o ly t ic  in  pre-eclam ptic  
p a tien ts  (Bowman & Rand, 1980) as w e ll as a l^ o t e n s iv e  agent supports 
th e  t h e s i s  th a t  u t e r in e  r e la x a n ts  red uce PGI2 s y n t h e s is  by th e  r a t  
pregnant myometrium.
Thus o x y to c ic  drugs would reduce in tr a c e llu la r  cAMP v ia  receptor- 
m ed ia ted  in h ib i t io n  o f  a d e n y la te  c y c la s e ,  and in c r e a s e  in t r a c e l lu la r  
ca lc iu m  r e s u lt in g  in  a c t iv a t io n  o f  PLA2 , PG r e le a s e  and m yom étria l 
contraction . Indeed, in h ib it io n  o f cyclo-oxygenase reduces th e oxytocic
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e ff ic a c y  o f oxytocin  (Vane & W illiam s, 197 3 ), angioten sin  II  (Baudouin- 
L egros e t  a l . ,  1974) and 5-HT (S o rren tin o  e t  a l . ,  1972). Drugs w hich  
reduce u te r in e  c o n t r a c t i l i t y  would a c t  in  th e  r e v e r se  manner by 
in creasin g  in tr a c e llu la r  cAMP.
Further e v id en ce  fo r  th e  in v o lv em en t o f  cAMP in  r e g u la t in g  
m yom étr ia l PGI2 s y n t h e s is  com es from  th e  o b se r v a t io n  th a t  f o r s k o l in  
in h ib it e d  p regn an t r a t  m yom étr ia l PGI2 s y n t h e s is .  F o r sk o lin  i s  a 
diterpene which s e le c t iv e ly  a c t iv a te s  a s u b -u n it  o f  a d e n y la te  c y c la s e  
(Seaman & D aly , 197 9 ). A lthough i t s  a c t io n  on r a t  myometrium has n o t  
been r ep o r ted , th e r e  a re  r e p o r ts  th a t  f o r s k o l in  has sm ooth m u sc le  
relaxan t a c t iv i t y  (Seaman & Daly, 1983).
I t  i s  generally  a c ce p ted  th a t  sm ooth m u sc le  c e l l  a c t iv a t io n  i s  
accom panied by a r i s e  in  c y to p la s m ic  ca lc iu m  from 10”  ^ t o  10”  ^ m olar. 
PLA2 i s  gen era lly  a c tiv a ted  by m illim o la r  concentrations o f calcium  (see  
van den Bosch, 1980) w h ils t  PLC responds to  micromolar concen trations  
(Mauko, Chap & D ouste-Blazy, 1979; A llan & M itch e ll, 1974). PLZ^  however 
could be activ a ted  b y  calm odulin (Wong & Cheung, 1979; Walenga, Opas & 
F e in s t e in ,  1981) w h i l s t  PLC i s  n o t (Walenga e t  a l . ,  1981). C alm odulin  
present in  u terin e  muscle (Grand & Perry, 197 8) could thus increase th e  
a c t iv i t y  o f lower concentrations o f calcium  in  s tim u la tin g  u ter in e  PLA2 .
A recent, though co n tro v ers ia l, hypothesis for  receptor co n tro lled  
r e le a s e  o f  AA from g ly c e r o p h o sp h o lip id s  in v o lv e s  th e  co n cep t o f  th e  
in c r e a s e  in  PI tu rn over  and PLC a c t iv a t io n  (L ap etin a , 1982; Chap, 
L affont, Lensta, Mauco, P erret, P la tav id , Simon, Thomas & D ouste-B lazy, 
1983) and has been ch aracterised  m ainly using p la t e le t s .
Ihe a c tiv a tio n  o f  PLC r e s u lt s  in  the form ation o f 1,2 ,d ia c y lg ly c e ro l  
from PI. The a c tio n  o f 1 ,2  ,d ia c y lg ly c e ro l k inase forms PA and lyso-PA  
from 1 ,2 ,d ia cy lg ly cero l before and a fte r  th e actio n  o f l ip a se s . PA and
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lysoPA  a re  both  ca lc iu m  ion op h ores and r e le a s e  ca lc iu m  from c a r d ia c  
sarcoplasm ic reticulum  (Limas, 1980) and p l a t e l e t  membrane f r a c t io n s  
(G errard, B u t le r , P e te r se n  & W h ite, 1976) w h i l s t  th ey  a l s o  cau se  
p la t e le t  aggregation (Benton, Gerrard, M ichiel & Kindom, 1982; Tokunua, 
Fukuzawa, Isob & Tsukatani, 1981) and may m ediate con traction  in  smooth 
m uscle (Salmon & Honeyman, 1980). Since they p o ssess  th ese  p ro p er tie s , 
PA and lysoPA  may s t im u la t e  th e  l ib e r a t io n  o f  AA v ia  a c t iv a t in g  PLA2 
(Z^itz-C astro, Cruz, Mas & Ja in , 1981; Lapetina, B illa h  & Cuatrecasas,
1981) and m im ic ca lm o d u lin  (N ig g l i ,  Z\dunyah & C a r a fo l i ,  1981). 
D ifferen ces in  t is s u e s  may e x is t  s in ce  a c tiv a tio n  o f PI s p e c if ic  PLA2 by 
bradykinin in  p ig  a o r tic  en d o th e lia l c e l l s  precedes th a t o f PLC (Hong & 
Deykin, 1982). However care must be taken in  in terp retin g  th ese  r e s u lt s  
s in c e  a t  has r e c e n t ly  been  shown th a t  PA d eg ra d a tio n  p ro d u cts  may 
m ed ia te  PA-induced r e le a s e  o f  Ca"*"^  from  PC lip o so m e s  (Holmes & Y oss,
1983).
I t  i s  in t e r e s t in g  t o  n o te  th a t  human am nion, ch o r io n  la e v a e  and 
d e c id u a  v e r a  c o n t a in  PI s p e c i f i c  PLC (D iR en zo , e t  a l . ,  1 9 8 1 ) ,  
1 ,2 ,d ia cy lg ly cero l l ip a se  (Okazaki, Sagawa, Okita, B leasedale , MacDonald 
& Johnstone, 1981) and 1 ,2 -d ia cy lg ly ce r o l k inase (Okita, Sagawa, Casey & 
Snyder, 1983). PI and PE are both reduced in  labour in  women, PE more so  
than PI (Okita, MacDonald & Johnston, 1980) th erefore  th e  r e le a se  o f PA 
in t o  th e  a m n io tic  f l u i d  a t  term  (MacDonald, e t  a l . ,  197 4) a r i s e s  from  
e i t h e r  t h e  a c t i v a t i o n  o f  PLA2 a l o n e  o r  w i t h  PLC. S i n c e  
1 ,2  , d i a c y l g l y c e r o l  i s  r e l e a s e d  i n t o  t h e  a m n io t ic  f l u i d  during  
p a rtu r it io n  i t  would be o f in te r e s t  to  observe PA le v e l s  and co rre la te  
t h is  w ith  PA re lea se .
The c o n t r a d i c t  ory a c t i o n s  o f  t h e  v a s o d i la t o r s  d ip y r id a m o le
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(increase) and hydralazine (decrease) on ra t myométrial PGI2 sy n th esis  
a re  p u z z lin g  s in c e  both  drugs have many a s p e c t s  in  common. Both  
s tim u la te  a o r tic  PGI2 sy n th es is  (Greenwald, Wong, Alexander & Bianchine,
1980); e x h ib i t  a n t i-p h o s p h o d ie s te r a s e  a c t i v i t y  (M ills  & S m ith , 1971; 
In a to m i, Takoyonaki & T akagi, 197 5); p o s s e s s  a n t i - p l a t e l e t  a c t i v i t y  
(Bologna, 1972; P f is te r  & Imhof, 1979); in h ib it  p la t e le t  TXA2 sy n th es is  
(Greenwald, Wong, Rao, Bianchine & Panganamale, 1979) and s tim u la te  PGI2 
p ro d u ctio n  by v a sc u la r  sm ooth m u scle  c e l l s  (van de V e ld e , B u lt ,  
W eisenb erger & Herman, 1982; D yer, H u ttn er , Tan & Mulrow, 198 1 ). 
H yd ralazin e  s t im u la t e s  th e  s y n t h e s is  o f  v a s o d ila to r y  PGs in  t i s s u e s  
o th er  than  th e  u te r u s , such a s  r a t  a o r ta , b ra in  and r en a l m ed u lla  
(Taube, H auser, Duneman & F o e r s te r , 197 8 ). B ecause o f  th e s e  a c t io n s  
th e s e  w orkers a s c r ib e  a r o le  fo r  PGI2 in  th e  v a s o d ila to r y  and a n t i ­
hypertensive a c tio n s o f th ese  drugs.
T his d i f f e r e n c e  m ust be found in  t h e ir  mechanism o f  a c t io n  and 
whether th ese  drugs are a ffe c t in g  the same pool o f enzymes involved in  
PGI2 s y n t h e s is .  A d ir e c t  com parison  o f  th e  e f f e c t  o f  d ip y r id a m o le  and 
h y d ra la z in e  on th e  m etab o lism  o f  exogenous AA by r a t  lun g and a o r ta  
show s th a t  w h ile  d ip y r id a m o le  s t im u la t e s  6-oxo-PGFj^ re lea se  by both 
t i s s u e s ,  h y d ra la z in e  i n h ib i t s  lu n g  s y n t h e s is  and te n d s  t o  s t im u la te  
a o r t i c  G-oxo-PGF^^^ r e l e a s e  ( S r iv a s t a v a  & A lw a c h i ,  1 9 8 3 ) .  T h is  
i l l u s t r a t e s  th a t  th e r e  a re  t i s s u e  d i f f e r e n c e s  in  th e  a c t io n  o f  th e s e  
drugs on AA metabolism .
H yd ra lazin e  has been rep o rted  t o  ca u se  an a ccu m u la tio n  o f  cAMP in  
r a b b it  a o r t ic  t i s s u e  (A ndersson, 1973) and red u ces ca lc iu m  uptake by 
v a s c u la r  t i s s u e  (M clea n , du S o u ic h , B arron  & B r ig g s ,  197 8 ) .  
Noradrenaline -induced re lea se  o f in tr a c e llu la r  calcium  i s  a lso  reduced 
in  th e  p resen ce  o f  h y d ra la z in e  (M clean, B arron, du S o u ich , H aegele ,
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McNay, Carrier & B riggs, 1978) and would exp la in  th e reduction o f  PGI2 
sy n th es is  b y  pregnant ra t myometrium by hydralazine.
The actio n  o f dipyridam ole on PG sy n th es is  has been pursued s in c e  i t  
was found to  s tim u la te  PGI2 sy n th es is  in  th e  human forearm (M asotti e t  
a l . ,  1979). At a concentration  o f lOOuM, dipyridam ole stim u la te s  cyclo^  
oxygenase and th e  co n v e rs io n  o f  PGH2 t o  PGE2 by a o r t i c  m icrosom es  
(M entz, P on ick e , B lo ck , B la s s ,  G e is s le r  & F o r s te r , 1 980). T h is i s  
su p p o sed ly  u n r e la te d  t o  i t s  a n t i -o x id a n t  a c t i v i t y  (M o risa k i, S t i t t s ,  
B a r te ls -T o m e i, M ilo , Panganamala & C o rn w ell, 1982) or i t s  a n t i ­
phosphodiesterase a c t iv i t y  s in ce  th ese  enzymes are un affected  by c y c l ic  
n u cleo tid es .
There have been no r e p o r ts  o f  a d ir e c t  e f f e c t  o f  d ip y r id a m o le  on 
PILA2 a c t iv i t y  however. In d irect evidence comes from observations th a t  
dipyridam ole stim u la te s  PGI2 sy n th es is  from endogenous AA by u m b ilica l 
v e s s e l s  (Menta, Menta & H at, 1980) human forearm  (M a so tti e t  a l . ,  
197 9 ) , and r a t  a o r ta  (van de V eld  e t  a l . ,  1982). A lthough i t  has been  
shown th a t  drugs such  a s  throm bin and b rad y k in in  s t im u la t e  3T3 
f i b r o b l a s t  c y c lo - o x y g e n a s e  in  a m anner w h ic h  ca n  c o n t r ib u t e  
s ig n if ic a n t ly  to  the stim u la tio n  o f PG sy n th es is  (Bonser, Cgandrebose & 
Cuatrecasas, 1980), t h is  e f f e c t  has no a c tio n  w ithout th e induction  o f  
PLA2 to  re lea se  excess  q u a n tit ie s  o f AA.
The issu e  i s  further com plicated by th e  fin d in g  th a t th e stim u la tio n  
o f PGI2 sy n th es is  o f the pregnant ra t myometrium was not susta in ed  by 
dipyridam ole a t  400uM. This reduction in  s tim u la tio n  could in d ica te  an 
in h ib it io n  o f cyclo-oxygenase a t  th ese  concen trations as has been noted  
by B u lt , Herman & van de V elde (1982). A nother fa c to r  w hich cou ld  
con trib u te to  t h is  reduction o f PGI2 sy n th es is  a t  high concentrations of
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d ip y r id a m o le  i s  th e  a c t io n  o f  th e  v e h ic l e ,  e th a n o l. E thanol reduced  
b asal sy n th es is  a t  a l l  co n cen tra tio n s  u sed . E than ol a d m in is tr a t io n  in  
prem ature labour in  women i s  t o c o l y t i c  (Fuchs, Fuchs, P p b le te  & R isk , 
1961) and has been found to  a c t on th e myométrial membrane to  reduce th e  
e f f e c t  o f oxytocin  (Mantel 1 & L igg in s, 1970).
I t  m ust be n o ted  th a t  in  a l l  th e  ex p er im en ts  u s in g  u t e r in e  
s t im u la n ts  and r e la x a n ts ,  r e l a t i v e l y  h ig h  c o n c e n tr a t io n s  w ere used  
compared to  those required to  in h ib it  or s tim u la te  u ter in e  c o n tr a c t i l i ty  
in  v itr o . I h is  may be a r e s u lt  o f d iffe re n c e s  in  th e p h y sio lo g ica l s ta te  
of the preparation and th e  fa c t  th a t th e  PG sy n th esis in g  cap acity  o f th e  
t i s s u e s  was s tu d ie d  a s  opposed t o  PG c o n te n t . The a l t e r a t io n  o f  PGI2 
production i s  not a s  a r e s u lt  o f membrane d is to r t io n  as a r e s u lt  o f  drug 
tr e a tm e n t s in c e  PGF2^, a p o te n t  u t e r in e  s t im u la n t ,  d oes n o t a f f e c t  
myom étrial PGI2 output (W illiam s & El Tahir, 1978b).
The w hole u te r u s  c o n s i s t s  o f  tw o t i s s u e s ,  th e  myometrium and 
deciduum. Ihe e f f e c t s  o f any drugs would depend on th e in ter r e la t io n sh ip  
o f the two and r e la t iv e  e f f e c t s  o f th e  drugs on th e two. The re lea se  o f  
PGs by th e  tw o f r a c t io n s  d i f f e r s .  The d is t r ib u t io n  o f  PLA2 w ith in  th e  
pregnant rat uterus was not found to  be homogeneous. Hie decidua, which 
c o n s i s t s  o f  l e s s  th an  30% o f  th e  w hole  t i s s u e ,  c o n ta in ed  57% o f  th e  
t o t a l  u ter in e  PLA2 a c t iv ity .  A s im ila r  d is tr ib u tio n  o f PLA2 a c t iv i t y  has 
been rep o rted  fo r  both  human and o v in e  u te r in e  t i s s u e s  (G rieves & 
L ig g in s , 1976). The d ecid u a  c o n ta in s  h ig h er  l e v e l s  o f  AA th an  th e  
myometrium ( F i l s h ie  and A n stey , 197 8) and has th e  a b i l i t y  t o  r e le a s e  
su b sta n tia l q u a n tit ie s  o f PGF, PGD and PGE (W illiam s & Downing, 1977). 
Abel and K elly  (1979) provided evidence th a t th e  endometrium o f th e  non­
pregnant human u te r u s  d on ates AA t o  th e  myometrium fo r  m eta b o lism  t o  
PGI2 a t  th e c o st  o f PGF and PGE sy n th es is . However i t  must be noted th a t
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S t im u la t io n  o f  PGI2 r e le a s e  from th e  human myometrium by PLA2 and AA 
r e s u lt e d  in  s y n t h e s is  e q u iv a le n t  t o  th a t  o f  th e  40 week pregnant 
myometrium, and not more. This su ggests  th a t donation o f AA would only  
a f f e c t  PGI2 sy n th es is  up to  th e  th ir ty  n inth  week o f pregnancy. Evidence 
fo r  th e  d o n a tio n  o f  AA by th e  d ec id u a  t o  th e  myometrium has n o t  been  
found in  th e  pregnan t r a t  (El T ahir & W illia m s , 1 9 8 1 ), in  f a c t  th e  
o p p o s ite  was rep o rted  t o  o c cu r , i . e .  m yom étria l PGI2 s y n t h e s is  was 
in h ib ited  by a p la te le t-d e r iv e d  lipoxygenase product released  from the  
d ec id u a . A fte r  rem oval o f  trapped  b lood  e le m e n ts  th e r e  was no 
stim u la tio n  o f myométrial PG%2 sy n th es is  by th e decidua. Campos, L iggins  
and Seamark (1982) have con firm ed  t h a t  th e r e  i s  no AA d o n a tio n  by th e  
d ecid uu m  in  th e  r a t .  They s e p a r a te ly  su p er fu sed  e n d o m etr ia l and 
myométrial layers in  th e whole non-pregnant rat uterus and assayed the  
PG content w ith in  th e superfusate. PGF and 6-oxo-PGFj^ production from 
both layers was the same whether togeth er or separate. Hie myometrium 
r e le a se s  l i t t l e  PGF but su b sta n tia l amounts o f  th e  weak o x y to c ic , PGI2 
w h ils t  th e deciduum re lea ses  su b sta n tia l PGF w ith  l i t t l e  PGI2 .
Hie considerab le r e le a se  o f  AA by decidual PLA2 in  comparison to  the  
myometrium, and i t s  c lo se  proxim ity to  th e  myometrium, could r e s u lt  in  
the donation o f oxy toc ic  PGs to  th e myometrium. Hie a c tio n  o f oxytocin  , 
for example, would thus be compounded sev era l fo ld  s in ce  i t  s tim u la tes  
both  d e c id u a l PGF and PG%2 , and m yom étr ia l PGI2 s y n t h e s is  in  th e  
pregnant ra t (Campos e t  a l . ,  1982) and both PGs p o ten tia te  th e actio n  
o f oxytocin  (W illiam s e t  a l . ,  1978).
This may be i l lu s tr a te d  more c le a r ly  in  the human pregnant uterus. 
Ergometrine and oxytocin  did  not a f f e c t  human pregnant myom étrial PGI2 
s y n t h e s is .  I t  has a l s o  been shown th a t  o x y to c in  d oes n o t a f f e c t  PGE or
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PGF r e le a se  by la t e  pregnant myonetrium (Fuchs, H usslein & Fuchs, 1981), 
even though th e  myometrium and deciduum p o s s e s s  o x y to c in  r e c e p to r s  
(Fuchs, Fuchs, H e ss le in  & S o l o f f ,  198 1 ). S in ce  th e  d ec id u a  i s  a 
su b sta n tia l source o f PG production (as w e ll  as th e amnion [Schwartz e t  
a l . ,  197 5 ] ) ,  PGs m ust be don ated  t o  th e  myometrium t o  e x e r t  t h e ir  
a c tio n s .
The q u e s t io n  o f  th e  r o le  o f  th e  PGI2 s y n th e s is e d  by th e  r a t  and 
human pregnant myometrium now a r i s e s .  The d i f f e r e n c e s  in  th e  am ounts 
r e le a s e d , a c t io n  on u t e r in e  c o n t r a c t i l i t y  and th e  a c t io n  o f  o x y to c ic  
drugs on the amount re lea sed , in d ica te  a d ifferen ce  in  th e r o le  o f  PGI2 
between th e two sp ec ie s .
The su b sta n tia l increase in  PGI2 sy n th es is  w ith  th e  g e s ta tio n a l age 
o f  th e  r a t  c r e a te s  l e v e l s  g r e a te r  than  th o se  o f  PGF, PGE and TXB2 
(Wilson e t  a l . ,  1982). This in crease  i s  probably myométrial in  nature 
w ith  l i t t l e  or no con trib u tion  from vascu lar sources (W illiam s e t  a l . ,  
1978). The presence o f a mechanism for th e s tim u la tio n  and in h ib it io n  o f  
sy n th es is  by oxy toc ic  and to c o ly t ic  drugs, coupled w ith  th e a b i l i t y  o f  
PGI2 t o  p o t e n t ia t e  th e  u te r o to n ic  a c t i v i t i e s  o f  PGF and o x y to c in  
c e r t a in ly  s u g g e s ts  a r o le  o f  PGI2 in  r e g u la t in g  u te r in e  to n e  o f  th e  
pregnant ra t a t  term. The lack  o f such a mechanism and th e poor b ip h asic  
stim u lan t and relaxan t a c tio n s , coupled w ith  comparably low sy n th etic  
c a p a c ity ,  s u g g e s ts  th a t  such an a c t io n  i s  un im p ortan t in  th e  pregn an t 
human myometrium. However th e  p o te n t  a n t i-a g g r e g a to r y  and v a s o a c t iv e  
p ro p erties  o f PG%2 cannot be ignored.
An in tera c tio n  between th e proaggregatory substance TXA2 released  by 
p l a t e l e t s  and in t im a i  t i s s u e  o f  v e s s e l s ,  and PGI2 r e le a s e d  by th e  
endothelium i s  sa id  to  e x is t  (Moncada & Vane, 1980). I t  has alreacfy been 
n oted  th a t  e x c e s s iv e  m en stru a l b lood  l o s s  i s  a s s o c ia te d  w ith  a h igh
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production o f PGI2 by the endometrium (Smith, K elly , Abel & Baird, 1981) 
which could r e su lt  in  v a so d ila ta tio n  and reduced p la t e le t  a g g reg a b ility  
leading to  increased b leeding.
There i s  an in c r e a s e  in  p l a t e l e t  a g g r e g a b i l i t y  (Kunze, B r i e l ,  
Kunze & S c h l o t t e r ,  197 5) a s  w e l l  a s  TXA2 r e l e a s e  by p l a t e l e t s  
(Ylikorkala & V iin ik a , 1980) w ith  the progression  o f human pregnancy and 
a r ed u c tio n  in  th e  s e n s i t i v i t y  o f  p l a t e l e t s  t o  PGI2 in  l a t e  pregnancy  
(B r ie l  & L ip p e r t, 1981 ). Throm boem bolic c o m p lic a t io n s  a re  a l s o  more 
common post-partum as opposed to  p r e -  and p er i-p a r tu m  ( B e l le r ,  1 9 6 8 ), 
when th e  myometrium has a reduced c a p a b ility  for PGI2 sy n th esis .
C ir c u m sta n tia l ev id en ce  th a t  PGI2 i s  im p ortan t in  c o n tr o llin g
u t e r o -p la c e n t a l  h a e m o sta s is  in  th e  human p r im a r ily  r e v o lv e s  around  
during
observations taken pre-eclam psia. Pre-eclam psia i s  ch aracterised  by 
an in c r e a s e  in  m atern a l b lood  p r e ssu r e  and in tr a v a s c u la r  c o a g u la t io n  
during the th ird  tr im ester , to  such an ex ten t as to  threaten  the l i f e  o f  
th e  c h i ld  s in c e  u t e r o -p la c e n t a l  b lood  f lo w  i s  s e v e r e ly  d ep ressed . The 
c o n d it io n , i f  l e f t  u n tr e a te d , can d e v e lo p  in t o  e c la m p sia  w hich  i s  
ch aracterised  ty  a fu rther r is e  in  blood p ressure, convu lsion s, abruptio  
p la c e n ta e  and d ea th . P r e -e c la m p sia  i s  a s s o c ia te d  w ith  p l a t e l e t  
d ep osition  in  th e u ter in e  and p la cen ta l vascu lar beds (Wardle, 1972). 
Trophoblastic invasion  o f sp ir a l and ra d ia l a r te r ie s  i s  reduced w ith  a 
c o n c o m itta n t c o n s t r ic t io n  o f  th e  r a d ia l  a r t e r i e s  a t  th e  d ec id u o -  
m yom etria l ju n c t io n  (R obertson, B rosen s & D ixon, 1976). T rop h o b la sts  
s y n th e s is e  PGI2 in  am ounts e q u iv a le n t  t o  e n d o t h e l ia l  c e l l s  and t h i s  
could account for  the lack o f p la t e le t  d ep o sition  and vascular d isea se  
in  th e s e  v e s s e l s  w hich do n ot p o s s e s s  e n d o t h e l ia l  c e l l s  in  l a t e  
pregnancy. F o e ta l v e s s e l s  s y n th e s is e  g r e a te r  am ounts o f  PGI2 than
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m atern a l v e s s e l s  (Rem uzzi, M is ia n i,  M uratore, M arches!, L iv io ,  
S c h ie p a t t i ,  Mecca, de G aetano & D o n a ti, 1979) w hich  i s  reduced in  
p r e ec la m p sia  (Rem uzzi, M arches!, Z oja, M uratore, M is ia n i, R o ss i ,  
Barbato, Capella, Donati & de Gaetano, 1980). Urinary excretion  o f 2 ,3 -  
dinor-^-oxo-PGF^Q and 1 5 -o x o -1 3 ,1 4 -d ih y d r 0 - 2 ,3 -dinor-ô-oxo-PGF^^ are  
a lso  reduced when compared to  norm otensive pregnant co n tro ls  (Goodman, 
K illa m , Brash & Branch, 198 2 ). A s in g le  c a se  stu d y  has rep o rted  th e  
p l a t e l e t  co u n ts  o f  a p r e e c la m p tic  woman and showed a d e c r e a se  in  th e  
maternal p la t e le t  count co in c id en t w ith  fo e ta l  death (Jespersen, 1980).
In v iew  o f  th e s e  and o th er  r e p o r ts  o f  reduced PGI2 s y n t h e s is  in  
pre-eclam p tic  p a t ien ts  i t  has been suggested th a t th ere  may be a causal 
l in k  betw een  th e  tw o (L ew is, 1 983 ). Indom ethacin  c e r t a in ly  red u ces  
u ter in e  blood flow  in  pregnant sheep (McLaughlin, Brennan & Chez, 197 8) 
and d o g s  (Tferragno e t  a l . , 197 4 ) .  The p r e g n a n t  dog u t e r u s  a l s o  
sy n th es ises  and re le a se s  PGI2 in  amounts which could a ttr ib u te  to  the  
con tro l o f u tero -p la cen ta l vascu lar tone (Gerber, Payne, Murphy & N ies,
1981) e s p e c i a l l y  s in c e  th e  p la c e n t a l  bed has no n euronal c o n tr o l .  
Makila, Jou p ila , Kihonin, V iin ika and Y likorkala (1983) have shown th ere  
i s  a p o s i t i v e  c o r r e la t io n  b etw een  u m b ilic a l  b lood  f lo w  and PGI2 
form ation in  various d isea se  s ta te s  including pre-eclam psia.
As has a lr e a d y  been s u g g e s te d , p la c e n ta l  b lood  f lo w  co u ld  be 
a ffec te d  by myom étrial PGI2 r e le a se , as w e ll a s  haem ostasis. Hie a n t i­
a g g reg a to ry  a c t i v i t y  r e le a s e d  by th e  p la c e n ta  i t s e l f  th ough , was n o t  
PGI2 b u t an ADPase. T h is  ADPase i s  a l s o  r e le a s e d  in  v i t r o  by p la c e n ta l  
c e l l s  in  c u ltu r e  (Khoker, O i l i e r ,  Dandona, H utton & Lane, 1981). 
A lthough PGI2 i s  co n s id e re d  t o  be a m ajor f a c t o r  in  m a in ta in in g  
haem ostasis i t  must be remembered th a t donation o f  ADP by erythrocytes  
i s  a contribu ting  fa c to r  to  p la t e le t  aggregation in  whole blood and any
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re lea se  o f an ADPase may reduce t h is  cooperation (Born & K ratzer, 1982).
In summary, th e experim ents undertaken here show th a t th e  human 
and r a t  m yom etria s y n th e s is e  an a n t ia g g r e g a to r y  AA m e ta b o lit e ,  w ith  
p ro p erties  s im ila r  to  PGI2 . Hie human p lacenta  was found to  r e le a se  an 
anti-aggregatory  m ateria l which could be a ttr ib u ted  p a r tly  or w holly  to  
a f a c t o r  w ith  ADP-degrading p r o p e r t ie s .  The c a p a c ity  o f  th e  human 
myometrium in c r e a se d  over th e  th ir d  t r im e s te r  t o  term  in  a manner 
s im ila r  to  the r a t, but was found to  in h ib it  spontaneous c o n tr a c t i l i ty  
of th e human myometrium.
The cap acity  o f th e pregnant ra t myometrium to  sy n th es ise  PGI2 
co u ld  be m odulated  by r e c e p to r  a c t iv a t io n  by u te r in e  s t im u la n ts  and 
relaxan ts which may be mediated in  turn by myométrial adenylate cy c la se  
a c t i v i t y .  U te r in e  s t im u la n ts  d id  n o t  a l t e r  th e  c a p a c ity  o f  th e  human 
myometrium to  sy n th es ise  PGI2 .
Phospholipase A2 a c t iv i ty  was described in  th e  pregnant ra t uterus 
w hich co u ld  p ro v id e  a fu r th e r  b a s is  fo r  r e se a rc h  in t o  th e  a c t io n  o f  
s te ro id s  or drugs on decidual and myométrial phospholipase A2 a c t iv ity  
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PRP P la te le t - r ic h  plasma
S olu tion  1 Tris-HCl (100 mMolar)
Solu tion  2 Tris-HCl (100 mMolar) + Hveen 80 (0.1%)
S o lu t io n  3 HEPES (50 mMolar) : HEPES (50 mMolar) + 0.2% T r ito n  
XlOO: 0 .25  M olar sucrose^ (5:3:1 .7 )
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